US20050103624A1 - Biosensor and method of making - Google Patents
Biosensor and method of making Download PDFInfo
- Publication number
- US20050103624A1 US20050103624A1 US10/871,937 US87193704A US2005103624A1 US 20050103624 A1 US20050103624 A1 US 20050103624A1 US 87193704 A US87193704 A US 87193704A US 2005103624 A1 US2005103624 A1 US 2005103624A1
- Authority
- US
- United States
- Prior art keywords
- electrode
- biosensor
- gap
- distance
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
- H05K3/00—Apparatus or processes for manufacturing printed circuits
- H05K3/02—Apparatus or processes for manufacturing printed circuits in which the conductive material is applied to the surface of the insulating support and is thereafter removed from such areas of the surface which are not intended for current conducting or shielding
- H05K3/027—Apparatus or processes for manufacturing printed circuits in which the conductive material is applied to the surface of the insulating support and is thereafter removed from such areas of the surface which are not intended for current conducting or shielding the conductive material being removed by irradiation, e.g. by photons, alpha or beta particles
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
- H05K1/00—Printed circuits
- H05K1/02—Details
- H05K1/03—Use of materials for the substrate
- H05K1/0393—Flexible materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
- Y10T29/49117—Conductor or circuit manufacturing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
- Y10T29/49117—Conductor or circuit manufacturing
- Y10T29/49124—On flat or curved insulated base, e.g., printed circuit, etc.
- Y10T29/49155—Manufacturing circuit on or in base
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
- Y10T29/49117—Conductor or circuit manufacturing
- Y10T29/49124—On flat or curved insulated base, e.g., printed circuit, etc.
- Y10T29/49155—Manufacturing circuit on or in base
- Y10T29/49156—Manufacturing circuit on or in base with selective destruction of conductive paths
Definitions
- the present invention relates to a method of making a biosensor, more specifically a biosensor having electrode sets formed by laser ablation.
- Electrochemical biosensors are well known and have been used to determine the concentration of various analytes from biological samples, particularly from blood. Examples of such electrochemical biosensors are described in U.S. Pat. Nos. 5,413,690; 5,762,770 and 5,798,031; and 6,129,823 each of which is hereby incorporated by reference.
- electrochemical biosensors It is desirable for electrochemical biosensors to be able to analyze analytes using as small a sample as possible, and it is therefore necessary to minimize the size of their parts, including the electrodes, as much as possible.
- screen-printing, laser scribing, and photolithography techniques have been used to form miniaturized electrodes.
- Electrodes formed by screen-printing techniques are formed from compositions that are both electrically conductive and screen-printable. Furthermore, screen printing is a wet chemical technique that generally allows reliable formation of structures and patterns having a gap width or feature size of approximately 75 ⁇ m or greater. Such techniques are well known to those of ordinary skill in the art.
- Laser scribing is a technique that usually uses a high power excimer laser, such as a krypton-fluoride excimer laser with an illumination wavelength of 248 nm, to etch or scribe individual lines in the conductive surface material and to provide insulating gaps between residual conductive material which forms electrodes and other desired components.
- a high power excimer laser such as a krypton-fluoride excimer laser with an illumination wavelength of 248 nm
- This scribing is accomplished by moving the laser beam across the surface to be ablated.
- the scribing beam generally has a relatively small, focused size and shape, which is smaller than the features desired for the product, and the formation of the product therefore requires rastering techniques.
- Such a technique can be rather time consuming if a complex electrode pattern is to be formed on the surface. Further, the precision of the resulting edge is rather limited.
- the present invention provides an electrochemical biosensor with electrode elements that possess smooth, high-quality edges. These smooth edges define gaps between electrodes, electrode traces and contact pads. Due to the remarkable edge smoothness achieved with the present invention, the gaps can be quite small, the advantages of which are described below. Further, the present invention provides a novel biosensor production method in which entire electrode patterns for the inventive biosensors can be formed all at one, in nanoseconds—irrespective of the complexity of the electrode patterns or the amount of conductive material that must be ablated to form them.
- the present invention provides a biosensor comprising a base substrate having first and second electrode elements formed thereon.
- the first and second electrode elements have first and second respective edges defining a gap therebetween.
- the gap has a width and a length.
- the first edge is spaced by a first distance from a first “theoretical line” that corresponds to the desired or ideal shape and location of the first edge. This first distance varies along the length of the gap because the edge actually produced is not as smooth or perfect as the desired theoretical line.
- the standard deviation of the first distance is less than about 6 ⁇ m over the entire length of the gap.
- the biosensor also includes a reagent at least partially covering the base substrate and one or more layers overlying and adhered to the base substrate. The one or more layers cooperate to form a sample-receiving chamber and a cover for the biosensor, and at least a portion of both the reagent and an electrode are positioned in the chamber.
- the actual or real deviation of the edge from the theoretical line is no more than about 6 ⁇ m along the entire length of the gap.
- the distance between the edge actually produced and the theoretical line (if the edge were perfect) is less than 6 ⁇ m no matter where along the gap the distance is measured.
- the real deviation is less than about 4 ⁇ m, most preferably less than about 2 ⁇ m.
- the width of the features of the electrical pattern such as electrode fingers or traces can be as narrow as about 10 ⁇ m.
- the close spacing of electrode components allowed by the present invention in turn allows a greater number of electrode elements and thus greater functionality in a smaller area.
- the smoothness or quality of the edges is most important in areas of the biosensor where adjacent edges are positioned close to one another, e.g., the gap between two electrodes.
- the second edge is spaced from a second theoretical line by a second distance that varies along the length of the gap.
- the first and the second theoretical lines thus define a “theoretical gap” therebetween. If the production process were perfect, and if the edges were intended to be straight and parallel to one another, the theoretical gap width would be constant along its length. In practice, however, the actual gap width varies from the theoretical one along the length of the gap.
- Deviations from theoretical of the first and second edges can be compounded to produce larger variations in the actual gap width than are produced in either edge alone.
- the standard deviation of the second distance is less than about 6 ⁇ m over the entire length of the gap. More preferably, the standard deviation of both the first and second distances is less than about 2 ⁇ m, even more preferably, less than about 1 ⁇ m.
- the method comprises removing at least 10% of the conductive material, more preferably at least 50% of the conductive material, and most preferably at least 90% of the conductive material.
- the conductive material is preferably removed by broad field laser ablation, which allows relatively large percentages of the conductive layer to be removed from the base substrate very quickly to form electrode patterns.
- the entire electrode pattern for a biosensor is formed by broad field laser ablation in less than about 0.25 seconds, more preferably in less than about 50 nanoseconds, and most preferably in less than about 25 nanoseconds.
- the inventive method also allows for the placement of two or more electrode sets having different feature sizes in the same biosensor. Furthermore, as noted above, the feature sizes can be quite small and spaced close together.
- the present invention provides an efficient and fast method for mass producing biosensors having electrode patterns with the highly desirable smooth edges discussed above.
- a web of base substrate material having a metal conductive layer formed thereon is provided.
- An image of an electrode pattern is projected onto the metal conductive layer with a laser apparatus such that an electrode pattern that corresponds to the image is formed by laser ablation on the web of base substrate material.
- Either the laser apparatus or the web of base substrate material (or both) is moved and this process is repeated to produce many electrode patterns at spaced intervals along the web of base substrate material.
- a reagent is deposited on the web of base substrate material and at least partially covers each electrode pattern of the plurality of electrode patterns.
- At least one web of a covering layer or a spacing layer is laminated over the web of base substrate material, thereby forming a cover and a sample-receiving cavity for each biosensor.
- the resulting laminated web of layers is then cut into individual biosensors.
- the image projected by the laser apparatus is of the complete electrode pattern for one of the biosensors, such that the complete electrode pattern for each biosensor is formed in a single step with a single laser image.
- more than one entire electrode pattern is formed all at once; i.e., the image includes patterns for two or more biosensors.
- the electrode pattern includes at least two electrode sets having different feature sizes. Examples of this may include one set of electrodes for measuring analyte concentration and another set for detecting whether and when the biosensor has received an adequate dose of sample fluid.
- the inventive biosensor may also include electrode elements providing other features, such as biosensor identification, calibration or other information associated with the biosensor.
- One advantage of this inventive mass production process is that it is much faster than prior art processes that require forming electrode patterns by screen printing, lithography, rastering and the like.
- the entire electrode pattern for a biosensor can be formed all at once, in a single step, in only nanoseconds. This allows a continuous web of material from which the individual biosensors will ultimately be cut to be processed at speeds of 60 meters per minute or greater.
- the inventive process provides biosensors with electrode patterns whose edges have much better edge quality than prior art biosensors. Edge quality becomes increasingly important as electrode spacing becomes closer. Close electrode spacing is desirable because it generally increases the accuracy of the test result, reduces sample size, and yields a quicker test. Additionally, it allows a greater quantity of electrode elements and associated functionalities to be packed into a single biosensor.
- Yet another advantage of the inventive production method is that it allows a large percentage of the electrically conductive layer to be removed from the base substrate all at once.
- prior art rastering processes use a collimated laser beam that slowly scribes and removes only a thin line of conductive material, which is a much longer and less versatile process in comparison with the present invention.
- the manufacturing process of the present invention provides great freedom in the shape and variation in the electrode pattern produced in the inventive biosensors.
- Asymmetric or anisotropic electrode patterns do not present a problem with the manufacturing process of the present invention.
- the electrode pattern is preferably projected on the base substrate by a laser image formed by a mask, limitations as to size, shape, number of electrode patterns, gap width, etc. that are encountered with prior art processes are reduced.
- rastering processes are typically limited to movement of a focused laser beam along axes that are oriented 90 degrees relative to one another.
- the resulting patterns typically are limited to thin lines of the same width oriented parallel or perpendicular to one another.
- separate but adjacent conductive metal planes used to carry separate signals in a device can capacitively couple when the separation distance between the planes becomes very small resulting in signal degradation and interference between the planes.
- a method that allows removal of more conductive material between isolated traces therefore can be advantageous in minimizing such interference.
- electrically conductive material refers to a layer made of a material that is a conductor of electricity, non-limiting examples of which include a pure metal or alloys.
- electrically insulative material refers to a material that is a nonconductor of electricity.
- Electrode means a conductor that collects or emits electric charge and controls the movement of electrons.
- An electrode may include one or more elements attached to a common electrical trace and/or contact pad.
- the term “electrical component” means a constituent part of the biosensor that has electrical functionality.
- electrode system refers to an electrical component including at least one electrode, electrical traces and contacts that connect the element with a measuring instrument.
- electrode element refers to a constituent part of an electrode system. Specific non-limiting examples of electrode elements include electrodes, contact pads and electrode traces.
- electrode set is a grouping of at least two electrodes that cooperate with one another to measure the biosensor response.
- pattern means a design of one or more intentionally formed gaps, a non-limiting example of which is a single linear gap having a constant width. Not included in the term “pattern” are natural, unintentional defects.
- insulative pattern means a design of one or more intentionally formed gaps positioned within or between electrically insulative material(s). It is appreciated that electrically conductive material may form the one or more gaps.
- conductive pattern means a design of one or more intentionally formed gaps positioned within or between electrically conductive material(s). It is appreciated that exposed electrically insulative material may form the one or more gaps.
- microelectrode array means a group of microelectrodes having a predominantly spherical diffusional characteristic.
- microelectrode array means a group of macroelectrodes having a predominantly radial diffusional characteristic.
- electrode pattern means the relative configuration of the intentionally formed gaps situated between the elements of electrodes in an electrode set specifically or biosensor generally.
- electrode patterns include any configuration of microelectrode arrays, macroelectrode arrays or combinations thereof that are used to measure biosensor response.
- Electrode pattern may also refer to the shape and configuration of all electrical components that are formed on the biosensor.
- the phrase “feature size” is the smallest dimension of gaps or spaces found in a pattern.
- the feature size is the smallest dimension of electrically conductive gaps found within or between the electrically insulative material(s).
- the pattern is a conductive pattern
- the feature size is the smallest dimension of electrically insulative gaps found within or between the electrically conductive material(s). Therefore, in a conductive pattern the feature size represents the shortest distance between the corresponding edges of adjacent elements.
- interlaced means an electrode pattern wherein the elements of the electrodes are interwoven relative to one another.
- interlaced electrode patterns include electrodes having elements, which are interdigitated with one another.
- interlaced elements include a first electrode having a pair of elements and a second electrode having a single element received within the pair of elements of the first electrode.
- the term “ablating” means the removing of material.
- the term “ablating” is not intended to encompass and is distinguished from loosening, weakening or partially removing the material.
- Broad field laser ablation means the removal of material from a substrate using a laser having a laser beam with a dimension that is greater than the feature size of the formed pattern.
- Broad field ablation includes the use of a mask, pattern or other device intermediate a laser source and a substrate. The laser is projected through the mask, the latter of which forms an image of an electrode pattern which is projected onto and impinges on the substrate to create all or part of the electrode patterns on the substrate. Broad field laser ablation simultaneously creates the pattern over a significant area of the substrate.
- the use of broad field laser ablation avoids the need for rastering or other similar techniques that scribe or otherwise define the pattern by continuous movement of a relatively focused laser beam relative to the substrate.
- a non-limiting example of a process for broad field laser ablation is described below with reference to biosensor 210 .
- an electrode pattern means a geometric figure formed by a point moving in a first direction along a pre-determined linear or curved path and in a reverse direction along the same path.
- an electrode pattern includes various elements having edges that are defined by lines forming the perimeters of the conductive material. Such lines demarcating the edges have desired shapes, and it is a feature of the present invention that the smoothness of these edges is very high compared to the desired shape.
- Theoretical line refers to the desired or ideal shape and location of an edge of an electrode element that would be obtained if the manufacturing process were perfect. In most cases, if the edge is straight, the theoretical line will coincide with the average location of the edge.
- point means a dimensionless geometric object having no properties except location.
- the smoothness or quality of the edge of an electrode element can be defined by the distance that the placement of the edge differs from the theoretical line that represents the perfect or ideal edge. That is, the edge will be spaced from the theoretical line by a distance that varies along the length of the edge. This distance will range from zero to a maximum value.
- One useful way to define the quality or smoothness of an edge is to simply specify the maximum distance that the edge is spaced from the theoretical line over a specified length of the edge.
- the smoothness or quality of an edge can also be specified in terms of the “standard deviation” of the distance between the edge and the theoretical line over a specified length of the edge.
- the distance To calculate the standard deviation, the distance must be measured at discrete intervals along the length, as described in further detail herein. If the varying distance is denoted “d” and the number of data points is denoted n, then the standard deviation of the distance is calculated as ⁇ (d i ) 2 /(n ⁇ 1) ⁇ 1/2 . So that the equation just noted accurately approximates the integral equation from which it is derived, the intervals at which data points are taken should be spaced closely together. All standard deviations expressed herein are measured by taking data points that are spaced by no more than about 20 ⁇ m, preferably closer.
- the term “smoothness standard deviation,” when referring to an edge of an electrode element, refers to the standard deviation of the distance that the edge is spaced from a theoretical line over a specified length of the edge.
- the quality of a gap between electrode elements can be expressed in terms of the individual deviations or standard deviations of the two edges forming the gap from the theoretical lines corresponding to the two edges.
- biological fluid includes any bodily fluid in which the analyte can be measured, for example, interstitial fluid, dermal fluid, sweat, tears, urine, amniotic fluid, spinal fluid and blood.
- blood includes whole blood and its cell-free components, namely plasma and serum.
- working electrode is an electrode at which analyte, or product, is electrooxidized or electroreduced with or without the agency of a redox mediator.
- counter electrode refers to an electrode that is paired with the working electrode and through which passes an electrochemical current equal in magnitude and opposite in sign to the current passed through the working electrode.
- counter electrode is meant to include counter electrodes, which also function as reference electrodes (i.e., a counter/reference or auxiliary electrode).
- electrochemical biosensor means a device configured to detect the presence and/or measure the concentration of an analyte by way of electrochemical oxidation and reduction reactions within the biosensor. These reactions are transduced to an electrical signal that can be correlated to an amount or concentration of the analyte.
- FIG. 1 is a perspective view of a biosensor of the present invention
- FIG. 2 is an exploded assembly view of the biosensor of FIG. 1 ;
- FIG. 3 is an enlarged plan view of the biosensor of FIG. 1 showing a macroelectrode array and a microelectrode array;
- FIG. 4 is a diagram of the deviation of an edge of an electrode element from a theoretical or ideal line representing the desired shape and placement of the edge;
- FIG. 5 is a diagram of the deviation in gap width and placement resulting from the deviations in the two individual edges forming the gap
- FIG. 6 is an enlarged section of the microelectrode array of FIG. 3 ;
- FIG. 7 is a diagram of the deviation of an edge of an electrode element from a theoretical or ideal line representing the desired shape and placement of the edge;
- FIG. 8 illustrates a cross-section taken along lines 8 - 8 of FIG. 1 ;
- FIG. 9 illustrates a cross-section taken along lines 9 - 9 of FIG. 1 ;
- FIG. 10 is a graph showing the deviation from mean or theoretical of an electrode edge of the microelectrode array of FIG. 3 ;
- FIG. 11 is an exploded assembly view of a biosensor in accordance with another embodiment of the invention.
- FIG. 12 is an exploded assembly view of a biosensor in accordance with another embodiment of the invention.
- FIG. 13 is an exploded assembly view of a biosensor in accordance with another embodiment of the invention.
- FIG. 14 is an exploded assembly view of a biosensor in accordance with another embodiment of the invention.
- FIG. 15 is an exploded assembly view of a biosensor in accordance with another embodiment of the invention.
- FIG. 16 is an enlarged perspective view of a biosensor in accordance with another embodiment of the invention.
- FIG. 17 is a view of an ablation apparatus suitable for use with the present invention.
- FIG. 18 is a view of the laser ablation apparatus of FIG. 17 showing a second mask
- FIG. 19 is a view of an ablation apparatus suitable for use with the present invention.
- FIG. 20 is a schematic of an electrode set ribbon of the present invention.
- FIG. 21 is a photograph illustrating a biosensor substrate initially coated with a gold conductive layer from which approximately 10% of the conductive material has been removed;
- FIG. 22 is a photograph illustrating a biosensor substrate having an electrical pattern with a gap width of approximately 20 ⁇ m and where approximately 20% of the conductive material initially covering the substrate has been removed to form the electrical pattern;
- FIG. 23 is a photograph illustrating a biosensor substrate having an electrical pattern with a gap width of approximately 20 ⁇ m and where approximately 50% of the of a conductive material initially covering the substrate has been removed to form the electrical pattern;
- FIG. 24 is a photograph illustrating a biosensor substrate having an electrical pattern with a gap width of approximately 250 ⁇ m and where approximately 90% of the conductive material initially covering the substrate has been removed to form the electrical pattern.
- a biosensor in accordance with the present invention provides a surface with electrode patterns formed thereon, the electrode patterns preferably having a smooth edge quality. It is a particular aspect of the present invention that precise quality is obtained for the edges of the electrical components located on the biosensor. Having a smooth or high edge quality of the elements can contribute to greater precision, accuracy, and reproducibility of test results. Further, a smooth or high edge quality also allows for a great number of electrode arrays to be formed on a defined surface area of the biosensor. By increasing the edge quality of the elements, it is possible to increase the number of electrode elements and thus increase the achievable functionality in the defined surface area.
- These functions may include, for example: multiple measurement electrode pairs for simultaneous measurement of the same or different analytes, including by alternative means; electrodes used to provide correction factors for the basic measurement electrodes; electrodes for detecting dose application or sample sufficiency; multiple electrode traces to monitor electrode functioning or to provide detection or correction of defective traces; and multiple contact pads for coupling to the foregoing functionalities, or for providing additional features such as identification, calibration, or other information pertaining to the biosensor.
- the selected functionalities for a given biosensor can be provided in a smaller space when the high edge quality allows closer placement of the electrical components. It is a feature of the present invention to enable all of this, and more, in a manner that is relatively fast, reliable and cost effective.
- a biosensor of the present invention has electrical components with edges that are smooth and are precisely located.
- the precise locating of the smooth edge is important, particularly relative to a corresponding edge of another electrical component, and especially with respect to a paired element.
- the importance and the degree of quality of a component's edge quality and placement will vary with the nature of the component.
- the edge smoothness and placement are important for the quality of the electrochemical results obtained by use of the macroelectrodes.
- One factor in the accuracy of such a test is the reproducibility of the area of each macroelectrode. Obtaining precise edge smoothness and placement will yield an area which is highly accurate.
- Another factor in the use of macroelectrodes is the placement of one of the electrodes relative to the other, e.g., the position of the counter element(s) in relationship to the position of the working element(s).
- biosensors are generally operated based on calibration methods that rely on the reproducibility of the sizes and locations of the measuring electrodes, the ability to consistently produce lots of such tests trips can enhance the results achieved with the tests.
- the edge smoothness and placement contribute to the results obtained from microelectrodes.
- the issues can be magnified because of the number and relatively close placement of the numerous microelements. Poor edge quality can greatly affect the operating characteristics of microelectrodes, and the present invention helps to overcome this potential problem.
- an advantage of placing microelements in close proximity is the rapid establishment of steady-state operation. High edge quality and precise edge placement enables closer placement of the elements and in turn faster achievement of steady-state operation. In addition, such closer placement allows for a greater number of microelements to be placed in a given space.
- the present invention provides a high quality edge for the various electrical components on a biosensor.
- the quality of the edge relates to the smoothness or uniformity of the edge relative to a theoretical profile of the edge.
- Non-limiting examples of such “smooth” edges formed in accordance with the present invention are shown in FIGS. 21-24 .
- the smoothness relates simply to the deviation of the edge surface relative to the theoretical line defining the desired shape of the edge. It will be appreciated that any electrical component on a biosensor has an intended location and shape that will not be exactly duplicated by the physical embodiment.
- the extent to which the actual edge of the component varies from the theoretical one is a measure of the smoothness of the edge. As discussed above, this smoothness or quality of the edge can be expressed in terms of the varying distance that the edge is spaced from a theoretical line over a specified length. This distance can be measured at closely spaced intervals, as discussed in detail below, and the standard deviation of the distance can be calculated. Further, the maximum value the distance achieves over a specified length is also a meaningful parameter.
- the manufacturing process must be capable of producing edges that will vary by less (preferably much less) than 5 ⁇ m over the length of the gap. Otherwise, the electrodes may touch and thus short circuit.
- the extent to which a given portion of the component is “smooth” may vary.
- certain edges of the elements are more critical than others.
- certain edges of the counter and working electrodes are adjacent one another and spaced closely together, while others are not.
- certain edges are located within the sample-receiving chamber, and others are not.
- the present invention relates to providing smooth edges for all of the edges of the measuring electrodes.
- the invention provides smooth edges particularly for the edges of the measuring electrodes located within the sample-receiving chamber, and more particularly for the edges of the measuring elements that are adjacent to one another. “Adjacent edges” in this context refers to the fact that an edge of a counter element is closest to, i.e., adjacent to, an edge of an element of a working electrode with which the counter electrode is paired.
- the present invention relates in one aspect to providing macroelectrodes having a closely determined area.
- the desired accuracy of the provided area can vary based on the absolute size of the macroelectrode, as determined by the quality of the edges defining the electrode.
- the smoothness of the edges improves, the difference between the area actually occupied by the electrode and the desired area decreases.
- the edges forming the gap preferably have a smoothness standard deviation of less than about 4 ⁇ m over the entire length of the edges; for elements spaced apart by 100 ⁇ m, the standard deviation is preferably less than about 2 ⁇ m.
- the desired smoothness can differ.
- the adjacent edges have a smoothness standard deviation of less than about 6 ⁇ m, preferably less than about 2 ⁇ m, and most preferably less than about 1 ⁇ m.
- the smoothness standard deviation is preferably less than about 1 ⁇ m, more preferably less than about 0.5 ⁇ m.
- the smoothness standard deviation for microelectrodes is preferably less than about 5% of the width of the gap between adjacent microelements (i.e., feature size), more preferably less than about 2% of the feature size.
- the other electrical components can be provided with smooth edges to facilitate close placement of such components.
- Such other components preferably have a smoothness standard deviation that is less than about 6 ⁇ m, and more preferably less than about 2 ⁇ m.
- the present invention also provides for the accurate placement of the electrical components relative to one another and to the overall biosensor.
- the relative placement of components is achieved, at least in part, by the use of broad field laser ablation that is performed through a mask or other device that has a precise pattern for the electrical components.
- the relative placement of the components therefore does not depend on the controlled movement of a rastering laser or of the substrate relative to the rastering laser.
- this accurate positioning of adjacent edges is further enhanced by the close tolerances for the smoothness of the edges.
- the invention provides electrical components that have gaps or features that are precisely controlled. More specifically, the electrical components will have designed, theoretical configurations for the gaps between adjacent edges, whereas the physical embodiments will have variations and irregularities.
- the present invention provides gaps between adjacent edges that are highly uniform. Specifically, the present invention provides a “uniform gap,” which is defined as a gap for which the smoothness standard deviation for each edge defining the gap is less than about 6 ⁇ m. Preferably, the smoothness standard deviation of both edges defining the gap is less than about 2 ⁇ m, more preferably less than about 1 ⁇ m.
- the biosensor of the present invention is suitable for use in a system for assessing an analyte in a sample fluid.
- the system includes a meter (not shown) and provides methods for evaluating the sample fluid for the target analyte. The evaluation may range from detecting the presence of the analyte to determining the concentration of the analyte.
- the analyte and the sample fluid may be any for which the test system is appropriate.
- a preferred embodiment is described in which the analyte is glucose and the sample fluid is blood or interstitial fluid.
- the present invention clearly is not so limited in scope.
- Non-limiting examples of meters suitable for use with the biosensor of the present invention for determination of the analyte in the sample fluid are disclosed in U.S. Pat. Nos. 4,963,814; 4,999,632; 4,999,582; 5,243,516; 5,352,351; 5,366,609; 5,405,511; and 5,438,271, the disclosures of each being incorporated herein by reference.
- the suitable meter (not shown) will include a connection with electrodes of the biosensor, and circuitry to evaluate an electrochemical signal corresponding to the concentration of the analyte.
- the meter may also include electrical components that determine whether the sample fluid has been received by the biosensor and whether the amount of sample fluid is sufficient for testing.
- the meter typically will store and display the results of the analysis, or may alternatively provide the data to a separate device.
- the biosensor of the present invention forming part of the system can provide either a qualitative or quantitative indication for the analyte.
- the biosensor cooperates with the meter to indicate simply the presence of the analyte in the sample fluid.
- the biosensor and meter may also provide a reading of the quantity or concentration of the analyte in the sample fluid.
- the biosensor is useful for the determination of a wide variety of analytes.
- the biosensor for example, is readily adapted for use with any suitable chemistry that can be used to assess the presence of the analyte.
- the biosensor is configured and used for the testing of an analyte in a biological fluid.
- the system is described with respect to the detection of glucose in a biological fluid.
- the biosensor is also useful with a wide variety of sample fluids, and is preferably used for the detection of analytes in a biological fluid.
- the biosensor is useful in connection with reference fluids that are used in conventional fashion to verify the integrity of the system for testing.
- the biosensor is employed for the testing of glucose.
- the sample fluid in this instance may specifically include, for example, fresh capillary blood obtained from the finger tip or approved alternate sites (e.g., forearm, palm, upper arm, calf and thigh), fresh venous blood, and control solutions supplied with or for the system.
- the fluid may be acquired and delivered to the biosensor in any fashion.
- a blood sample may be obtained in conventional fashion by incising the skin, such as with a lancet, and then contacting the biosensor with fluid that appears at the skin surface. It is an aspect of the present invention that the biosensor is useful with very small fluid samples. It is therefore a desirable feature that only a slight incising of the skin is necessary to produce the volume of fluid required for the test, and the pain and other concerns with such method can be minimized or eliminated.
- Biosensor 210 in accordance with an embodiment of the present invention has two electrode patterns having different feature sizes on a common planar surface and thus permits the accurate measurement of an analyte in a fluid.
- biosensor 210 comprises a base or base substrate 212 , conductive material 216 positioned on the base 212 , a spacer 214 , and a cover 218 .
- the cover 218 and spacer 214 cooperate with the base 212 to define a sample-receiving chamber 220 ( FIG. 9 ) having a sample inlet opening 221 for the sample fluid, and a reagent 264 for producing an electrochemical signal in the presence of a test analyte.
- the biosensor 210 is formed as a test strip, particularly one having a laminar construction providing an edge or surface opening to the sample-receiving chamber 220 .
- the reagent 264 as shown in FIGS. 2 and 9 , is exposed by the sample-receiving chamber 220 to provide the electrochemical signal to a working electrode also positioned within the chamber 220 .
- the reagent may contain an enzyme and optionally a mediator.
- the base 212 of biosensor 210 includes edges 222 that define opposite ends 224 , 226 and sides 228 , 230 extending between the ends 224 , 226 .
- Base 212 also has a top surface 232 supporting the conductive material 216 and an opposite bottom surface 234 ( FIGS. 8 and 9 ).
- base 212 has a length of 40 mm and a width of 10 mm. It is appreciated, however that these values are merely illustrative and that the dimensions of the base 212 may vary in accordance with the present disclosure.
- the base 212 is a substrate that is formed from an insulating material, so that it will not provide an electrical connection between electrodes formed from the conductive material 216 .
- suitable insulating materials include glass, ceramics and polymers.
- the base is a flexible polymer and has a strong absorbance in the UV.
- suitable materials include polyethylene terephthalate (PET), polyethylene naphthalate (PEN), and polyimide films.
- PET polyethylene terephthalate
- PEN polyethylene naphthalate
- the suitable films are commercially available as MELINEX®, KALADEX® and KAPTON®, respectively from E.I. duPont de Nemours, Wilmington, Del., USA (“duPont”) and UPILEX®, a polyimide film from UBE Industries Ltd, Japan.
- Preferred materials are selected from 10 mil thick MELINEX® 329 or KAPTON®, which are coated with 50 ⁇ 4 nm gold within-lot C.V. of ⁇ 5% by: Techni-Met Advanced Depositions, Inc., Windsor, Conn., USA. It is appreciated that the base 212 may be either purchased pre-coated with conductive material 216 or may be coated by sputtering or vapor deposition, in accordance with this disclosure. It is further appreciated that the thickness of the conductive material can vary in accordance with this disclosure.
- Spacer 214 is illustratively positioned on the top surface 232 of the base 212 adjacent to end 224 .
- Spacer 214 has an upper surface 236 and a lower surface 238 ( FIG. 9 ) facing the base 212 .
- the spacer 214 has edges 240 , 242 , 244 , 246 .
- spacer 214 has a length of about 6 mm, a width of about 10 mm and a height of about 4 mil. It is appreciated, however that these values are merely illustrative and that the biosensor may be formed without a spacer and that the dimensions of the spacer 214 may vary in accordance with the present disclosure.
- Spacer 214 is formed from an insulating material, so that it will not provide an electrical connection between electrodes formed from the conductive material 216 .
- suitable insulating materials include glass, ceramics, polymers, photoimageable coverlay materials, and photoresists—non-limiting examples of which are disclosed in U.S. patent application Ser. No. 10/264,891, filed Oct. 4, 2002, the disclosure of which is incorporated herein by reference.
- spacer 214 is formed of 4 mil MELINEX® polyester film, which is preferred for use with whole blood samples. It is appreciated, however, that when the sample is plasma or serum, 1-2 mil film may be preferred for use in accordance with this disclosure. It is appreciated, however that these values are merely illustrative and that the composition and dimension of the spacer 214 may vary in accordance with the desired height of the sample-receiving chamber.
- a slit or void 248 is formed in the spacer 214 and extends from the edge 240 toward the edge 242 .
- the slit 248 defines at least the length and width of the sample-receiving chamber 220 and is defined by edges 249 .
- the slit 248 has a length of 5 mm, a width of 1 mm, and a height of 0.1 mm, but may have a variety of lengths and widths in accordance with the present disclosure. It is further appreciated that the edges 249 of the slit may also be curved or angular in accordance with this disclosure.
- the cover 218 is positioned on the upper surface 236 of spacer 214 .
- Cover 218 has a first surface 250 and a second surface 252 ( FIG. 9 ) facing the base 212 . Further, the cover 218 has edges 254 , 256 , 258 , 260 .
- the cover 218 has a length that is less than the length of the slit 248 .
- cover 218 has a length of about 4 mm, a width of about 10 mm and a height of about 0.1 mm. It is appreciated, however that these values are merely illustrative and that the biosensor may be formed without a cover and that the dimensions of the cover 218 may vary in accordance with the present disclosure.
- the cover 218 is illustratively formed of a clear material having a hydrophilic adhesive layer in proximity to the spacer.
- materials suitable for cover 218 include polyethylene, polypropylene, polyvinylchloride, polyimide, glass, or polyester.
- a preferred material for cover 218 is 100 ⁇ m polyester.
- a preferred adhesive is ARCare 8586 having a MA-55 hydrophilic coating, commercially available from Adhesives Research Inc., Glen Rock, Pa. Further, it is appreciated that the cover may have markings in accordance with this disclosure.
- This sample-receiving chamber 220 can act as a capillary channel, drawing the fluid to be tested from the opening 221 onto a sensing region of the conductive material 216 and toward a vent 262 .
- the biosensor may be formed without a spacer in accordance with this disclosure and that in addition to or instead of the spacer and the cover, a variety of dielectric materials may cover the base 212 exposing only selected portions of the conductive material in accordance with this disclosure.
- the dimensions of the channel 220 may vary in accordance with this disclosure.
- FIG. 2 illustrates the conductive material 216 defining electrode systems comprising a first electrode set 266 and a second electrode set 268 , and corresponding traces 279 , 277 and contact pads 278 , 282 , respectively.
- the conductive material 216 may contain pure metals or alloys, or other materials, which are metallic conductors.
- the conductive material is transparent at the wavelength of the laser used to form the electrodes and of a thickness amenable to rapid and precise processing.
- Non-limiting examples include aluminum, carbon, copper, chromium, gold, indium tin oxide (ITO), palladium, platinum, silver, tin oxide/gold, titanium, mixtures thereof, and alloys or metallic compounds of these elements.
- the conductive material includes noble metals or alloys or their oxides. Most preferably, the conductive material includes gold, palladium, aluminum, titanium, platinum, ITO and chromium.
- the conductive material ranges in thickness from about 10 nm to 80 nm, more preferably, 30 nm to 70 nm.
- FIGS. 1-3 , 6 , and 8 - 9 illustrate the biosensor 210 with a 50 nm gold film. It is appreciated that the thickness of the conductive material depends upon the transmissive property of the material and other factors relating to use of the biosensor.
- the conductive material 216 is ablated into two electrode systems that comprise sets 266 , 268 .
- the conductive material 216 is removed from at least about 5% of the surface area of the base 212 , more preferably at least about 50% of the surface area of the base 212 , and most preferably at least about 90% of the surface area of the base 212 .
- the only conductive material 216 remaining on the base 212 forms at least a portion of an electrode system.
- the resulting patterned conductive material can be coated or plated with additional metal layers.
- the conductive material may be copper, which is then ablated with a laser, into an electrode pattern; subsequently, the copper may be plated with a titanium/tungsten layer, and then a gold layer, to form the desired electrodes.
- a single layer of conductive material is used, which lies on the base 212 .
- seed or ancillary layers such as chromium nickel or titanium.
- biosensor 210 has a single layer of gold, palladium, platinum or ITO.
- the biosensor 210 includes an electrode system comprising at least a working electrode and a counter electrode within the sample-receiving chamber 220 .
- the sample-receiving chamber 220 is configured such that sample fluid entering the chamber is placed in electrolytic contact with both the working electrode and the counter electrode. This allows electrical current to flow between the electrodes to effect the electrooxidation or electroreduction of the analyte or its products.
- the first electrode set 266 of the electrode system includes two electrodes 270 , 272 .
- electrode 270 is a working electrode and electrode 272 is a counter electrode.
- the electrodes 270 , 272 each have a single element or finger 280 that is in communication with a contact pad 278 via a connecting trace 279 (shown in FIG. 2 ).
- the electrode fingers 280 of the electrodes 270 , 272 cooperate to define an electrode pattern formed as a macroelectrode array. It is appreciated, as will be discussed hereafter, that the electrodes 270 , 272 can include more than one finger each in accordance with this disclosure. It is further appreciated that the shape, size and relative configuration of the electrodes or electrode fingers may vary in accordance with the present disclosure.
- the second electrode set 268 includes two electrodes 274 , 276 .
- electrode 274 is a working electrode and electrode 276 is a counter electrode.
- the electrodes 274 , 276 each have five electrode elements or fingers 284 that are in communication with a contact pad 282 via a connecting trace 277 .
- the electrode fingers 284 cooperate to define an electrode pattern formed as an interlaced microelectrode array. While five electrode fingers 284 are illustrated, it is appreciated that the elements of electrodes 274 , 276 can each be formed with greater or fewer than five electrode fingers in accordance with this disclosure. It is further appreciated that the shape, size and relative configuration of the electrodes may vary in accordance with the present disclosure.
- the values for the dimensions of the electrode sets 266 , 268 as illustrated in FIG. 2 are for a single specific embodiment, and these values may be selected as needed for the specific use.
- the length of the electrode sets may be any length up to the length of the base, depending upon the orientation of the electrode sets on the base.
- the width of the conducting traces in communication with the electrode sets may vary, a non-limiting example of which is from about 0.4 mm to about 5 mm.
- the width of each contact pad may vary, a non-limiting example of which is from about 1 mm to about 5 mm.
- each base 212 can contain, for example 1 to 1000 electrode sets, preferably 2 to 20 electrode sets, more preferably 2 to 3 electrode sets.
- each electrode finger 280 is defined by an inner edge 281 , an outer edge 283 , and opposite third and fourth edges 285 , 287 .
- Each edge 218 , 283 , 285 , 287 has a smooth edge quality.
- the edge quality of the electrodes 270 , 272 is defined by the edge's deviation from a theoretical line extending between first and second points. The following description of deviations can apply to each edge of electrodes 270 , 272 of biosensor 210 . For clarity purposes, however, only the edge 281 of electrode 270 will be discussed hereafter.
- the edge 281 of electrode 270 extends between points 289 , 291 located on the base 212 .
- Points 289 , 291 are located at opposite ends of the inner edge 281 , which represents the entire length of the gap 286 between electrodes 280 . It is appreciated that the points 289 , 291 may be positioned at a variety of locations and at a variety of distances relative to one another depending upon the length of the desired edge in accordance with this disclosure. However, the length of interest will typically be the entire length over which a gap extends, since the smoothness of the adjacent edges is normally most important over this entire length.
- FIG. 4 illustrates the theoretical line 293 that extends exactly between points 289 , 291 . That is, line 293 represents the ideal or desired edge that would be obtained if the process of forming the electrodes were perfect. However, at any given point along the length of line 293 , the edge 281 will be spaced in either direction from theoretical line 293 by a distance “d i .” The distance d i varies from zero to a maximum value depending upon where it happens to be measured, as shown, e.g., with reference to distances d 1 , d 2 , d 3 and d 4 in FIG. 4 .
- a standard deviation of this distance over the length of line 293 is less than about 6 ⁇ m in accordance with this disclosure, creating an edge with a smooth edge quality.
- the standard deviation of the edge 281 from theoretical line 293 is less than 2 ⁇ m, and most preferably less than 1.0 ⁇ m.
- An example of this deviation from mean or theoretical is illustrated in FIG. 10 .
- the edge quality illustrated in FIG. 10 was measured using Micro-Measure system commercially available from LPKF Laser Electronic GmbH, of Garbsen, Germany with Metric 6.21 software.
- the Metric software allows the display and measuring of video images on a PC. Measurements were made by capturing the image and then allowing the software to place a 10 ⁇ m grid over the image. The grid was aligned with the edge by moving the electrode structure under the measurement objective. (By physically manipulating the image, the edge can be vertically aligned to be parallel with the grid.) Using the software, measurements from the grid line to the electrode edge were then made at 10 ⁇ m intervals along the length of a line 250 ⁇ m long using a point-to-point process.
- Standard deviations were calculated from measurements made at an average interval of 0.69 ⁇ m for a length of at least 250 ⁇ m.
- Ring lighting Intensity 89, Position 60
- the standard deviation from the mean value was less than about 2 ⁇ m.
- the line 293 is illustratively a straight line. It is appreciated, however, that the shape of the line 293 may be curved or angular, so long as the standard deviation of the distance of edge 281 from that line 293 over the length of the edge is less than about 6 ⁇ m.
- the electrode fingers 280 are separated from one another by an electrode gap 286 , which corresponds to the feature size of the electrode pattern of the electrode set 266 .
- the electrode gap 286 shown in FIG. 3 is shown as formed by two straight edges 281 .
- the placement of edges 281 varies from theoretical value 293 ( FIG. 4 ) by a distance that varies along the length of the edge.
- the electrically insulative material of the top surface 232 is exposed between the electrode fingers 280 along a length 290 . It is appreciated, however, that rather than top surface 232 being exposed, the base can be coated with materials, or recesses can be formed between the electrodes as disclosed in U.S. patent application Ser. No. 09/704,145, filed on Nov. 1, 2000, now U.S. Pat. No. 6,540,890, the disclosure of which is incorporated herein by reference.
- the inner edges 281 of electrode fingers 280 have an equal length, illustrated by the numeral 290 and are separated from one another by the electrode gap 286 , whose length is also represented by length 290 . Because the two edges 281 defining gap 286 are not perfect, gap 286 will in fact vary in width and placement over its length, as shown with reference to gaps 292 a - 292 d in FIG. 5 . When the deviations of the two edges defining gap 286 are in the same direction, they tend to cancel each other as to width deviation, at least in part, and cause a net shift in placement of the gap, as illustrated with respect to reference numerals 292 c and 292 d of FIG. 5 .
- a theoretical gap can be defined by two theoretical lines 293 associated with edges 281 .
- the quality of the gap or its deviation from the theoretical gap can be specified in terms of the quality of the two individual edges defining it.
- the smoothness standard deviation of both edges defining gap 286 is less 6 ⁇ m, preferably less than 2.0 ⁇ m, and most preferably less than 1 ⁇ m.
- the electrode fingers 284 which define the elements of electrodes 274 , 276 are illustrated in FIGS. 3 and 6 . For clarity purposes, however, only three of these electrode fingers 284 will be discussed hereafter as they are illustrated in FIG. 6 .
- Each electrode finger 284 is defined by a first edge 296 and a second edge 297 . Further, adjacent fingers 284 have spaced-apart third and fourth edges 298 , 299 respectively. These edges 296 , 297 , 298 , 299 of fingers 284 can also have a smooth edge quality. As previously described with reference to electrodes 270 , 272 , the edge quality of the electrodes 274 , 276 is defined by the respective edge's deviation from a line extending between first and second points. The following description of deviations will apply to each edge of electrode fingers 284 of biosensor 210 . For clarity purposes, however, only one edge 296 of electrode finger 284 will be discussed hereafter.
- the edge 296 of electrode finger 284 extends between first and second points 301 , 302 located on the base 212 .
- a theoretical line 300 extends exactly between points 301 , 302 , which is typically the length of the gap formed by edge 296 and 297 .
- a standard deviation of the varying distance of edge 296 from line 300 is less than about 6 ⁇ m, in accordance with this disclosure, creating an edge with a smooth edge quality.
- the standard deviation of the edge 296 from theoretical line 300 is less than 2 ⁇ m, and most preferably less than 1.0 ⁇ m.
- the line 300 is a straight line. It is appreciated, however, that the shape of the line 300 may be curved or angular. It is also appreciated that the specific positions of first and second locations 300 , 301 on the surface 232 may vary in accordance with the disclosure, although the lengths of most importance are typically the entire length of the gaps between these closely spaced electrode fingers.
- the electrode fingers 284 are separated from one another by an electrode gap 288 , which corresponds to the feature size of the electrode pattern of the electrode set 268 .
- the electrode gap 288 relates to the width between adjacent edges 296 , 297 of fingers 284 . Because the two edges defining gap 288 are not perfect, gap 288 will in fact vary in position and placement over its length.
- the electrically insulative material of the base 212 is exposed between the electrode fingers 284 along a length 303 . It is appreciated, however, that rather than top surface 232 being exposed, the base can be coated with materials, or recesses can be formed between the electrodes as disclosed in U.S. patent application Ser. No. 09/704,145, filed on Nov. 1, 2000, now U.S. Pat. No. 6,540,890, entitled “Biosensor”, the disclosure of which is incorporated herein by reference.
- the electrode gap 288 which corresponds to the feature size of the electrode pattern of the electrode set 268 is different than the feature size of the electrode pattern of the electrode set 266 .
- the feature size, or gap 288 between the electrode fingers 284 has a width of about 100 ⁇ m or less, including about 1 ⁇ m to about 100 ⁇ m, even more preferably 75 ⁇ m or less, including about 17 ⁇ m to about 50 ⁇ m.
- the electrode gap for a microelectrode array can vary.
- the electrode gap can be less than 1 ⁇ m in accordance with the present disclosure.
- the size of the achievable gap is dependent upon the quality of the optics, the wavelength of the laser, and the window size of a mask field.
- the gap 288 has a width along a length 303 of the opposing edges 296 , 297 of the electrode fingers 284 .
- the quality of gap 286 or its deviation from a theoretical gap can be specified in terms of the quality of the two individual edges defining it.
- the smoothness standard deviation of both edges defining gap 286 is less 6 ⁇ m, preferably less than 2.0 ⁇ m, and most preferably less than 1 ⁇ m.
- the electrode fingers 284 are covered with the reagent 264 and may be used to provide electrochemical probes for specific analytes.
- the starting reagents are the reactants or components of the reagent, and are often compounded together in liquid form before application to the ribbons or reels, or in capillary channels on sheets of electrodes. The liquid may then evaporate, leaving the reagent in solid form.
- the choice of a specific reagent depends on the specific analyte or analytes to be measured, and is not critical to the present invention.
- Various reagent compositions are well known to those of ordinary skill in the art. It is also appreciated that the placement choice for the reagent on the base may vary and depends on the intended use of the biosensor. Further, it is appreciated that the techniques for applying the reagent onto the base may vary. For example, it is within the scope of the present disclosure to have the reagent screen-printed onto the fingers.
- a non-limiting example of a dispensable reagent for measurement of glucose in a human blood sample contains 62.2 mg polyethylene oxide (mean molecular weight of 100-900 kilodaltons), 3.3 mg NATROSOL 250 M, 41.5 mg AVICEL RC-591 F, 89.4 mg monobasic potassium phosphate, 157.9 mg dibasic potassium phosphate, 437.3 mg potassium ferricyanide, 46.0 mg sodium succinate, 148.0 mg trehalose, 2.6 mg TRITON X-100 surfactant, and 2,000 to 9,000 units of enzyme activity per gram of reagent.
- the enzyme is prepared as an enzyme solution from 12.5 mg coenzyme PQQ and 1.21 million units of the apoenzyme of quinoprotein glucose dehydrogenase, forming a solution of quinoprotein glucose dehydrogenase.
- This reagent is further described in U.S. Pat. No. 5,997,817, the disclosure of which is expressly incorporated herein by reference.
- a non-limiting example of a dispensable reagent for measurement of hematocrit in a sample contains oxidized and reduced forms of a reversible electroactive compound (potassium hexacyanoferrate (III) (“ferricyanide”) and potassium hexacyanoferrate (II) (“ferrocyanide”), respectively), an electrolyte (potassium phosphate buffer), and a microcrystalline material (Avicel RC-591F—a blend of 88% microcrystalline cellulose and 12% sodium carboxymethyl-cellulose, available from FMC Corp.).
- Concentrations of the components within the reagent before drying are as follows: 400 millimolar (mM) ferricyanide, 55 mM ferrocyanide, 400 mM potassium phosphate, and 2.0% (weight: volume) Avicel.
- mM millimolar
- ferrocyanide a further description of the reagent for a hematocrit assay is found in U.S. Pat. No. 5,385,846, the disclosure of which is expressly incorporated herein by reference.
- Non-limiting examples of enzymes and mediators that may be used in measuring particular analytes in biosensors of the present invention are listed below in Table 1.
- Table 1 Mediator Analyte Enzymes (Oxidized Form) Additional Mediator Glucose Glucose Dehydrogenase Ferricyanide and Diaphorase Osmium complexes, nitrosoanaline complexes Glucose Glucose-Dehydrogenase Ferricyanide (Quinoprotein) Cholesterol Cholesterol Esterase and Ferricyanide 2,6-Dimethyl-1,4- Cholesterol Oxidase Benzoquinone 2,5-Dichloro-1,4- Benzoquinone or Phenazine Ethosulfate HDL Cholesterol Esterase Ferricyanide 2,6-Dimethyl-1,4- Cholesterol and Cholesterol Oxidase Benzoquinone 2,5-Dichloro-1,4- Benzoquinone or
- At least one additional enzyme is used as a reaction catalyst.
- some of the examples shown in Table 1 may utilize an additional mediator, which facilitates electron transfer to the oxidized form of the mediator.
- the additional mediator may be provided to the reagent in lesser amount than the oxidized form of the mediator.
- nitrosoanaline reagent which includes a PQQ-GDH and para-Nitroso-Aniline mediator.
- a protocol for the preparation of the nitrosoanaline reagent is the same in all respects as disclosed in U.S. patent application Ser. No. 10/688,312, entitled “System And Method For Analyte Measurement Using AC Phase Angle Measurement”, filed Oct. 17, 2003, the disclosure of which is incorporated herein by reference.
- the reagent mass composition—prior to dispensing and drying is as set forth in Table 2.
- a coatable reagent suitable for use with the present disclosure is as follows in Table 3. TABLE 3 Component % w/w Mass for 1 kg Keltrol F, xanthan gum 0.2136% 2.1358 g Sodium Carboxymethylcellulose (CMC) 0.5613% 5.6129 g Polyvinylpyrrolidone, (PVP K25) 1.8952% 18.9524 g PROPIOFAN ®, 2.8566% 28.5657 g GlucDOR 0.3310% 3.3098 g PQQ 0.0092% 0.0922 g Sipernat 320 DS 2.0039% 20.0394 g Na-Succinat ⁇ 6H2O 0.4803% 4.8027 g Trehalose 0.4808% 4.8081 g KH 2 PO 4 0.4814% 4.8136 g K 2 HPO 4 1.1166% 11.1658 g Mediator 31.1144 0.6924% 6.9242 g Mega 8 0.2806% 2.8065 g Geropon T 77 0.0298% 0.2980
- Biosensor 210 is illustratively manufactured using two apparatuses 10 , 10 ′, shown in FIGS. 17-18 and 19 , respectively. It is appreciated that unless otherwise described, the apparatuses 10 , 10 ′ operate in a similar manner. Referring first to FIG. 17 , biosensor 210 is manufactured by feeding a roll of ribbon or web 20 having an 80 nm gold laminate, which is about 40 mm in width, into a custom fit broad field laser ablation apparatus 10 .
- the apparatus 10 comprises a laser source 11 producing a beam of laser light 12 , a chromium-plated quartz mask 14 , and optics 16 . It is appreciated that while the illustrated optics 16 is a single lens, optics 16 is preferably a variety of lenses that cooperate to make the light 12 in a pre-determined shape or image that is then projected onto the web of base substrate 20 .
- a non-limiting example of a suitable ablation apparatus 10 is a customized MicrolineLaser 200-4 laser system commercially available from LPKF Laser Electronic GmbH, of Garbsen, Germany, which incorporates an LPX-400, LPX-300 or LPX-200 laser system commercially available from Lambda Physik AG, Gottingen, Germany and a chromium-plated quartz mask commercially available from International Phototool Company, Colorado Springs, Co.
- the laser source 11 is a LPX-200 KrF-UV-laser. It is appreciated, however, that higher wavelength UV lasers can be used in accordance with this disclosure.
- the laser source 11 works at 248 nm, with a pulse energy of 600 mJ, and a pulse repeat frequency of 50 Hz.
- the intensity of the laser beam 12 can be infinitely adjusted between 3% and 92% by a dielectric beam attenuator (not shown).
- the beam profile is 27 ⁇ 15 mm 2 (0.62 sq. inch) and the pulse duration 25 ns.
- the layout on the mask 14 is homogeneously projected by an optical elements beam expander, homogenizer, and field lens (not shown).
- the performance of the homogenizer has been determined by measuring the energy profile.
- the imaging optics 16 transfer the structures of the mask 14 onto the ribbon 20 .
- the imaging ratio is 2:1 to allow a large area to be removed on the one hand, but to keep the energy density below the ablation point of the applied chromium mask on the other hand. While an imaging of 2:1 is illustrated, it is appreciated that the any number of alternative ratios are possible in accordance with this disclosure depending upon the desired design requirements.
- the ribbon 20 moves as shown by arrow 25 to allow a number of layout segments to be ablated in succession.
- the positioning of the mask 14 , movement of the ribbon 20 , and laser energy are computer controlled. As shown in FIG. 17 , the laser beam 12 is projected onto the ribbon 20 to be ablated. Light 12 passing through the clear areas or windows 18 of the mask 14 ablates the metal from the ribbon 20 . Chromium coated areas 24 of the mask 14 blocks the laser light 12 and prevent ablation in those areas, resulting in a metallized structure on the ribbon 20 surface. Referring now to FIG. 18 , a complete structure of electrical components may require additional ablation steps through a second mask 14 ′. It is appreciated that depending upon the optics and the size of the electrical component to be ablated, that only a single ablation step or greater than two ablation steps may be necessary in accordance with this disclosure. Further, it is appreciated that instead of multiple masks, that multiple fields may be formed on the same mask in accordance with this disclosure.
- a second non-limiting example of a suitable ablation apparatus 10 ′ is a customized laser system commercially available from LPKF Laser Electronic GmbH, of Garbsen, Germany, which incorporates a Lambda STEEL (Stable energy eximer laser) laser system commercially available from Lambda Physik AG, Göttingen, Germany and a chromium-plated quartz mask commercially available from International Phototool Company, Colorado Springs, Co.
- the laser system features up to 1000 mJ pulse energy at a wavelength of 308 nm. Further, the laser system has a frequency of 100 Hz.
- the apparatus 10 ′ may be formed to produce biosensors with two passes as shown in FIGS. 17 and 18 , but preferably its optics permit the formation of a 10 ⁇ 40 mm pattern in a 25 ns single pass.
- the laser pulse or beam 12 that passes through the mask 14 , 14 ′, 14 ′′ is absorbed within less than 1 ⁇ m of the surface 232 on the ribbon 20 .
- the photons of the beam 12 have an energy sufficient to cause photo-dissociation and the rapid breaking of chemical bonds at the metal/polymer interface. It is believed that this rapid chemical bond breaking causes a sudden pressure increase within the absorption region and forces material (metal film 216 ) to be ejected from the polymer base surface. Since typical pulse durations are around 20-25 nanoseconds, the interaction with the material occurs very rapidly and thermal damage to edges of the conductive material 216 and surrounding structures is minimized. The resulting edges of the electrical components have high edge quality and accurate placement as contemplated by the present invention.
- Fluence energies used to remove or ablate metals from the ribbon 20 are dependent upon the material from which the ribbon 20 is formed, adhesion of the metal film to the base material, the thickness of the metal film, and possibly the process used to place the film on the base material, i.e. supporting and vapor deposition.
- Fluence levels for gold on KALADEX® range from about 50 to about 90 mJ/cm 2 , on polyimide about 100 to about 120 mJ/cm 2 , and on MELINEX® about 60 to about 120 mJ/cm 2 . It is understood that fluence levels less than or greater than the above mentioned can be appropriate for other base materials in accordance with the disclosure.
- Patterning of areas of the ribbon 20 is achieved by using the masks 14 , 14 ′.
- Each mask 14 , 14 ′ illustratively includes a mask field 22 containing a precise two-dimensional illustration of a pre-determined portion of the electrode component patterns to be formed.
- FIG. 17 illustrates the mask field 22 including contact pads and a portion of traces.
- the second mask 14 ′ contains a second corresponding portion of the traces and the electrode patterns containing fingers.
- the mask 14 can contain a complete illustration of the entire electrode pattern for each biosensor ( FIG. 19 ), or partial patterns different from those illustrated in FIGS. 17 and 18 in accordance with this disclosure.
- the entire pattern of the electrical components on the test strip are laser ablated at one time, i.e., the broad field encompasses the entire size of the test strip ( FIG. 19 ), or even encompasses the entire size of two or more test strips (not shown).
- the entire pattern of the electrical components on the test strip are laser ablated at one time, i.e., the broad field encompasses the entire size of the test strip ( FIG. 19 ), or even encompasses the entire size of two or more test strips (not shown).
- portions of the entire biosensor are done successively.
- mask 14 will be discussed hereafter, it is appreciated that unless indicated otherwise, the discussion will apply to masks 14 ′, 14 ′′ as well.
- areas 24 of the mask field 22 protected by the chrome will block the projection of the laser beam 12 to the ribbon 20 .
- Clear areas or windows 18 in the mask field 22 allow the laser beam 12 to pass through the mask 14 and to impact predetermined areas of the ribbon 20 .
- the clear area 18 of the mask field 22 corresponds to the areas of the ribbon 20 from which the conductive material 216 is to be removed.
- the mask field 22 has a length shown by line 30 and a width as shown by line 32 .
- the length 30 of the mask is two times the length of a length 34 of the resulting pattern and the width 32 of the mask is two times the width of a width 36 of the resulting pattern on ribbon 20 .
- the optics 16 reduces the size of laser beam 12 that strikes the ribbon 20 . It is appreciated that the relative dimensions of the mask field 22 and the resulting pattern can vary in accordance with this disclosure.
- Mask 14 ′ ( FIG. 18 ) is used to complete the two-dimensional illustration of the electrical components.
- the excimer laser source 11 emits beam 12 , which passes through the chrome-on-quartz mask 14 .
- the mask field 22 causes parts of the laser beam 12 to be reflected while allowing other parts of the beam to pass through in the form of an image of part or all of an electrode pattern.
- the image or part of laser beam 12 that passes through mask 14 in turn creates a pattern on the gold film where impacted by the laser beam 12 .
- ribbon or web 20 can be stationary relative to apparatus 10 or move continuously on a roll through apparatus 10 .
- non-limiting rates of movement of the ribbon 20 can be from about 0 m/min to about 100 m/min, more preferably about 30 m/min to about 60 m/min. It is appreciated that the rate of movement of the ribbon 20 is limited only by the apparatus 10 selected and may well exceed 100 m/min depending upon the pulse duration of the laser source 11 in accordance with the present disclosure.
- masks 14 , 14 ′ large areas of the web or ribbon 20 can be patterned using step-and-repeat processes involving multiple mask fields 22 in the same mask area to enable the economical creation of intricate electrode patterns and other electrical components on a substrate of the base, the precise edges of the electrode components, and the removal of greater amounts of the metallic film from the base material.
- FIG. 20 is a non-limiting schematic of an electrode set ribbon 124 formed in accordance with the present disclosure, although having an electrode pattern different from that illustrated in FIGS. 17 and 18 .
- the ribbon 124 includes a plurality of panels 120 , each of which includes a plurality of electrode systems 116 . Each system includes two electrodes, both labeled 104 and having a sensing region 110 . Also shown is the original metallic laminate ribbon 122 that is subject to laser ablation to form the electrode set ribbon 124 .
- the width of the ribbon 122 is selected to accommodate the laser ablation system 10 , 10 ′, and may be, for example, 40 to 0.4 inches (1.2 m to 10.25 mm).
- the ribbon may be any length, and is selected based on the desired number of electrode sets, and/or the ease of handling and transport of the ribbons.
- the size of each individual panel is selected to fit conveniently on the ribbon, and therefore each panel may contain 1 to 1000 electrode sets, preferably 2 to 20 electrode sets.
- the ribbon 20 may be coupled to a spacer and a cover using any number of well-known commercially available methods.
- a non-limiting example of a suitable method of manufacture is described in detail in U.S. Application Ser. No. 60/480,397, filed Jun. 20, 2003, entitled “Devices And Methods Relating To Analyte Sensors”, the disclosure of which is incorporated herein by reference.
- a reagent film is placed upon the ribbon and dried conventionally with an in-line drying system. The rate of processing is nominally 30-38 meters per minute and depends upon the rheology of the reagent.
- Reagents suitable for the biosensor 210 are given above, but a preferable reagent is set out in Table 2.
- the materials are processed in continuous reels such that the electrode pattern is orthogonal to the length of the reel, in the case of the base.
- the spacer material is laminated onto the coated ribbon 20 .
- a portion of the spacer material Prior to laminating the spacer material, however, a portion of the spacer material is removed, thereby forming a slit.
- a punching process is used to remove the unneeded portion of the spacer.
- the die set governs the shape of the slit.
- the resulting slit-spacer is placed in a reel-to-reel process onto the base.
- a cover is then laminated onto the spacer using a reel-to reel process.
- the biosensors can then be produced from the resulting reels of material by means of slitting and cutting.
- the slit in the spacer preferably forms a capillary fill space between the base and the cover.
- a hydrophobic adhesive on the spacer prevents the test sample from flowing into the reagent under the spacer and therefore the fill space defines the test chamber volume. It is appreciated that the chamber volume can vary in accordance with this disclosure depending upon the application of the biosensor. A non-limiting detailed description of suitable fill volumes is found in U.S. Application Ser. No. 60/480,397, noted above.
- biosensor 210 has two electrode patterns having different feature sizes on a common planar surface and thus achieves multiple functionalities on that surface.
- electrode set 266 has an electrode pattern formed as a macro electrode array with a first pre-defined feature size.
- a non-limiting example of a suitable functionality of the macroelectrode array is hematocrit level correction, which is described in U.S. patent application Ser. No. 10/688,312, entitled “System And Method For Analyte Measurement Using AC Phase Angle Measurement”, filed Oct. 17, 2003, the disclosure of which is incorporated herein by reference.
- a test meter (not shown) applies a voltage to one electrode and measures the current response at the other electrode to obtain a signal as described in U.S. patent application Ser. No. 10/688,312 just noted.
- Electrode set 268 has an electrode pattern formed as an interlaced microelectrode array with a second pre-defined feature size.
- a non-limiting example of a suitable functionality of the microelectrode array is glucose estimation, which is also described in U.S. patent application Ser. No. 10/688,312.
- a test meter (not shown) applies a voltage to one electrode and measures the current response at the other electrode to obtain a signal as described in U.S. patent application Ser. No. 10/688,312.
- a user places his or her lanced finger at opening 221 of biosensor 210 .
- a liquid sample (whole blood) flows from the finger into the opening 221 .
- the liquid sample is transported via capillary action through the sample-receiving chamber 220 and across the fingers 280 of the element of the electrode set 266 .
- the liquid sample flows through the sample-receiving chamber 220 toward vent 262 and into engagement with the reagent 264 situated upon the fingers 284 of the element of the electrode set 268 .
- hematocrit correction values are determined from the interaction of the liquid sample with the fingers 280 and a glucose determination from the interaction of the liquid sample/reagent mixture with the fingers 284 . While hematocrit and glucose determination functionalities are described with reference to biosensor 210 , it is appreciated that the electrode patterns, may be used for a variety of functionalities in accordance with the present disclosure.
- biosensors especially for use in diagnostic devices.
- electrochemical biosensors for non-diagnostic uses, such as measuring an analyte in any biological, environmental, or other, sample.
- biosensors may stand alone or be combined with one another in accordance with this disclosure.
- each of the disclosed biosensors operates from the standpoint of a user in a manner similar to that described above with reference from 210 .
- like components of the biosensors are numbered alike.
- a biosensor 310 is formed and manufactured in a manner similar to biosensor 210 except for the pattern of the conductive material 216 positioned on the base 212 .
- the conductive material 216 of biosensor 310 defines a first electrode system 366 and a second electrode system 368 .
- the electrode systems 366 , 368 are similar to the systems of biosensor 210 except for the resulting pattern of the connecting traces 377 , 379 and contact pads 378 , 383 on the base 212 . It is submitted that the traces 377 , 379 and pads 378 , 383 may take on a variety of shapes and sizes in accordance with this disclosure.
- a biosensor 510 is formed in a manner similar to biosensor 210 except for the pattern of the conductive material 216 positioned on the base 212 .
- the conductive material 216 of biosensor 510 defines a first electrode set 566 .
- the electrode set 566 is similar to set 366 except for the configuration of the interlacing electrode pattern formed by the elements of the electrodes.
- the first electrode set 566 includes a working electrode having an element with one electrode finger 581 and a counter electrode having an element with two electrode fingers 580 .
- the fingers 580 , 581 cooperate with one another to create an interlaced electrode pattern configured as a macroelectrode array having a feature size or gap width of about 250 ⁇ m.
- the electrodes 580 , 581 each have an electrode width of about 250 ⁇ m. As discussed above with set 266 , the electrode and gap widths may vary in accordance with this disclosure.
- the first and second electrode sets 566 , 268 have different feature sizes and are used to create different functionalities on biosensor 510 .
- a non-limiting example of a suitable functionality of the first electrode set 566 is for determining correction factors for hematocrit levels. The measurement methods are as discussed above with reference to biosensor 210 .
- a biosensor 610 is formed in a manner similar to biosensor 210 except for the pattern of the conductive material 216 positioned on the base 212 .
- the conductive material 216 of biosensor 610 defines a second electrode set 668 spaced-apart from set 566 .
- the electrode set 668 is similar to set 268 except for the pattern of interlacing electrode pattern in the element of the electrodes.
- the second electrode set 668 includes a working electrode and a counter electrode, each having an element with three electrode fingers 661 .
- the fingers 661 cooperate with one another to define an interlaced electrode pattern configured as a microelectrode array having a feature size or gap width of about 50 ⁇ m, which is less than the feature size of the electrode pattern of the set 566 .
- the electrodes 661 each have an electrode width of about 50 ⁇ m. As discussed above with set 268 , the electrode and gap widths may vary in accordance with this disclosure.
- biosensor 610 includes a reagent 664 .
- Reagent 664 is similar to reagent 264 , and only differs in its width as it is applied onto the base 212 . Specifically, the reagent 664 extends across electrode fingers 661 .
- a non-limiting example of a suitable functionality of the second electrode set 668 is a glucose determination functionality. The measurement methods are as discussed above with reference to biosensor 210 .
- a biosensor 710 is formed in a manner similar to biosensor 210 except for the pattern of the conductive material 216 positioned on the base 212 .
- the conductive material 216 of biosensor 710 defines the first electrode set 366 as discussed above and a second electrode set 768 .
- the electrode set 768 is similar to set 268 except for the pattern of an interlacing electrode pattern formed by the element of the electrodes.
- the second electrode set 768 includes a working electrode and a counter electrode, each having element with five electrode fingers 770 .
- the fingers 770 cooperate with one another to define an interlaced electrode pattern configured as a microelectrode array having a feature size or gap width of about 30 ⁇ m, which is less than the feature size of electrode pattern of set 366 .
- the electrode fingers 770 each have an electrode width of about 50 ⁇ m.
- a non-limiting example of a suitable functionality of the second electrode set 668 is a glucose determination functionality. The measurement methods are as discussed above with reference to biosensor 210 .
- biosensor 710 includes a reagent 364 that is dispensed upon the fingers 770 by any of a variety of dispensing methods that are well known to those skilled in the art.
- Reagent 364 is preferably the reagent set forth in Table 3.
- reagents non-limiting examples of which have been discussed above, may be used in accordance with this disclosure.
- FIG. 15 illustrates a biosensor 1310 in accordance with this disclosure.
- Biosensor 1310 is formed in a manner similar to biosensor 210 except for the configuration of the conductive material 216 positioned on the base 212 , the cover 1118 , and the spacer 1114 .
- the cover 1118 and spacer 1114 are similar to cover 218 and spacer 214 except for their dimensions relative to the base 212 as shown in FIG. 15 .
- the conductive material 216 of biosensor 1310 defines a first electrode set 1366 and a second electrode set 1368 .
- the first electrode set 1366 includes a working electrode and a counter electrode, each having five electrode fingers 1370 .
- the fingers 1370 cooperate with one another to define an interlaced electrode pattern formed as a microelectrode array having a feature size or gap width of about 17 ⁇ m.
- the electrode fingers 1370 each have an electrode width of about 20 ⁇ m.
- the second electrode set 1368 includes a working electrode and a counter electrode, each having three electrode fingers 1371 .
- the electrode fingers 1371 cooperate with one another to define an interlaced electrode pattern formed as a microelectrode array having a feature size or gap width of about 10 ⁇ m.
- the electrode fingers 1371 each have an electrode width of about 20 ⁇ m. As discussed above with set 266 , the electrode and gap widths of fingers 1370 and 1371 may vary in accordance with this disclosure.
- the reagent 264 extends across the electrode fingers 1371 of the electrode set 1368 .
- a non-limiting example of a suitable functionality of the first electrode set 1366 includes hematocrit correction as described above with reference to biosensor 210 .
- a non-limiting example of a suitable functionality of the second electrode set 1368 is used for determining a glucose estimate as described above with reference to biosensor 210 .
- the method of measurement for the electrode sets, 1366 and 1368 is also as described above with reference to biosensor 210 .
- FIG. 16 illustrates biosensor 1510 .
- Biosensor 1510 is identical to biosensor 210 , except for the reagent 1564 .
- Reagent 364 is dispensed onto the electrode fingers 284 as discussed above with reference to biosensor 710 of FIG. 14 .
- FIGS. 21-24 are photographs of electrical patterns formed using the principles of the present invention.
- FIG. 21 is a photograph of a base substrate having an electrical pattern formed thereon by removing 10% of the conductive material initially covering the base substrate.
- the conductive material is gold.
- the pattern was formed with a single pulse of a laser.
- FIG. 22 is a photograph of a base substrate having an electrical pattern formed thereon by removing 20% of the conductive material initially covering the base substrate.
- the conductive material is gold and the gap widths are approximately 20 ⁇ m as indicated.
- the pattern was formed with a single pulse of a laser.
- FIG. 23 is a photograph of a base substrate having an electrical pattern formed thereon by removing 50% of the conductive material initially covering the base substrate.
- the conductive material is gold and the gap widths are approximately 20 ⁇ m as indicated.
- the pattern was formed with a single pulse of a laser.
- FIG. 24 is a photograph of a base substrate having an electrical pattern formed thereon by removing 90% of the conductive material initially covering the base substrate.
- the conductive material is gold and the gap widths are approximately 250 ⁇ m as indicated.
- the pattern was formed with a single pulse of a laser.
- FIGS. 21-24 are photos taken of selected ones of the electrode structures, as also indicated in Table 4.
- the masks used to make the patterns included both “Structure 1” and “Structure 2” listed in Table 4.
- a single laser pulse of about 25 nanoseconds was used to form the patterns.
- long webs (about 450 m or more) of material were passed under the laser ablation apparatus at a controlled speed as the electrical patterns were formed.
- the “patterns per minute” column reflects the speed at which substrates for individual biosensors can be formed. For example, in Run No. 1, 2585 base substrates each corresponding to a single biosensor, and each having two (2) electrode feature sizes, are formed in a single minute. As can be seen from the above table 4, the method embodied by the present invention is well suited to fast mass production.
Abstract
Description
- The present application is a Continuation in Part of U.S. patent application Ser. No. 09/840,843, filed Apr. 24, 2001; a Continuation in Part of U.S. application Ser. No. 10/264,891, filed Oct. 4, 2002; a Continuation-in-Part of U.S. application Ser. No. 10/601,144, filed Jun. 20, 2003; and claims priority to U.S. patent application Ser. No. 60/480,397, filed Jun. 20, 2003, each of which is hereby incorporated by reference in its entirety.
- The present invention relates to a method of making a biosensor, more specifically a biosensor having electrode sets formed by laser ablation.
- Electrochemical biosensors are well known and have been used to determine the concentration of various analytes from biological samples, particularly from blood. Examples of such electrochemical biosensors are described in U.S. Pat. Nos. 5,413,690; 5,762,770 and 5,798,031; and 6,129,823 each of which is hereby incorporated by reference.
- It is desirable for electrochemical biosensors to be able to analyze analytes using as small a sample as possible, and it is therefore necessary to minimize the size of their parts, including the electrodes, as much as possible. As discussed below, screen-printing, laser scribing, and photolithography techniques have been used to form miniaturized electrodes.
- Electrodes formed by screen-printing techniques are formed from compositions that are both electrically conductive and screen-printable. Furthermore, screen printing is a wet chemical technique that generally allows reliable formation of structures and patterns having a gap width or feature size of approximately 75 μm or greater. Such techniques are well known to those of ordinary skill in the art.
- Laser scribing is a technique that usually uses a high power excimer laser, such as a krypton-fluoride excimer laser with an illumination wavelength of 248 nm, to etch or scribe individual lines in the conductive surface material and to provide insulating gaps between residual conductive material which forms electrodes and other desired components. This scribing is accomplished by moving the laser beam across the surface to be ablated. The scribing beam generally has a relatively small, focused size and shape, which is smaller than the features desired for the product, and the formation of the product therefore requires rastering techniques. Such a technique can be rather time consuming if a complex electrode pattern is to be formed on the surface. Further, the precision of the resulting edge is rather limited. This scribing technique has been used to ablate metals, polymers, and biological material. Such systems are well known to those of ordinary skill in the art, and are described in U.S. Pat. Nos. 5,287,451, 6,004,441, 6,258,229, 6,309,526, WO 00/73785, WO 00/73788, WO 01/36953, WO 01/75438, and
EP 1 152 239 each of which is hereby incorporated by reference. It would be desirable to have a new method of forming electrodes which allows precise electrode edges, a variety of feature sizes, and which can be formed in a high speed/throughput fashion without the use of rastering. - The present invention provides an electrochemical biosensor with electrode elements that possess smooth, high-quality edges. These smooth edges define gaps between electrodes, electrode traces and contact pads. Due to the remarkable edge smoothness achieved with the present invention, the gaps can be quite small, the advantages of which are described below. Further, the present invention provides a novel biosensor production method in which entire electrode patterns for the inventive biosensors can be formed all at one, in nanoseconds—irrespective of the complexity of the electrode patterns or the amount of conductive material that must be ablated to form them.
- In one form thereof, the present invention provides a biosensor comprising a base substrate having first and second electrode elements formed thereon. The first and second electrode elements have first and second respective edges defining a gap therebetween. The gap has a width and a length. The first edge is spaced by a first distance from a first “theoretical line” that corresponds to the desired or ideal shape and location of the first edge. This first distance varies along the length of the gap because the edge actually produced is not as smooth or perfect as the desired theoretical line. The standard deviation of the first distance is less than about 6 μm over the entire length of the gap. The biosensor also includes a reagent at least partially covering the base substrate and one or more layers overlying and adhered to the base substrate. The one or more layers cooperate to form a sample-receiving chamber and a cover for the biosensor, and at least a portion of both the reagent and an electrode are positioned in the chamber.
- In a related form of the inventive biosensor described above, the actual or real deviation of the edge from the theoretical line is no more than about 6 μm along the entire length of the gap. Stated another way, the distance between the edge actually produced and the theoretical line (if the edge were perfect) is less than 6 μm no matter where along the gap the distance is measured. More preferably, the real deviation is less than about 4 μm, most preferably less than about 2 μm. In this most preferred form, it is possible to space the electrodes as close as about 5 μm without having the electrical components touch and thus short. Similarly, the width of the features of the electrical pattern such as electrode fingers or traces can be as narrow as about 10 μm. As discussed in detail below, the close spacing of electrode components allowed by the present invention in turn allows a greater number of electrode elements and thus greater functionality in a smaller area.
- The smoothness or quality of the edges is most important in areas of the biosensor where adjacent edges are positioned close to one another, e.g., the gap between two electrodes. In a preferred aspect of the present invention, like the first edge discussed above, the second edge is spaced from a second theoretical line by a second distance that varies along the length of the gap. The first and the second theoretical lines thus define a “theoretical gap” therebetween. If the production process were perfect, and if the edges were intended to be straight and parallel to one another, the theoretical gap width would be constant along its length. In practice, however, the actual gap width varies from the theoretical one along the length of the gap. Deviations from theoretical of the first and second edges can be compounded to produce larger variations in the actual gap width than are produced in either edge alone. In a preferred form of the invention, the standard deviation of the second distance is less than about 6 μm over the entire length of the gap. More preferably, the standard deviation of both the first and second distances is less than about 2 μm, even more preferably, less than about 1 μm.
- In another preferred form of the invention, the method comprises removing at least 10% of the conductive material, more preferably at least 50% of the conductive material, and most preferably at least 90% of the conductive material. The conductive material is preferably removed by broad field laser ablation, which allows relatively large percentages of the conductive layer to be removed from the base substrate very quickly to form electrode patterns. For example, in preferred forms, the entire electrode pattern for a biosensor is formed by broad field laser ablation in less than about 0.25 seconds, more preferably in less than about 50 nanoseconds, and most preferably in less than about 25 nanoseconds.
- As noted above, the inventive method also allows for the placement of two or more electrode sets having different feature sizes in the same biosensor. Furthermore, as noted above, the feature sizes can be quite small and spaced close together.
- In another form, the present invention provides an efficient and fast method for mass producing biosensors having electrode patterns with the highly desirable smooth edges discussed above. In this method, a web of base substrate material having a metal conductive layer formed thereon is provided. An image of an electrode pattern is projected onto the metal conductive layer with a laser apparatus such that an electrode pattern that corresponds to the image is formed by laser ablation on the web of base substrate material. Either the laser apparatus or the web of base substrate material (or both) is moved and this process is repeated to produce many electrode patterns at spaced intervals along the web of base substrate material. A reagent is deposited on the web of base substrate material and at least partially covers each electrode pattern of the plurality of electrode patterns. At least one web of a covering layer or a spacing layer is laminated over the web of base substrate material, thereby forming a cover and a sample-receiving cavity for each biosensor. The resulting laminated web of layers is then cut into individual biosensors.
- In a preferred form, the image projected by the laser apparatus is of the complete electrode pattern for one of the biosensors, such that the complete electrode pattern for each biosensor is formed in a single step with a single laser image. In another preferred form, more than one entire electrode pattern is formed all at once; i.e., the image includes patterns for two or more biosensors.
- In another preferred form, the electrode pattern includes at least two electrode sets having different feature sizes. Examples of this may include one set of electrodes for measuring analyte concentration and another set for detecting whether and when the biosensor has received an adequate dose of sample fluid. The inventive biosensor may also include electrode elements providing other features, such as biosensor identification, calibration or other information associated with the biosensor.
- One advantage of this inventive mass production process is that it is much faster than prior art processes that require forming electrode patterns by screen printing, lithography, rastering and the like. With the laser ablation process employed by the present invention, the entire electrode pattern for a biosensor can be formed all at once, in a single step, in only nanoseconds. This allows a continuous web of material from which the individual biosensors will ultimately be cut to be processed at speeds of 60 meters per minute or greater.
- Not only is the inventive process much faster than prior art processes, it provides biosensors with electrode patterns whose edges have much better edge quality than prior art biosensors. Edge quality becomes increasingly important as electrode spacing becomes closer. Close electrode spacing is desirable because it generally increases the accuracy of the test result, reduces sample size, and yields a quicker test. Additionally, it allows a greater quantity of electrode elements and associated functionalities to be packed into a single biosensor.
- Yet another advantage of the inventive production method is that it allows a large percentage of the electrically conductive layer to be removed from the base substrate all at once. By contrast, prior art rastering processes use a collimated laser beam that slowly scribes and removes only a thin line of conductive material, which is a much longer and less versatile process in comparison with the present invention.
- Another advantage related to the one just noted is that the manufacturing process of the present invention provides great freedom in the shape and variation in the electrode pattern produced in the inventive biosensors. Asymmetric or anisotropic electrode patterns do not present a problem with the manufacturing process of the present invention. Further, since the electrode pattern is preferably projected on the base substrate by a laser image formed by a mask, limitations as to size, shape, number of electrode patterns, gap width, etc. that are encountered with prior art processes are reduced. By comparison, rastering processes are typically limited to movement of a focused laser beam along axes that are oriented 90 degrees relative to one another. The resulting patterns typically are limited to thin lines of the same width oriented parallel or perpendicular to one another. In addition, separate but adjacent conductive metal planes used to carry separate signals in a device can capacitively couple when the separation distance between the planes becomes very small resulting in signal degradation and interference between the planes. A method that allows removal of more conductive material between isolated traces therefore can be advantageous in minimizing such interference.
- The following definitions are used throughout the specification and claims:
- As used herein, the phrase “electrically conductive material” refers to a layer made of a material that is a conductor of electricity, non-limiting examples of which include a pure metal or alloys.
- As used herein, the phrase “electrically insulative material” refers to a material that is a nonconductor of electricity.
- As used herein, the term “electrode” means a conductor that collects or emits electric charge and controls the movement of electrons. An electrode may include one or more elements attached to a common electrical trace and/or contact pad.
- As used herein, the term “electrical component” means a constituent part of the biosensor that has electrical functionality.
- As used herein, the phrase “electrode system” refers to an electrical component including at least one electrode, electrical traces and contacts that connect the element with a measuring instrument.
- As used herein, the term “electrode element” refers to a constituent part of an electrode system. Specific non-limiting examples of electrode elements include electrodes, contact pads and electrode traces.
- As used herein, the phrase “electrode set” is a grouping of at least two electrodes that cooperate with one another to measure the biosensor response.
- As used herein, the term “pattern” means a design of one or more intentionally formed gaps, a non-limiting example of which is a single linear gap having a constant width. Not included in the term “pattern” are natural, unintentional defects.
- As used herein, the phrase “insulative pattern” means a design of one or more intentionally formed gaps positioned within or between electrically insulative material(s). It is appreciated that electrically conductive material may form the one or more gaps.
- As used herein, the phrase “conductive pattern” means a design of one or more intentionally formed gaps positioned within or between electrically conductive material(s). It is appreciated that exposed electrically insulative material may form the one or more gaps.
- As used herein, the phrase “microelectrode array” means a group of microelectrodes having a predominantly spherical diffusional characteristic.
- As used herein, the phrase “macroelectrode array” means a group of macroelectrodes having a predominantly radial diffusional characteristic.
- As used herein, the phrase “electrode pattern” means the relative configuration of the intentionally formed gaps situated between the elements of electrodes in an electrode set specifically or biosensor generally. Non-limiting examples of “electrode patterns” include any configuration of microelectrode arrays, macroelectrode arrays or combinations thereof that are used to measure biosensor response. “Electrode pattern” may also refer to the shape and configuration of all electrical components that are formed on the biosensor.
- As used herein, the phrase “feature size” is the smallest dimension of gaps or spaces found in a pattern. For example, in an insulative pattern, the feature size is the smallest dimension of electrically conductive gaps found within or between the electrically insulative material(s). When, however, the pattern is a conductive pattern, the feature size is the smallest dimension of electrically insulative gaps found within or between the electrically conductive material(s). Therefore, in a conductive pattern the feature size represents the shortest distance between the corresponding edges of adjacent elements.
- As used herein, the term “interlaced” means an electrode pattern wherein the elements of the electrodes are interwoven relative to one another. In a particular embodiment, interlaced electrode patterns include electrodes having elements, which are interdigitated with one another. In the simplest form, interlaced elements include a first electrode having a pair of elements and a second electrode having a single element received within the pair of elements of the first electrode.
- As used herein, the term “ablating” means the removing of material. The term “ablating” is not intended to encompass and is distinguished from loosening, weakening or partially removing the material.
- As used herein, the phrase “broad field laser ablation” means the removal of material from a substrate using a laser having a laser beam with a dimension that is greater than the feature size of the formed pattern. Broad field ablation includes the use of a mask, pattern or other device intermediate a laser source and a substrate. The laser is projected through the mask, the latter of which forms an image of an electrode pattern which is projected onto and impinges on the substrate to create all or part of the electrode patterns on the substrate. Broad field laser ablation simultaneously creates the pattern over a significant area of the substrate. The use of broad field laser ablation avoids the need for rastering or other similar techniques that scribe or otherwise define the pattern by continuous movement of a relatively focused laser beam relative to the substrate. A non-limiting example of a process for broad field laser ablation is described below with reference to
biosensor 210. - As used herein, the term “line” means a geometric figure formed by a point moving in a first direction along a pre-determined linear or curved path and in a reverse direction along the same path. In the present context, an electrode pattern includes various elements having edges that are defined by lines forming the perimeters of the conductive material. Such lines demarcating the edges have desired shapes, and it is a feature of the present invention that the smoothness of these edges is very high compared to the desired shape.
- “Theoretical line” as used herein refers to the desired or ideal shape and location of an edge of an electrode element that would be obtained if the manufacturing process were perfect. In most cases, if the edge is straight, the theoretical line will coincide with the average location of the edge.
- As used herein, the term “point” means a dimensionless geometric object having no properties except location.
- The smoothness or quality of the edge of an electrode element can be defined by the distance that the placement of the edge differs from the theoretical line that represents the perfect or ideal edge. That is, the edge will be spaced from the theoretical line by a distance that varies along the length of the edge. This distance will range from zero to a maximum value. One useful way to define the quality or smoothness of an edge is to simply specify the maximum distance that the edge is spaced from the theoretical line over a specified length of the edge.
- The smoothness or quality of an edge can also be specified in terms of the “standard deviation” of the distance between the edge and the theoretical line over a specified length of the edge. To calculate the standard deviation, the distance must be measured at discrete intervals along the length, as described in further detail herein. If the varying distance is denoted “d” and the number of data points is denoted n, then the standard deviation of the distance is calculated as {Σ(di)2/(n−1)}1/2. So that the equation just noted accurately approximates the integral equation from which it is derived, the intervals at which data points are taken should be spaced closely together. All standard deviations expressed herein are measured by taking data points that are spaced by no more than about 20 μm, preferably closer.
- As used herein, the term “smoothness standard deviation,” when referring to an edge of an electrode element, refers to the standard deviation of the distance that the edge is spaced from a theoretical line over a specified length of the edge. The quality of a gap between electrode elements can be expressed in terms of the individual deviations or standard deviations of the two edges forming the gap from the theoretical lines corresponding to the two edges.
- As used herein, the phrase “biological fluid” includes any bodily fluid in which the analyte can be measured, for example, interstitial fluid, dermal fluid, sweat, tears, urine, amniotic fluid, spinal fluid and blood.
- As used herein, the term “blood” includes whole blood and its cell-free components, namely plasma and serum.
- As used herein, the term “working electrode” is an electrode at which analyte, or product, is electrooxidized or electroreduced with or without the agency of a redox mediator.
- As used herein, the term “counter electrode” refers to an electrode that is paired with the working electrode and through which passes an electrochemical current equal in magnitude and opposite in sign to the current passed through the working electrode. The term “counter electrode” is meant to include counter electrodes, which also function as reference electrodes (i.e., a counter/reference or auxiliary electrode).
- As used herein, the term “electrochemical biosensor” means a device configured to detect the presence and/or measure the concentration of an analyte by way of electrochemical oxidation and reduction reactions within the biosensor. These reactions are transduced to an electrical signal that can be correlated to an amount or concentration of the analyte.
- Additional features of the invention will become apparent to those skilled in the art upon consideration of the following detailed description of the preferred embodiment exemplifying the best mode known for carrying out the invention. It should be understood, however, that the detailed description and the specific examples, while indicating embodiments of the invention, are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description.
- The following drawings form part of the present specification and are included to further demonstrate certain aspects of the present invention. The invention may be better understood by reference to one or more of these drawings in combination with the detailed description of specific embodiments presented herein:
-
FIG. 1 is a perspective view of a biosensor of the present invention; -
FIG. 2 is an exploded assembly view of the biosensor ofFIG. 1 ; -
FIG. 3 is an enlarged plan view of the biosensor ofFIG. 1 showing a macroelectrode array and a microelectrode array; -
FIG. 4 is a diagram of the deviation of an edge of an electrode element from a theoretical or ideal line representing the desired shape and placement of the edge; -
FIG. 5 is a diagram of the deviation in gap width and placement resulting from the deviations in the two individual edges forming the gap; -
FIG. 6 is an enlarged section of the microelectrode array ofFIG. 3 ; -
FIG. 7 is a diagram of the deviation of an edge of an electrode element from a theoretical or ideal line representing the desired shape and placement of the edge; -
FIG. 8 illustrates a cross-section taken along lines 8-8 ofFIG. 1 ; -
FIG. 9 illustrates a cross-section taken along lines 9-9 ofFIG. 1 ; -
FIG. 10 is a graph showing the deviation from mean or theoretical of an electrode edge of the microelectrode array ofFIG. 3 ; -
FIG. 11 is an exploded assembly view of a biosensor in accordance with another embodiment of the invention; -
FIG. 12 is an exploded assembly view of a biosensor in accordance with another embodiment of the invention; -
FIG. 13 is an exploded assembly view of a biosensor in accordance with another embodiment of the invention; -
FIG. 14 is an exploded assembly view of a biosensor in accordance with another embodiment of the invention; -
FIG. 15 is an exploded assembly view of a biosensor in accordance with another embodiment of the invention; -
FIG. 16 is an enlarged perspective view of a biosensor in accordance with another embodiment of the invention; -
FIG. 17 is a view of an ablation apparatus suitable for use with the present invention; -
FIG. 18 is a view of the laser ablation apparatus ofFIG. 17 showing a second mask; -
FIG. 19 is a view of an ablation apparatus suitable for use with the present invention; -
FIG. 20 is a schematic of an electrode set ribbon of the present invention; -
FIG. 21 is a photograph illustrating a biosensor substrate initially coated with a gold conductive layer from which approximately 10% of the conductive material has been removed; -
FIG. 22 is a photograph illustrating a biosensor substrate having an electrical pattern with a gap width of approximately 20 μm and where approximately 20% of the conductive material initially covering the substrate has been removed to form the electrical pattern; -
FIG. 23 is a photograph illustrating a biosensor substrate having an electrical pattern with a gap width of approximately 20 μm and where approximately 50% of the of a conductive material initially covering the substrate has been removed to form the electrical pattern; and -
FIG. 24 is a photograph illustrating a biosensor substrate having an electrical pattern with a gap width of approximately 250 μm and where approximately 90% of the conductive material initially covering the substrate has been removed to form the electrical pattern. - For the purposes of promoting an understanding of the principles of the invention, reference will now be made to the embodiments illustrated in the drawings, and specific language will be used to describe the embodiments. It will nevertheless be understood that no limitation of the scope of the invention is intended. Alterations and modifications in the illustrated devices, and further applications of the principles of the invention as illustrated therein, as would normally occur to one skilled in the art to which the invention relates are contemplated, are desired to be protected.
- A biosensor in accordance with the present invention provides a surface with electrode patterns formed thereon, the electrode patterns preferably having a smooth edge quality. It is a particular aspect of the present invention that precise quality is obtained for the edges of the electrical components located on the biosensor. Having a smooth or high edge quality of the elements can contribute to greater precision, accuracy, and reproducibility of test results. Further, a smooth or high edge quality also allows for a great number of electrode arrays to be formed on a defined surface area of the biosensor. By increasing the edge quality of the elements, it is possible to increase the number of electrode elements and thus increase the achievable functionality in the defined surface area. These functions may include, for example: multiple measurement electrode pairs for simultaneous measurement of the same or different analytes, including by alternative means; electrodes used to provide correction factors for the basic measurement electrodes; electrodes for detecting dose application or sample sufficiency; multiple electrode traces to monitor electrode functioning or to provide detection or correction of defective traces; and multiple contact pads for coupling to the foregoing functionalities, or for providing additional features such as identification, calibration, or other information pertaining to the biosensor. Further, the selected functionalities for a given biosensor can be provided in a smaller space when the high edge quality allows closer placement of the electrical components. It is a feature of the present invention to enable all of this, and more, in a manner that is relatively fast, reliable and cost effective.
- Specifically, a biosensor of the present invention has electrical components with edges that are smooth and are precisely located. The precise locating of the smooth edge is important, particularly relative to a corresponding edge of another electrical component, and especially with respect to a paired element. The importance and the degree of quality of a component's edge quality and placement will vary with the nature of the component.
- For macroelectrodes, the edge smoothness and placement are important for the quality of the electrochemical results obtained by use of the macroelectrodes. One factor in the accuracy of such a test is the reproducibility of the area of each macroelectrode. Obtaining precise edge smoothness and placement will yield an area which is highly accurate. Another factor in the use of macroelectrodes is the placement of one of the electrodes relative to the other, e.g., the position of the counter element(s) in relationship to the position of the working element(s). Moreover, since biosensors are generally operated based on calibration methods that rely on the reproducibility of the sizes and locations of the measuring electrodes, the ability to consistently produce lots of such tests trips can enhance the results achieved with the tests.
- Similarly, the edge smoothness and placement contribute to the results obtained from microelectrodes. For microelectrodes, the issues can be magnified because of the number and relatively close placement of the numerous microelements. Poor edge quality can greatly affect the operating characteristics of microelectrodes, and the present invention helps to overcome this potential problem. Moreover, an advantage of placing microelements in close proximity is the rapid establishment of steady-state operation. High edge quality and precise edge placement enables closer placement of the elements and in turn faster achievement of steady-state operation. In addition, such closer placement allows for a greater number of microelements to be placed in a given space.
- In a first aspect, the present invention provides a high quality edge for the various electrical components on a biosensor. The quality of the edge relates to the smoothness or uniformity of the edge relative to a theoretical profile of the edge. Non-limiting examples of such “smooth” edges formed in accordance with the present invention are shown in
FIGS. 21-24 . - In one respect, the smoothness relates simply to the deviation of the edge surface relative to the theoretical line defining the desired shape of the edge. It will be appreciated that any electrical component on a biosensor has an intended location and shape that will not be exactly duplicated by the physical embodiment. The extent to which the actual edge of the component varies from the theoretical one is a measure of the smoothness of the edge. As discussed above, this smoothness or quality of the edge can be expressed in terms of the varying distance that the edge is spaced from a theoretical line over a specified length. This distance can be measured at closely spaced intervals, as discussed in detail below, and the standard deviation of the distance can be calculated. Further, the maximum value the distance achieves over a specified length is also a meaningful parameter. For example, in a design where electrodes are to form a gap having a desired width of, e.g., 10 μm, the manufacturing process must be capable of producing edges that will vary by less (preferably much less) than 5 μm over the length of the gap. Otherwise, the electrodes may touch and thus short circuit.
- As relates to the various electrical components, the extent to which a given portion of the component is “smooth” may vary. Referring in particular to the measuring electrodes, it will be appreciated that certain edges of the elements are more critical than others. For example, certain edges of the counter and working electrodes are adjacent one another and spaced closely together, while others are not. Also, certain edges are located within the sample-receiving chamber, and others are not. In a first aspect, the present invention relates to providing smooth edges for all of the edges of the measuring electrodes. In another aspect, the invention provides smooth edges particularly for the edges of the measuring electrodes located within the sample-receiving chamber, and more particularly for the edges of the measuring elements that are adjacent to one another. “Adjacent edges” in this context refers to the fact that an edge of a counter element is closest to, i.e., adjacent to, an edge of an element of a working electrode with which the counter electrode is paired.
- As indicated previously, the present invention relates in one aspect to providing macroelectrodes having a closely determined area. The desired accuracy of the provided area can vary based on the absolute size of the macroelectrode, as determined by the quality of the edges defining the electrode. Thus, as the smoothness of the edges improves, the difference between the area actually occupied by the electrode and the desired area decreases.
- The spacing of macroelectrodes also can benefit from the present invention. For example, for macroelectrodes that are spaced apart by 250 μm, the edges forming the gap preferably have a smoothness standard deviation of less than about 4 μm over the entire length of the edges; for elements spaced apart by 100 μm, the standard deviation is preferably less than about 2 μm.
- For microelectrodes, the desired smoothness can differ. For example, for microelements that are spaced apart by 50 μm, the adjacent edges have a smoothness standard deviation of less than about 6 μm, preferably less than about 2 μm, and most preferably less than about 1 μm. If the microelements are spaced apart by about 10 μm, then the smoothness standard deviation is preferably less than about 1 μm, more preferably less than about 0.5 μm. In general, the smoothness standard deviation for microelectrodes is preferably less than about 5% of the width of the gap between adjacent microelements (i.e., feature size), more preferably less than about 2% of the feature size.
- It is also an aspect of the present invention that the other electrical components can be provided with smooth edges to facilitate close placement of such components. Such other components preferably have a smoothness standard deviation that is less than about 6 μm, and more preferably less than about 2 μm.
- The present invention also provides for the accurate placement of the electrical components relative to one another and to the overall biosensor. The relative placement of components is achieved, at least in part, by the use of broad field laser ablation that is performed through a mask or other device that has a precise pattern for the electrical components. The relative placement of the components therefore does not depend on the controlled movement of a rastering laser or of the substrate relative to the rastering laser. Moreover, this accurate positioning of adjacent edges is further enhanced by the close tolerances for the smoothness of the edges.
- Therefore, in a further aspect the invention provides electrical components that have gaps or features that are precisely controlled. More specifically, the electrical components will have designed, theoretical configurations for the gaps between adjacent edges, whereas the physical embodiments will have variations and irregularities. The present invention provides gaps between adjacent edges that are highly uniform. Specifically, the present invention provides a “uniform gap,” which is defined as a gap for which the smoothness standard deviation for each edge defining the gap is less than about 6 μm. Preferably, the smoothness standard deviation of both edges defining the gap is less than about 2 μm, more preferably less than about 1 μm.
- It is appreciated that the biosensor of the present invention is suitable for use in a system for assessing an analyte in a sample fluid. In addition to the biosensor, the system includes a meter (not shown) and provides methods for evaluating the sample fluid for the target analyte. The evaluation may range from detecting the presence of the analyte to determining the concentration of the analyte. The analyte and the sample fluid may be any for which the test system is appropriate. For purposes of explanation only, a preferred embodiment is described in which the analyte is glucose and the sample fluid is blood or interstitial fluid. However, the present invention clearly is not so limited in scope.
- Non-limiting examples of meters suitable for use with the biosensor of the present invention for determination of the analyte in the sample fluid are disclosed in U.S. Pat. Nos. 4,963,814; 4,999,632; 4,999,582; 5,243,516; 5,352,351; 5,366,609; 5,405,511; and 5,438,271, the disclosures of each being incorporated herein by reference. The suitable meter (not shown) will include a connection with electrodes of the biosensor, and circuitry to evaluate an electrochemical signal corresponding to the concentration of the analyte. The meter may also include electrical components that determine whether the sample fluid has been received by the biosensor and whether the amount of sample fluid is sufficient for testing. The meter typically will store and display the results of the analysis, or may alternatively provide the data to a separate device.
- The biosensor of the present invention forming part of the system can provide either a qualitative or quantitative indication for the analyte. In one embodiment, the biosensor cooperates with the meter to indicate simply the presence of the analyte in the sample fluid. The biosensor and meter may also provide a reading of the quantity or concentration of the analyte in the sample fluid. In a preferred embodiment, it is a feature of the present invention that a highly accurate and precise reading of the analyte concentration is obtained.
- The biosensor is useful for the determination of a wide variety of analytes. The biosensor, for example, is readily adapted for use with any suitable chemistry that can be used to assess the presence of the analyte. Most preferably, the biosensor is configured and used for the testing of an analyte in a biological fluid. Commensurate modifications to the system will be apparent to those skilled in the art. For purposes of explanation, and in a particularly preferred embodiment, the system is described with respect to the detection of glucose in a biological fluid.
- The biosensor is also useful with a wide variety of sample fluids, and is preferably used for the detection of analytes in a biological fluid. In addition, the biosensor is useful in connection with reference fluids that are used in conventional fashion to verify the integrity of the system for testing.
- In a preferred embodiment, the biosensor is employed for the testing of glucose. The sample fluid in this instance may specifically include, for example, fresh capillary blood obtained from the finger tip or approved alternate sites (e.g., forearm, palm, upper arm, calf and thigh), fresh venous blood, and control solutions supplied with or for the system. The fluid may be acquired and delivered to the biosensor in any fashion. For example, a blood sample may be obtained in conventional fashion by incising the skin, such as with a lancet, and then contacting the biosensor with fluid that appears at the skin surface. It is an aspect of the present invention that the biosensor is useful with very small fluid samples. It is therefore a desirable feature that only a slight incising of the skin is necessary to produce the volume of fluid required for the test, and the pain and other concerns with such method can be minimized or eliminated.
-
Biosensor 210 in accordance with an embodiment of the present invention has two electrode patterns having different feature sizes on a common planar surface and thus permits the accurate measurement of an analyte in a fluid. As shown inFIG. 1 ,biosensor 210 comprises a base orbase substrate 212,conductive material 216 positioned on thebase 212, aspacer 214, and acover 218. Thecover 218 andspacer 214 cooperate with the base 212 to define a sample-receiving chamber 220 (FIG. 9 ) having a sample inlet opening 221 for the sample fluid, and areagent 264 for producing an electrochemical signal in the presence of a test analyte. Thebiosensor 210 is formed as a test strip, particularly one having a laminar construction providing an edge or surface opening to the sample-receivingchamber 220. Thereagent 264, as shown inFIGS. 2 and 9 , is exposed by the sample-receivingchamber 220 to provide the electrochemical signal to a working electrode also positioned within thechamber 220. In appropriate circumstances, such as for glucose detection, the reagent may contain an enzyme and optionally a mediator. - The
base 212 ofbiosensor 210 includesedges 222 that defineopposite ends sides ends Base 212 also has atop surface 232 supporting theconductive material 216 and an opposite bottom surface 234 (FIGS. 8 and 9 ). Illustratively,base 212 has a length of 40 mm and a width of 10 mm. It is appreciated, however that these values are merely illustrative and that the dimensions of the base 212 may vary in accordance with the present disclosure. - The
base 212 is a substrate that is formed from an insulating material, so that it will not provide an electrical connection between electrodes formed from theconductive material 216. Non-limiting examples of suitable insulating materials include glass, ceramics and polymers. Preferably, the base is a flexible polymer and has a strong absorbance in the UV. Non-limiting examples of suitable materials include polyethylene terephthalate (PET), polyethylene naphthalate (PEN), and polyimide films. The suitable films are commercially available as MELINEX®, KALADEX® and KAPTON®, respectively from E.I. duPont de Nemours, Wilmington, Del., USA (“duPont”) and UPILEX®, a polyimide film from UBE Industries Ltd, Japan. Preferred materials are selected from 10 mil thick MELINEX® 329 or KAPTON®, which are coated with 50±4 nm gold within-lot C.V. of <5% by: Techni-Met Advanced Depositions, Inc., Windsor, Conn., USA. It is appreciated that the base 212 may be either purchased pre-coated withconductive material 216 or may be coated by sputtering or vapor deposition, in accordance with this disclosure. It is further appreciated that the thickness of the conductive material can vary in accordance with this disclosure. -
Spacer 214 is illustratively positioned on thetop surface 232 of the base 212 adjacent to end 224.Spacer 214 has anupper surface 236 and a lower surface 238 (FIG. 9 ) facing thebase 212. Referring now toFIG. 2 , thespacer 214 hasedges spacer 214 has a length of about 6 mm, a width of about 10 mm and a height of about 4 mil. It is appreciated, however that these values are merely illustrative and that the biosensor may be formed without a spacer and that the dimensions of thespacer 214 may vary in accordance with the present disclosure. -
Spacer 214 is formed from an insulating material, so that it will not provide an electrical connection between electrodes formed from theconductive material 216. Non-limiting examples of suitable insulating materials include glass, ceramics, polymers, photoimageable coverlay materials, and photoresists—non-limiting examples of which are disclosed in U.S. patent application Ser. No. 10/264,891, filed Oct. 4, 2002, the disclosure of which is incorporated herein by reference. Illustratively,spacer 214 is formed of 4 mil MELINEX® polyester film, which is preferred for use with whole blood samples. It is appreciated, however, that when the sample is plasma or serum, 1-2 mil film may be preferred for use in accordance with this disclosure. It is appreciated, however that these values are merely illustrative and that the composition and dimension of thespacer 214 may vary in accordance with the desired height of the sample-receiving chamber. - A slit or void 248 is formed in the
spacer 214 and extends from theedge 240 toward theedge 242. Theslit 248 defines at least the length and width of the sample-receivingchamber 220 and is defined byedges 249. Illustratively, theslit 248 has a length of 5 mm, a width of 1 mm, and a height of 0.1 mm, but may have a variety of lengths and widths in accordance with the present disclosure. It is further appreciated that theedges 249 of the slit may also be curved or angular in accordance with this disclosure. - As shown in
FIG. 1 , thecover 218 is positioned on theupper surface 236 ofspacer 214. Cover 218 has afirst surface 250 and a second surface 252 (FIG. 9 ) facing thebase 212. Further, thecover 218 hasedges FIG. 1 , thecover 218 has a length that is less than the length of theslit 248. Illustratively, cover 218 has a length of about 4 mm, a width of about 10 mm and a height of about 0.1 mm. It is appreciated, however that these values are merely illustrative and that the biosensor may be formed without a cover and that the dimensions of thecover 218 may vary in accordance with the present disclosure. - The
cover 218 is illustratively formed of a clear material having a hydrophilic adhesive layer in proximity to the spacer. Non-limiting examples of materials suitable forcover 218 include polyethylene, polypropylene, polyvinylchloride, polyimide, glass, or polyester. A preferred material forcover 218 is 100 μm polyester. A preferred adhesive is ARCare 8586 having a MA-55 hydrophilic coating, commercially available from Adhesives Research Inc., Glen Rock, Pa. Further, it is appreciated that the cover may have markings in accordance with this disclosure. - The
slit 248 in thespacer 214, together with thecover 218, and thebase 212, form the sample-receiving chamber 220 (FIG. 9 ), which acts to exposereagent 264 to a fluid to be tested from a user ofbiosensor 210. This sample-receivingchamber 220 can act as a capillary channel, drawing the fluid to be tested from theopening 221 onto a sensing region of theconductive material 216 and toward avent 262. It is appreciated that the biosensor may be formed without a spacer in accordance with this disclosure and that in addition to or instead of the spacer and the cover, a variety of dielectric materials may cover the base 212 exposing only selected portions of the conductive material in accordance with this disclosure. Moreover, it is appreciated that when present, the dimensions of thechannel 220 may vary in accordance with this disclosure. -
FIG. 2 illustrates theconductive material 216 defining electrode systems comprising a first electrode set 266 and a second electrode set 268, andcorresponding traces contact pads conductive material 216 may contain pure metals or alloys, or other materials, which are metallic conductors. Preferably, the conductive material is transparent at the wavelength of the laser used to form the electrodes and of a thickness amenable to rapid and precise processing. Non-limiting examples include aluminum, carbon, copper, chromium, gold, indium tin oxide (ITO), palladium, platinum, silver, tin oxide/gold, titanium, mixtures thereof, and alloys or metallic compounds of these elements. Preferably, the conductive material includes noble metals or alloys or their oxides. Most preferably, the conductive material includes gold, palladium, aluminum, titanium, platinum, ITO and chromium. The conductive material ranges in thickness from about 10 nm to 80 nm, more preferably, 30 nm to 70 nm.FIGS. 1-3 , 6, and 8-9 illustrate thebiosensor 210 with a 50 nm gold film. It is appreciated that the thickness of the conductive material depends upon the transmissive property of the material and other factors relating to use of the biosensor. - Illustratively, the
conductive material 216 is ablated into two electrode systems that comprise sets 266, 268. In forming these systems, theconductive material 216 is removed from at least about 5% of the surface area of thebase 212, more preferably at least about 50% of the surface area of thebase 212, and most preferably at least about 90% of the surface area of thebase 212. As shown inFIG. 2 , the onlyconductive material 216 remaining on the base 212 forms at least a portion of an electrode system. - While not illustrated, it is appreciated that the resulting patterned conductive material can be coated or plated with additional metal layers. For example, the conductive material may be copper, which is then ablated with a laser, into an electrode pattern; subsequently, the copper may be plated with a titanium/tungsten layer, and then a gold layer, to form the desired electrodes. Preferably, a single layer of conductive material is used, which lies on the
base 212. Although not generally necessary, it is possible to enhance adhesion of the conductive material to the base, as is well known in the art, by using seed or ancillary layers such as chromium nickel or titanium. In preferred embodiments,biosensor 210 has a single layer of gold, palladium, platinum or ITO. - As shown in
FIGS. 2 and 9 , thebiosensor 210 includes an electrode system comprising at least a working electrode and a counter electrode within the sample-receivingchamber 220. The sample-receivingchamber 220 is configured such that sample fluid entering the chamber is placed in electrolytic contact with both the working electrode and the counter electrode. This allows electrical current to flow between the electrodes to effect the electrooxidation or electroreduction of the analyte or its products. - Referring now to
FIG. 3 , the first electrode set 266 of the electrode system includes twoelectrodes electrode 270 is a working electrode andelectrode 272 is a counter electrode. Theelectrodes finger 280 that is in communication with acontact pad 278 via a connecting trace 279 (shown inFIG. 2 ). Theelectrode fingers 280 of theelectrodes electrodes - As shown in
FIG. 2 , the second electrode set 268 includes twoelectrodes electrode 274 is a working electrode andelectrode 276 is a counter electrode. Further, theelectrodes fingers 284 that are in communication with acontact pad 282 via a connectingtrace 277. Referring now toFIG. 3 , theelectrode fingers 284 cooperate to define an electrode pattern formed as an interlaced microelectrode array. While fiveelectrode fingers 284 are illustrated, it is appreciated that the elements ofelectrodes - It is appreciated that the values for the dimensions of the electrode sets 266, 268 as illustrated in
FIG. 2 are for a single specific embodiment, and these values may be selected as needed for the specific use. For example, the length of the electrode sets may be any length up to the length of the base, depending upon the orientation of the electrode sets on the base. Further, it is appreciated that the width of the conducting traces in communication with the electrode sets may vary, a non-limiting example of which is from about 0.4 mm to about 5 mm. It is further appreciated that the width of each contact pad may vary, a non-limiting example of which is from about 1 mm to about 5 mm. The electrode patterns shown inFIG. 2 are symmetric, however this is not required, and irregular or asymmetric patterns (or electrode shapes) are possible in accordance with this disclosure. Further, the number of electrode sets on thebase 212 may vary, and therefore each base 212 can contain, for example 1 to 1000 electrode sets, preferably 2 to 20 electrode sets, more preferably 2 to 3 electrode sets. - Referring again to the first electrode set 266 of
FIG. 3 , eachelectrode finger 280 is defined by aninner edge 281, anouter edge 283, and opposite third andfourth edges edge electrodes electrodes biosensor 210. For clarity purposes, however, only theedge 281 ofelectrode 270 will be discussed hereafter. - As shown in
FIG. 3 , theedge 281 ofelectrode 270 extends betweenpoints base 212.Points inner edge 281, which represents the entire length of thegap 286 betweenelectrodes 280. It is appreciated that thepoints -
FIG. 4 illustrates thetheoretical line 293 that extends exactly betweenpoints line 293 represents the ideal or desired edge that would be obtained if the process of forming the electrodes were perfect. However, at any given point along the length ofline 293, theedge 281 will be spaced in either direction fromtheoretical line 293 by a distance “di.” The distance di varies from zero to a maximum value depending upon where it happens to be measured, as shown, e.g., with reference to distances d1, d2, d3 and d4 inFIG. 4 . A standard deviation of this distance over the length ofline 293 is less than about 6 μm in accordance with this disclosure, creating an edge with a smooth edge quality. In preferred embodiments, the standard deviation of theedge 281 fromtheoretical line 293 is less than 2 μm, and most preferably less than 1.0 μm. An example of this deviation from mean or theoretical is illustrated inFIG. 10 . - The edge quality illustrated in
FIG. 10 was measured using Micro-Measure system commercially available from LPKF Laser Electronic GmbH, of Garbsen, Germany with Metric 6.21 software. The Metric software allows the display and measuring of video images on a PC. Measurements were made by capturing the image and then allowing the software to place a 10 μm grid over the image. The grid was aligned with the edge by moving the electrode structure under the measurement objective. (By physically manipulating the image, the edge can be vertically aligned to be parallel with the grid.) Using the software, measurements from the grid line to the electrode edge were then made at 10 μm intervals along the length of aline 250 μm long using a point-to-point process. The effective video magnification to video screen was 575×. (Using objective Q750). Video magnification=Actual measured “Scale length” on the video screen (μm)/Scale value (μm). For example, 115000 μcm/200 μm=575×. - In one analysis of an electrical pattern formed using the principles of the present invention, the deviation from mean of the edges was measured using a QVH-606 PRO Vision Measuring System (computer-controlled non-contact measurement system), commercially available from Mitutoyo America Corporation, Aurora, Ill. with an effective magnification to video screen=470×. Standard deviations were calculated from measurements made at an average interval of 0.69 μm for a length of at least 250 μm. Other settings: Ring lighting (Intensity 89, Position 60), Edge Detection (Edge Slope=Falling, Edge Detection TH=169, THS=18.5, THR=0.5 Scan Interval=1). The standard deviation from the mean value was less than about 2 μm.
- Referring again to
FIG. 4 , theline 293 is illustratively a straight line. It is appreciated, however, that the shape of theline 293 may be curved or angular, so long as the standard deviation of the distance ofedge 281 from thatline 293 over the length of the edge is less than about 6 μm. - The
electrode fingers 280, as shown inFIG. 3 , are separated from one another by anelectrode gap 286, which corresponds to the feature size of the electrode pattern of theelectrode set 266. Theelectrode gap 286 shown inFIG. 3 is shown as formed by twostraight edges 281. However, as just noted, the placement ofedges 281 varies from theoretical value 293 (FIG. 4 ) by a distance that varies along the length of the edge. Illustratively, inbiosensor 210, the electrically insulative material of thetop surface 232 is exposed between theelectrode fingers 280 along alength 290. It is appreciated, however, that rather thantop surface 232 being exposed, the base can be coated with materials, or recesses can be formed between the electrodes as disclosed in U.S. patent application Ser. No. 09/704,145, filed on Nov. 1, 2000, now U.S. Pat. No. 6,540,890, the disclosure of which is incorporated herein by reference. - As shown in
FIGS. 3 and 5 , theinner edges 281 ofelectrode fingers 280 have an equal length, illustrated by the numeral 290 and are separated from one another by theelectrode gap 286, whose length is also represented bylength 290. Because the twoedges 281 defininggap 286 are not perfect,gap 286 will in fact vary in width and placement over its length, as shown with reference to gaps 292 a-292 d inFIG. 5 . When the deviations of the twoedges defining gap 286 are in the same direction, they tend to cancel each other as to width deviation, at least in part, and cause a net shift in placement of the gap, as illustrated with respect toreference numerals FIG. 5 . A theoretical gap can be defined by twotheoretical lines 293 associated withedges 281. The quality of the gap or its deviation from the theoretical gap can be specified in terms of the quality of the two individual edges defining it. Preferably, the smoothness standard deviation of bothedges defining gap 286 is less 6 μm, preferably less than 2.0 μm, and most preferably less than 1 μm. - The
electrode fingers 284, which define the elements ofelectrodes FIGS. 3 and 6 . For clarity purposes, however, only three of theseelectrode fingers 284 will be discussed hereafter as they are illustrated inFIG. 6 . Eachelectrode finger 284 is defined by afirst edge 296 and asecond edge 297. Further,adjacent fingers 284 have spaced-apart third andfourth edges edges fingers 284 can also have a smooth edge quality. As previously described with reference toelectrodes electrodes electrode fingers 284 ofbiosensor 210. For clarity purposes, however, only oneedge 296 ofelectrode finger 284 will be discussed hereafter. - The
edge 296 ofelectrode finger 284 extends between first andsecond points base 212. As shown inFIG. 7 , atheoretical line 300 extends exactly betweenpoints edge edge 296 fromline 300 is less than about 6 μm, in accordance with this disclosure, creating an edge with a smooth edge quality. In preferred embodiments, the standard deviation of theedge 296 fromtheoretical line 300 is less than 2 μm, and most preferably less than 1.0 μm. Illustratively, theline 300 is a straight line. It is appreciated, however, that the shape of theline 300 may be curved or angular. It is also appreciated that the specific positions of first andsecond locations surface 232 may vary in accordance with the disclosure, although the lengths of most importance are typically the entire length of the gaps between these closely spaced electrode fingers. - Referring again to
FIG. 3 , theelectrode fingers 284 are separated from one another by anelectrode gap 288, which corresponds to the feature size of the electrode pattern of theelectrode set 268. Theelectrode gap 288 relates to the width betweenadjacent edges fingers 284. Because the twoedges defining gap 288 are not perfect,gap 288 will in fact vary in position and placement over its length. Illustratively, inbiosensor 210, the electrically insulative material of thebase 212 is exposed between theelectrode fingers 284 along alength 303. It is appreciated, however, that rather thantop surface 232 being exposed, the base can be coated with materials, or recesses can be formed between the electrodes as disclosed in U.S. patent application Ser. No. 09/704,145, filed on Nov. 1, 2000, now U.S. Pat. No. 6,540,890, entitled “Biosensor”, the disclosure of which is incorporated herein by reference. - The
electrode gap 288, which corresponds to the feature size of the electrode pattern of the electrode set 268 is different than the feature size of the electrode pattern of theelectrode set 266. Illustratively, the feature size, orgap 288 between theelectrode fingers 284 has a width of about 100 μm or less, including about 1 μm to about 100 μm, even more preferably 75 μm or less, including about 17 μm to about 50 μm. - It is appreciated that the electrode gap for a microelectrode array can vary. For example, it is understood that the electrode gap can be less than 1 μm in accordance with the present disclosure. The size of the achievable gap is dependent upon the quality of the optics, the wavelength of the laser, and the window size of a mask field.
- As illustrated in
FIG. 3 , thegap 288 has a width along alength 303 of the opposingedges electrode fingers 284. Likegap 286, the quality ofgap 286 or its deviation from a theoretical gap can be specified in terms of the quality of the two individual edges defining it. Preferably, the smoothness standard deviation of bothedges defining gap 286 is less 6 μm, preferably less than 2.0 μm, and most preferably less than 1 μm. - Referring now to
FIG. 9 , theelectrode fingers 284 are covered with thereagent 264 and may be used to provide electrochemical probes for specific analytes. The starting reagents are the reactants or components of the reagent, and are often compounded together in liquid form before application to the ribbons or reels, or in capillary channels on sheets of electrodes. The liquid may then evaporate, leaving the reagent in solid form. The choice of a specific reagent depends on the specific analyte or analytes to be measured, and is not critical to the present invention. Various reagent compositions are well known to those of ordinary skill in the art. It is also appreciated that the placement choice for the reagent on the base may vary and depends on the intended use of the biosensor. Further, it is appreciated that the techniques for applying the reagent onto the base may vary. For example, it is within the scope of the present disclosure to have the reagent screen-printed onto the fingers. - A non-limiting example of a dispensable reagent for measurement of glucose in a human blood sample contains 62.2 mg polyethylene oxide (mean molecular weight of 100-900 kilodaltons), 3.3 mg NATROSOL 250 M, 41.5 mg AVICEL RC-591 F, 89.4 mg monobasic potassium phosphate, 157.9 mg dibasic potassium phosphate, 437.3 mg potassium ferricyanide, 46.0 mg sodium succinate, 148.0 mg trehalose, 2.6 mg TRITON X-100 surfactant, and 2,000 to 9,000 units of enzyme activity per gram of reagent. The enzyme is prepared as an enzyme solution from 12.5 mg coenzyme PQQ and 1.21 million units of the apoenzyme of quinoprotein glucose dehydrogenase, forming a solution of quinoprotein glucose dehydrogenase. This reagent is further described in U.S. Pat. No. 5,997,817, the disclosure of which is expressly incorporated herein by reference.
- A non-limiting example of a dispensable reagent for measurement of hematocrit in a sample contains oxidized and reduced forms of a reversible electroactive compound (potassium hexacyanoferrate (III) (“ferricyanide”) and potassium hexacyanoferrate (II) (“ferrocyanide”), respectively), an electrolyte (potassium phosphate buffer), and a microcrystalline material (Avicel RC-591F—a blend of 88% microcrystalline cellulose and 12% sodium carboxymethyl-cellulose, available from FMC Corp.). Concentrations of the components within the reagent before drying are as follows: 400 millimolar (mM) ferricyanide, 55 mM ferrocyanide, 400 mM potassium phosphate, and 2.0% (weight: volume) Avicel. A further description of the reagent for a hematocrit assay is found in U.S. Pat. No. 5,385,846, the disclosure of which is expressly incorporated herein by reference.
- Non-limiting examples of enzymes and mediators that may be used in measuring particular analytes in biosensors of the present invention are listed below in Table 1.
TABLE 1 Mediator Analyte Enzymes (Oxidized Form) Additional Mediator Glucose Glucose Dehydrogenase Ferricyanide and Diaphorase Osmium complexes, nitrosoanaline complexes Glucose Glucose-Dehydrogenase Ferricyanide (Quinoprotein) Cholesterol Cholesterol Esterase and Ferricyanide 2,6-Dimethyl-1,4- Cholesterol Oxidase Benzoquinone 2,5-Dichloro-1,4- Benzoquinone or Phenazine Ethosulfate HDL Cholesterol Esterase Ferricyanide 2,6-Dimethyl-1,4- Cholesterol and Cholesterol Oxidase Benzoquinone 2,5-Dichloro-1,4- Benzoquinone or Phenazine Ethosulfate Triglycerides Lipoprotein Lipase, Ferricyanide or Phenazine Methosulfate Glycerol Kinase, and Phenazine Glycerol-3-Phosphate Ethosulfate Oxidase Lactate Lactate Oxidase Ferricyanide 2,6-Dichloro-1,4- Benzoquinone Lactate Lactate Dehydrogenase Ferricyanide and Diaphorase Phenazine Ethosulfate, or Phenazine Methosulfate Lactate Diaphorase Ferricyanide Phenazine Ethosulfate, or Dehydrogenase Phenazine Methosulfate Pyruvate Pyruvate Oxidase Ferricyanide Alcohol Alcohol Oxidase Phenylenediamine Bilirubin Bilirubin Oxidase 1-Methoxy- Phenazine Methosulfate Uric Acid Uricase Ferricyanide - In some of the examples shown in Table 1, at least one additional enzyme is used as a reaction catalyst. Also, some of the examples shown in Table 1 may utilize an additional mediator, which facilitates electron transfer to the oxidized form of the mediator. The additional mediator may be provided to the reagent in lesser amount than the oxidized form of the mediator. While the above assays are described, it is contemplated that current, charge, impedance, conductance, potential, or other electrochemically indicated property of the sample might be accurately correlated to the concentration of the analyte in the sample with biosensors in accordance with this disclosure.
- Another non-limiting example of a suitable dispensable reagent for use with biosensors of the present invention is nitrosoanaline reagent, which includes a PQQ-GDH and para-Nitroso-Aniline mediator. A protocol for the preparation of the nitrosoanaline reagent is the same in all respects as disclosed in U.S. patent application Ser. No. 10/688,312, entitled “System And Method For Analyte Measurement Using AC Phase Angle Measurement”, filed Oct. 17, 2003, the disclosure of which is incorporated herein by reference. The reagent mass composition—prior to dispensing and drying is as set forth in Table 2.
TABLE 2 Mass for Component % w/ w 1 kg solid Polyethylene oxide (300 KDa) 0.8054% 8.0539 g solid NATROSOL ® 250 M 0.0470% 0.4698 g solid AVICEL ® RC-591F 0.5410% 5.4104 g solid Monobasic potassium phosphate 1.1437% 11.4371 g (anhydrous) solid Dibasic potassium phosphate 1.5437% 15.4367 g (anhydrous) solid Sodium Succinate hexahydrate 0.5876% 5.8761 g solid Potassium Hydroxide 0.3358% 3.3579 g solid Quinoprotein glucose dehydrogenase 0.1646% 1.6464 g (EncC#: 1.1.99.17) solid PQQ 0.0042% 0.0423 g solid Trehalose 1.8875% 18.8746 g solid Mediator BM 31.1144 0.6636% 6.6363 g solid TRITON ® X-100 0.0327% 0.3274 g solvent Water 92.2389% 922.3888 g % Solids 0.1352687 Target pH 6.8 Specific Enzyme Activity Used (U/mg 689 DCIP Dispense Volume per Biosensor 4.6 mg - A coatable reagent suitable for use with the present disclosure is as follows in Table 3.
TABLE 3 Component % w/w Mass for 1 kg Keltrol F, xanthan gum 0.2136% 2.1358 g Sodium Carboxymethylcellulose (CMC) 0.5613% 5.6129 g Polyvinylpyrrolidone, (PVP K25) 1.8952% 18.9524 g PROPIOFAN ®, 2.8566% 28.5657 g GlucDOR 0.3310% 3.3098 g PQQ 0.0092% 0.0922 g Sipernat 320 DS 2.0039% 20.0394 g Na-Succinat × 6H2O 0.4803% 4.8027 g Trehalose 0.4808% 4.8081 g KH2PO4 0.4814% 4.8136 g K2HPO4 1.1166% 11.1658 g Mediator 31.1144 0.6924% 6.9242 g Mega 8 0.2806% 2.8065 g Geropon T 77 0.0298% 0.2980 g KOH 0.1428% 1.4276 g Water 88.4245% 884.2453 g % Solids 11.5755 Target pH 7.0 Specific Enzyme Activity Used (U/mg 2.23 DCIP Coat Weight 55 g/m2 -
Biosensor 210 is illustratively manufactured using twoapparatuses FIGS. 17-18 and 19, respectively. It is appreciated that unless otherwise described, theapparatuses FIG. 17 ,biosensor 210 is manufactured by feeding a roll of ribbon orweb 20 having an 80 nm gold laminate, which is about 40 mm in width, into a custom fit broad fieldlaser ablation apparatus 10. Theapparatus 10 comprises alaser source 11 producing a beam oflaser light 12, a chromium-platedquartz mask 14, andoptics 16. It is appreciated that while the illustratedoptics 16 is a single lens,optics 16 is preferably a variety of lenses that cooperate to make the light 12 in a pre-determined shape or image that is then projected onto the web ofbase substrate 20. - A non-limiting example of a suitable ablation apparatus 10 (
FIGS. 17-18 ) is a customized MicrolineLaser 200-4 laser system commercially available from LPKF Laser Electronic GmbH, of Garbsen, Germany, which incorporates an LPX-400, LPX-300 or LPX-200 laser system commercially available from Lambda Physik AG, Gottingen, Germany and a chromium-plated quartz mask commercially available from International Phototool Company, Colorado Springs, Co. - For the MicrolineLaser 200-4 laser system (
FIGS. 17-18 ), thelaser source 11 is a LPX-200 KrF-UV-laser. It is appreciated, however, that higher wavelength UV lasers can be used in accordance with this disclosure. Thelaser source 11 works at 248 nm, with a pulse energy of 600 mJ, and a pulse repeat frequency of 50 Hz. The intensity of thelaser beam 12 can be infinitely adjusted between 3% and 92% by a dielectric beam attenuator (not shown). The beam profile is 27×15 mm2 (0.62 sq. inch) and thepulse duration 25 ns. The layout on themask 14 is homogeneously projected by an optical elements beam expander, homogenizer, and field lens (not shown). The performance of the homogenizer has been determined by measuring the energy profile. Theimaging optics 16 transfer the structures of themask 14 onto theribbon 20. The imaging ratio is 2:1 to allow a large area to be removed on the one hand, but to keep the energy density below the ablation point of the applied chromium mask on the other hand. While an imaging of 2:1 is illustrated, it is appreciated that the any number of alternative ratios are possible in accordance with this disclosure depending upon the desired design requirements. Theribbon 20 moves as shown byarrow 25 to allow a number of layout segments to be ablated in succession. - The positioning of the
mask 14, movement of theribbon 20, and laser energy are computer controlled. As shown inFIG. 17 , thelaser beam 12 is projected onto theribbon 20 to be ablated.Light 12 passing through the clear areas orwindows 18 of themask 14 ablates the metal from theribbon 20. Chromium coatedareas 24 of themask 14 blocks thelaser light 12 and prevent ablation in those areas, resulting in a metallized structure on theribbon 20 surface. Referring now toFIG. 18 , a complete structure of electrical components may require additional ablation steps through asecond mask 14′. It is appreciated that depending upon the optics and the size of the electrical component to be ablated, that only a single ablation step or greater than two ablation steps may be necessary in accordance with this disclosure. Further, it is appreciated that instead of multiple masks, that multiple fields may be formed on the same mask in accordance with this disclosure. - Specifically, a second non-limiting example of a
suitable ablation apparatus 10′ (FIG. 19 ) is a customized laser system commercially available from LPKF Laser Electronic GmbH, of Garbsen, Germany, which incorporates a Lambda STEEL (Stable energy eximer laser) laser system commercially available from Lambda Physik AG, Göttingen, Germany and a chromium-plated quartz mask commercially available from International Phototool Company, Colorado Springs, Co. The laser system features up to 1000 mJ pulse energy at a wavelength of 308 nm. Further, the laser system has a frequency of 100 Hz. Theapparatus 10′ may be formed to produce biosensors with two passes as shown inFIGS. 17 and 18 , but preferably its optics permit the formation of a 10×40 mm pattern in a 25 ns single pass. - While not wishing to be bound to a specific theory, it is believed that the laser pulse or
beam 12 that passes through themask surface 232 on theribbon 20. The photons of thebeam 12 have an energy sufficient to cause photo-dissociation and the rapid breaking of chemical bonds at the metal/polymer interface. It is believed that this rapid chemical bond breaking causes a sudden pressure increase within the absorption region and forces material (metal film 216) to be ejected from the polymer base surface. Since typical pulse durations are around 20-25 nanoseconds, the interaction with the material occurs very rapidly and thermal damage to edges of theconductive material 216 and surrounding structures is minimized. The resulting edges of the electrical components have high edge quality and accurate placement as contemplated by the present invention. - Fluence energies used to remove or ablate metals from the
ribbon 20 are dependent upon the material from which theribbon 20 is formed, adhesion of the metal film to the base material, the thickness of the metal film, and possibly the process used to place the film on the base material, i.e. supporting and vapor deposition. Fluence levels for gold on KALADEX® range from about 50 to about 90 mJ/cm2, on polyimide about 100 to about 120 mJ/cm2, and on MELINEX® about 60 to about 120 mJ/cm2. It is understood that fluence levels less than or greater than the above mentioned can be appropriate for other base materials in accordance with the disclosure. - Patterning of areas of the
ribbon 20 is achieved by using themasks mask mask field 22 containing a precise two-dimensional illustration of a pre-determined portion of the electrode component patterns to be formed.FIG. 17 illustrates themask field 22 including contact pads and a portion of traces. As shown inFIG. 18 , thesecond mask 14′ contains a second corresponding portion of the traces and the electrode patterns containing fingers. As previously described, it is appreciated that depending upon the size of the area to be ablated, themask 14 can contain a complete illustration of the entire electrode pattern for each biosensor (FIG. 19 ), or partial patterns different from those illustrated inFIGS. 17 and 18 in accordance with this disclosure. Preferably, it is contemplated that in one aspect of the present invention, the entire pattern of the electrical components on the test strip are laser ablated at one time, i.e., the broad field encompasses the entire size of the test strip (FIG. 19 ), or even encompasses the entire size of two or more test strips (not shown). In the alternative, and as illustrated inFIGS. 17 and 18 , portions of the entire biosensor are done successively. - While
mask 14 will be discussed hereafter, it is appreciated that unless indicated otherwise, the discussion will apply tomasks 14′, 14″ as well. Referring toFIG. 17 ,areas 24 of themask field 22 protected by the chrome will block the projection of thelaser beam 12 to theribbon 20. Clear areas orwindows 18 in themask field 22 allow thelaser beam 12 to pass through themask 14 and to impact predetermined areas of theribbon 20. As shown inFIG. 17 , theclear area 18 of themask field 22 corresponds to the areas of theribbon 20 from which theconductive material 216 is to be removed. - Further, the
mask field 22 has a length shown byline 30 and a width as shown byline 32. Given the imaging ratio of 2:1 of the LPX-200, it is appreciated that thelength 30 of the mask is two times the length of alength 34 of the resulting pattern and thewidth 32 of the mask is two times the width of awidth 36 of the resulting pattern onribbon 20. Theoptics 16 reduces the size oflaser beam 12 that strikes theribbon 20. It is appreciated that the relative dimensions of themask field 22 and the resulting pattern can vary in accordance with this disclosure.Mask 14′ (FIG. 18 ) is used to complete the two-dimensional illustration of the electrical components. - Continuing to refer to
FIG. 17 , in thelaser ablation apparatus 10 theexcimer laser source 11 emitsbeam 12, which passes through the chrome-on-quartz mask 14. Themask field 22 causes parts of thelaser beam 12 to be reflected while allowing other parts of the beam to pass through in the form of an image of part or all of an electrode pattern. The image or part oflaser beam 12 that passes throughmask 14 in turn creates a pattern on the gold film where impacted by thelaser beam 12. It is appreciated that ribbon orweb 20 can be stationary relative toapparatus 10 or move continuously on a roll throughapparatus 10. Accordingly, non-limiting rates of movement of theribbon 20 can be from about 0 m/min to about 100 m/min, more preferably about 30 m/min to about 60 m/min. It is appreciated that the rate of movement of theribbon 20 is limited only by theapparatus 10 selected and may well exceed 100 m/min depending upon the pulse duration of thelaser source 11 in accordance with the present disclosure. - Once the pattern of the
mask 14 is created on theribbon 20, the ribbon is rewound and fed through theapparatus 10 again, withmask 14′ (FIG. 18 ). It is appreciated thatlaser apparatus 10 could, alternatively, be positioned in series in accordance with this disclosure. A detailed description of the step and repeat process is found in U.S. Application Ser. No. 60/480,397, filed Jun. 20, 2003, entitled “Devices And Methods Relating To Analyte Sensors”, the disclosure of which is incorporated herein by reference. Thus, by usingmasks ribbon 20 can be patterned using step-and-repeat processes involvingmultiple mask fields 22 in the same mask area to enable the economical creation of intricate electrode patterns and other electrical components on a substrate of the base, the precise edges of the electrode components, and the removal of greater amounts of the metallic film from the base material. -
FIG. 20 is a non-limiting schematic of an electrode set ribbon 124 formed in accordance with the present disclosure, although having an electrode pattern different from that illustrated inFIGS. 17 and 18 . The ribbon 124 includes a plurality of panels 120, each of which includes a plurality of electrode systems 116. Each system includes two electrodes, both labeled 104 and having a sensing region 110. Also shown is the original metallic laminate ribbon 122 that is subject to laser ablation to form the electrode set ribbon 124. The width of the ribbon 122 is selected to accommodate thelaser ablation system - Once the complete electrode patterns are created, it is appreciated that the
ribbon 20 may be coupled to a spacer and a cover using any number of well-known commercially available methods. A non-limiting example of a suitable method of manufacture, is described in detail in U.S. Application Ser. No. 60/480,397, filed Jun. 20, 2003, entitled “Devices And Methods Relating To Analyte Sensors”, the disclosure of which is incorporated herein by reference. In summary, however, it is appreciated that a reagent film is placed upon the ribbon and dried conventionally with an in-line drying system. The rate of processing is nominally 30-38 meters per minute and depends upon the rheology of the reagent. Reagents suitable for thebiosensor 210 are given above, but a preferable reagent is set out in Table 2. - The materials are processed in continuous reels such that the electrode pattern is orthogonal to the length of the reel, in the case of the base. Once the base has been coated, the spacer material is laminated onto the
coated ribbon 20. Prior to laminating the spacer material, however, a portion of the spacer material is removed, thereby forming a slit. A punching process is used to remove the unneeded portion of the spacer. The die set governs the shape of the slit. The resulting slit-spacer is placed in a reel-to-reel process onto the base. A cover is then laminated onto the spacer using a reel-to reel process. The biosensors can then be produced from the resulting reels of material by means of slitting and cutting. - The slit in the spacer preferably forms a capillary fill space between the base and the cover. A hydrophobic adhesive on the spacer prevents the test sample from flowing into the reagent under the spacer and therefore the fill space defines the test chamber volume. It is appreciated that the chamber volume can vary in accordance with this disclosure depending upon the application of the biosensor. A non-limiting detailed description of suitable fill volumes is found in U.S. Application Ser. No. 60/480,397, noted above.
- As discussed above,
biosensor 210 has two electrode patterns having different feature sizes on a common planar surface and thus achieves multiple functionalities on that surface. Preferably, electrode set 266 has an electrode pattern formed as a macro electrode array with a first pre-defined feature size. A non-limiting example of a suitable functionality of the macroelectrode array is hematocrit level correction, which is described in U.S. patent application Ser. No. 10/688,312, entitled “System And Method For Analyte Measurement Using AC Phase Angle Measurement”, filed Oct. 17, 2003, the disclosure of which is incorporated herein by reference. Further, it is appreciated that during use, a test meter (not shown) applies a voltage to one electrode and measures the current response at the other electrode to obtain a signal as described in U.S. patent application Ser. No. 10/688,312 just noted. - Electrode set 268 has an electrode pattern formed as an interlaced microelectrode array with a second pre-defined feature size. A non-limiting example of a suitable functionality of the microelectrode array is glucose estimation, which is also described in U.S. patent application Ser. No. 10/688,312. Further, it is appreciated that during use, a test meter (not shown) applies a voltage to one electrode and measures the current response at the other electrode to obtain a signal as described in U.S. patent application Ser. No. 10/688,312.
- In operation, a user places his or her lanced finger at opening 221 of
biosensor 210. A liquid sample (whole blood) flows from the finger into theopening 221. The liquid sample is transported via capillary action through the sample-receivingchamber 220 and across thefingers 280 of the element of theelectrode set 266. Subsequently, the liquid sample flows through the sample-receivingchamber 220 towardvent 262 and into engagement with thereagent 264 situated upon thefingers 284 of the element of theelectrode set 268. As discussed above, hematocrit correction values are determined from the interaction of the liquid sample with thefingers 280 and a glucose determination from the interaction of the liquid sample/reagent mixture with thefingers 284. While hematocrit and glucose determination functionalities are described with reference tobiosensor 210, it is appreciated that the electrode patterns, may be used for a variety of functionalities in accordance with the present disclosure. - The processes and products described include disposable biosensors, especially for use in diagnostic devices. However, also included are electrochemical biosensors for non-diagnostic uses, such as measuring an analyte in any biological, environmental, or other, sample. In addition, it is appreciated that various uses and available functions of the biosensor may stand alone or be combined with one another in accordance with this disclosure.
- As discussed below with reference to
FIGS. 11-16 , each of the disclosed biosensors operates from the standpoint of a user in a manner similar to that described above with reference from 210. In addition, like components of the biosensors are numbered alike. - Referring now to
FIG. 11 , abiosensor 310 is formed and manufactured in a manner similar tobiosensor 210 except for the pattern of theconductive material 216 positioned on thebase 212. Theconductive material 216 ofbiosensor 310 defines afirst electrode system 366 and asecond electrode system 368. Theelectrode systems biosensor 210 except for the resulting pattern of the connectingtraces contact pads base 212. It is submitted that thetraces pads - As shown in
FIG. 12 , abiosensor 510 is formed in a manner similar tobiosensor 210 except for the pattern of theconductive material 216 positioned on thebase 212. In addition toelectrode set 268, theconductive material 216 ofbiosensor 510 defines afirst electrode set 566. The electrode set 566 is similar to set 366 except for the configuration of the interlacing electrode pattern formed by the elements of the electrodes. - Specifically, the first electrode set 566 includes a working electrode having an element with one
electrode finger 581 and a counter electrode having an element with twoelectrode fingers 580. Thefingers electrodes set 266, the electrode and gap widths may vary in accordance with this disclosure. - As described above with reference to
biosensor 210, the first and second electrode sets 566, 268 have different feature sizes and are used to create different functionalities onbiosensor 510. A non-limiting example of a suitable functionality of the first electrode set 566 is for determining correction factors for hematocrit levels. The measurement methods are as discussed above with reference tobiosensor 210. - Referring now to
FIG. 13 , abiosensor 610 is formed in a manner similar tobiosensor 210 except for the pattern of theconductive material 216 positioned on thebase 212. In addition to the first electrode set 566 as discussed above, theconductive material 216 ofbiosensor 610 defines a second electrode set 668 spaced-apart fromset 566. - The electrode set 668 is similar to set 268 except for the pattern of interlacing electrode pattern in the element of the electrodes. Specifically, the second electrode set 668 includes a working electrode and a counter electrode, each having an element with three
electrode fingers 661. Thefingers 661 cooperate with one another to define an interlaced electrode pattern configured as a microelectrode array having a feature size or gap width of about 50 μm, which is less than the feature size of the electrode pattern of theset 566. Theelectrodes 661 each have an electrode width of about 50 μm. As discussed above withset 268, the electrode and gap widths may vary in accordance with this disclosure. - In addition,
biosensor 610 includes areagent 664.Reagent 664 is similar toreagent 264, and only differs in its width as it is applied onto thebase 212. Specifically, thereagent 664 extends acrosselectrode fingers 661. A non-limiting example of a suitable functionality of the second electrode set 668 is a glucose determination functionality. The measurement methods are as discussed above with reference tobiosensor 210. - As shown in
FIG. 14 , abiosensor 710 is formed in a manner similar tobiosensor 210 except for the pattern of theconductive material 216 positioned on thebase 212. Theconductive material 216 ofbiosensor 710 defines the first electrode set 366 as discussed above and asecond electrode set 768. The electrode set 768 is similar to set 268 except for the pattern of an interlacing electrode pattern formed by the element of the electrodes. Specifically, the second electrode set 768 includes a working electrode and a counter electrode, each having element with fiveelectrode fingers 770. Thefingers 770 cooperate with one another to define an interlaced electrode pattern configured as a microelectrode array having a feature size or gap width of about 30 μm, which is less than the feature size of electrode pattern ofset 366. Theelectrode fingers 770 each have an electrode width of about 50 μm. As discussed above withset 266, the electrode and gap widths may vary in accordance with this disclosure. A non-limiting example of a suitable functionality of the second electrode set 668 is a glucose determination functionality. The measurement methods are as discussed above with reference tobiosensor 210. - In addition,
biosensor 710 includes areagent 364 that is dispensed upon thefingers 770 by any of a variety of dispensing methods that are well known to those skilled in the art.Reagent 364 is preferably the reagent set forth in Table 3. Moreover, it is appreciated that a variety of reagents, non-limiting examples of which have been discussed above, may be used in accordance with this disclosure. -
FIG. 15 illustrates abiosensor 1310 in accordance with this disclosure.Biosensor 1310 is formed in a manner similar tobiosensor 210 except for the configuration of theconductive material 216 positioned on thebase 212, thecover 1118, and thespacer 1114. Thecover 1118 andspacer 1114 are similar to cover 218 andspacer 214 except for their dimensions relative to the base 212 as shown inFIG. 15 . Theconductive material 216 ofbiosensor 1310 defines afirst electrode set 1366 and asecond electrode set 1368. Thefirst electrode set 1366 includes a working electrode and a counter electrode, each having fiveelectrode fingers 1370. Thefingers 1370 cooperate with one another to define an interlaced electrode pattern formed as a microelectrode array having a feature size or gap width of about 17 μm. Theelectrode fingers 1370 each have an electrode width of about 20 μm. - The
second electrode set 1368 includes a working electrode and a counter electrode, each having threeelectrode fingers 1371. Theelectrode fingers 1371 cooperate with one another to define an interlaced electrode pattern formed as a microelectrode array having a feature size or gap width of about 10 μm. Theelectrode fingers 1371 each have an electrode width of about 20 μm. As discussed above withset 266, the electrode and gap widths offingers - The
reagent 264 extends across theelectrode fingers 1371 of theelectrode set 1368. A non-limiting example of a suitable functionality of thefirst electrode set 1366 includes hematocrit correction as described above with reference tobiosensor 210. Likewise, a non-limiting example of a suitable functionality of thesecond electrode set 1368 is used for determining a glucose estimate as described above with reference tobiosensor 210. The method of measurement for the electrode sets, 1366 and 1368 is also as described above with reference tobiosensor 210. -
FIG. 16 illustratesbiosensor 1510.Biosensor 1510 is identical tobiosensor 210, except for the reagent 1564.Reagent 364 is dispensed onto theelectrode fingers 284 as discussed above with reference tobiosensor 710 ofFIG. 14 . -
FIGS. 21-24 are photographs of electrical patterns formed using the principles of the present invention.FIG. 21 is a photograph of a base substrate having an electrical pattern formed thereon by removing 10% of the conductive material initially covering the base substrate. In this embodiment the conductive material is gold. The pattern was formed with a single pulse of a laser. -
FIG. 22 is a photograph of a base substrate having an electrical pattern formed thereon by removing 20% of the conductive material initially covering the base substrate. In this embodiment the conductive material is gold and the gap widths are approximately 20 μm as indicated. The pattern was formed with a single pulse of a laser. -
FIG. 23 is a photograph of a base substrate having an electrical pattern formed thereon by removing 50% of the conductive material initially covering the base substrate. In this embodiment the conductive material is gold and the gap widths are approximately 20 μm as indicated. The pattern was formed with a single pulse of a laser. -
FIG. 24 is a photograph of a base substrate having an electrical pattern formed thereon by removing 90% of the conductive material initially covering the base substrate. In this embodiment the conductive material is gold and the gap widths are approximately 250 μm as indicated. The pattern was formed with a single pulse of a laser. - Several production runs were made which demonstrate the very fast speed in which the electrical patterns of the biosensors in accordance with the present invention can be produced. Many of the runs included electrode patterns with two different feature sizes, as indicated in Table 4.
FIGS. 21-24 are photos taken of selected ones of the electrode structures, as also indicated in Table 4. The masks used to make the patterns included both “Structure 1” and “Structure 2” listed in Table 4. A single laser pulse of about 25 nanoseconds was used to form the patterns. As indicated, long webs (about 450 m or more) of material were passed under the laser ablation apparatus at a controlled speed as the electrical patterns were formed. The pitch or distance between the electrical patterns was 9.015 mm for all runs, which corresponds to a preferred width of a biosensor made in accordance with the present invention.TABLE 4 Roll Structure 1 Structure 2 Run time Patterns Length Run # Finger/Gap (μm) Finger/Gap (μm) (min) per min. Figure (m) 1 20/20 250/200 20 2585 466 2 250/50 — 40 1256 453 3 20/250 250/20 13 3873 24 454 (Structure 1) 4 20/20 250/20 22 2284 453 (Structure 2) 5 50/50 100/100 22 2289 454 6 100/50 — 20 2518 454 7 20/20 100/20 23 2363 FIG. 23 -490 Structure 1;FIG. 22 -Structure 2 8 50/100 — 19 2755 472 9 20/20 50/20 19 2860 490 - The “patterns per minute” column reflects the speed at which substrates for individual biosensors can be formed. For example, in Run No. 1, 2585 base substrates each corresponding to a single biosensor, and each having two (2) electrode feature sizes, are formed in a single minute. As can be seen from the above table 4, the method embodied by the present invention is well suited to fast mass production.
- Although the invention has been described in detail with reference to a preferred embodiment, variations and modifications exist within the scope and spirit of the invention, on as described and defined in the following claims.
Claims (102)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/871,937 US20050103624A1 (en) | 1999-10-04 | 2004-06-18 | Biosensor and method of making |
US12/238,023 US8287703B2 (en) | 1999-10-04 | 2008-09-25 | Biosensor and method of making |
US12/238,101 US8551308B2 (en) | 1999-10-04 | 2008-09-25 | Biosensor and method of making |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/411,940 US6662439B1 (en) | 1999-10-04 | 1999-10-04 | Laser defined features for patterned laminates and electrodes |
US09/684,257 US6645359B1 (en) | 2000-10-06 | 2000-10-06 | Biosensor |
US09/840,843 US6767440B1 (en) | 2001-04-24 | 2001-04-24 | Biosensor |
US10/264,891 US7276146B2 (en) | 2001-11-16 | 2002-10-04 | Electrodes, methods, apparatuses comprising micro-electrode arrays |
US10/601,144 US7073246B2 (en) | 1999-10-04 | 2003-06-20 | Method of making a biosensor |
US10/871,937 US20050103624A1 (en) | 1999-10-04 | 2004-06-18 | Biosensor and method of making |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/601,144 Continuation-In-Part US7073246B2 (en) | 1999-10-04 | 2003-06-20 | Method of making a biosensor |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/238,023 Division US8287703B2 (en) | 1999-10-04 | 2008-09-25 | Biosensor and method of making |
US12/238,023 Continuation US8287703B2 (en) | 1999-10-04 | 2008-09-25 | Biosensor and method of making |
US12/238,101 Division US8551308B2 (en) | 1999-10-04 | 2008-09-25 | Biosensor and method of making |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050103624A1 true US20050103624A1 (en) | 2005-05-19 |
Family
ID=43385575
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/871,937 Abandoned US20050103624A1 (en) | 1999-10-04 | 2004-06-18 | Biosensor and method of making |
US12/238,101 Expired - Fee Related US8551308B2 (en) | 1999-10-04 | 2008-09-25 | Biosensor and method of making |
US12/238,023 Expired - Lifetime US8287703B2 (en) | 1999-10-04 | 2008-09-25 | Biosensor and method of making |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/238,101 Expired - Fee Related US8551308B2 (en) | 1999-10-04 | 2008-09-25 | Biosensor and method of making |
US12/238,023 Expired - Lifetime US8287703B2 (en) | 1999-10-04 | 2008-09-25 | Biosensor and method of making |
Country Status (1)
Country | Link |
---|---|
US (3) | US20050103624A1 (en) |
Cited By (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060100543A1 (en) * | 2002-12-30 | 2006-05-11 | Raney Charles C | Integrated Analytical Test Element |
US20070040567A1 (en) * | 2005-08-16 | 2007-02-22 | Natasha Popovich | Method for test strip manufacturing and test card analysis |
US7465597B2 (en) | 2006-06-29 | 2008-12-16 | Home Diagnostics, Inc. | Method of manufacturing a diagnostic test strip |
US20080319295A1 (en) * | 2007-06-21 | 2008-12-25 | Abbott Diabetes Care, Inc. | Health management devices and methods |
US20090042306A1 (en) * | 2007-08-06 | 2009-02-12 | Reynolds Jeffery S | System and Method for Automatic Calibration |
FR2921157A1 (en) * | 2007-09-18 | 2009-03-20 | Saint Gobain | ELECTRODE FOR MICROFLUIDIC SYSTEM |
US7510985B1 (en) | 2005-10-26 | 2009-03-31 | Lpkf Laser & Electronics Ag | Method to manufacture high-precision RFID straps and RFID antennas using a laser |
US20090113981A1 (en) * | 2007-11-06 | 2009-05-07 | Bayer Healthcare, Llc | Auto-calibrating test sensors |
US20090117571A1 (en) * | 2007-08-15 | 2009-05-07 | State of Oregon by and through the State Board of Higher Education on behalf of Portland State Univ. | Impedance spectroscopy of biomolecules using functionalized nanoparticles |
US20090125268A1 (en) * | 2007-11-11 | 2009-05-14 | Bayer Healthcare Llc | Biosensor Coding System |
US20090205399A1 (en) * | 2008-02-15 | 2009-08-20 | Bayer Healthcare, Llc | Auto-calibrating test sensors |
US20090227898A1 (en) * | 2006-10-15 | 2009-09-10 | Hans-Peter Haar | Diagnostic test element and process for its production |
US20090288964A1 (en) * | 2006-12-13 | 2009-11-26 | Sung-Kwon Jung | Biosensor with coded information and method for manufacturing the same |
US20090294277A1 (en) * | 2008-05-30 | 2009-12-03 | Abbott Diabetes Care, Inc. | Method and system for producing thin film biosensors |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7666149B2 (en) | 1997-12-04 | 2010-02-23 | Peliken Technologies, Inc. | Cassette of lancet cartridges for sampling blood |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US20100084466A1 (en) * | 2008-10-07 | 2010-04-08 | Bayer Healthcare Llc | Method of forming an auto-calibration circuit or label |
US7699791B2 (en) | 2001-06-12 | 2010-04-20 | Pelikan Technologies, Inc. | Method and apparatus for improving success rate of blood yield from a fingerstick |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7731729B2 (en) | 2002-04-19 | 2010-06-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20100243441A1 (en) * | 2009-03-30 | 2010-09-30 | Henning Groll | Biosensor with predetermined dose response curve and method of manufacturing |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US7822455B2 (en) | 2006-02-28 | 2010-10-26 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US7833171B2 (en) | 2002-04-19 | 2010-11-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7841992B2 (en) | 2001-06-12 | 2010-11-30 | Pelikan Technologies, Inc. | Tissue penetration device |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7862520B2 (en) | 2002-04-19 | 2011-01-04 | Pelikan Technologies, Inc. | Body fluid sampling module with a continuous compression tissue interface surface |
US20110000785A1 (en) * | 2007-10-31 | 2011-01-06 | Raghbir Singh Bhullar | Electrical patterns for biosensor and method of making |
US7874994B2 (en) | 2002-04-19 | 2011-01-25 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909775B2 (en) | 2001-06-12 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US7909777B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7914465B2 (en) | 2002-04-19 | 2011-03-29 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7959582B2 (en) | 2002-04-19 | 2011-06-14 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7988645B2 (en) | 2001-06-12 | 2011-08-02 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US8007446B2 (en) | 2002-04-19 | 2011-08-30 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8079960B2 (en) | 2002-04-19 | 2011-12-20 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
WO2012003306A1 (en) * | 2010-06-30 | 2012-01-05 | Roche Diagnostics Operations, Inc. | Methods for manufacturing a dual biosensor test strip |
US20120022352A1 (en) * | 2005-10-12 | 2012-01-26 | Masaki Fujiwara | Blood sensor, blood testing apparatus, and method for controlling blood testing apparatus |
WO2012025208A1 (en) * | 2010-08-24 | 2012-03-01 | Roche Diagnostics Gmbh | Biosensor test member and method for making the same |
US8197421B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8252229B2 (en) | 2008-04-10 | 2012-08-28 | Abbott Diabetes Care Inc. | Method and system for sterilizing an analyte sensor |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8333710B2 (en) | 2002-04-19 | 2012-12-18 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US20130027042A1 (en) * | 2010-02-19 | 2013-01-31 | Schlumberger Technology Corporation | Fluid Sensor and Method of Using Same |
US20130032284A1 (en) * | 2005-06-08 | 2013-02-07 | Abbott Diabetes Care Inc. | Biosensors and Methods of Preparing Same |
US8435190B2 (en) | 2002-04-19 | 2013-05-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8439872B2 (en) | 1998-03-30 | 2013-05-14 | Sanofi-Aventis Deutschland Gmbh | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
GB2501128A (en) * | 2012-04-13 | 2013-10-16 | Phillip J Ainger | Resistance measurements across first and second electrode pairs to determine glucose and packed cell volume respectively |
US8617069B2 (en) | 2007-06-21 | 2013-12-31 | Abbott Diabetes Care Inc. | Health monitor |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8721671B2 (en) | 2001-06-12 | 2014-05-13 | Sanofi-Aventis Deutschland Gmbh | Electric lancet actuator |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US8880138B2 (en) | 2005-09-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Device for channeling fluid and methods of use |
US8894832B2 (en) | 2010-03-30 | 2014-11-25 | Jabil Circuit (Singapore) Pte, Ltd. | Sampling plate |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8992750B1 (en) | 2012-07-02 | 2015-03-31 | Roche Diagnostics Operations, Inc. | Biosensor and methods for manufacturing |
US9011658B2 (en) | 2010-03-30 | 2015-04-21 | Jabil Circuit (Singapore) Pte, Ltd. | Sampling plate |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US9069536B2 (en) | 2011-10-31 | 2015-06-30 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
US9072842B2 (en) | 2002-04-19 | 2015-07-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US20150298124A1 (en) * | 2014-04-16 | 2015-10-22 | Abbott Laboratories | Droplet actuator fabrication apparatus, systems, and related methods |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
CN105718504A (en) * | 2015-12-26 | 2016-06-29 | 小米科技有限责任公司 | Method and device for determining positioning information corresponding to address information |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
CN105793700A (en) * | 2013-11-27 | 2016-07-20 | 松下健康医疗控股株式会社 | Method of measuring blood component amount |
US9423374B2 (en) * | 2015-01-26 | 2016-08-23 | Lifescan Scotland Limited | Reference electrode error trap determined from a specified sampling time and a pre-determined sampling time |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9532737B2 (en) | 2011-02-28 | 2017-01-03 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9636450B2 (en) | 2007-02-19 | 2017-05-02 | Udo Hoss | Pump system modular components for delivering medication and analyte sensing at seperate insertion sites |
US9795326B2 (en) | 2009-07-23 | 2017-10-24 | Abbott Diabetes Care Inc. | Continuous analyte measurement systems and systems and methods for implanting them |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US10136816B2 (en) | 2009-08-31 | 2018-11-27 | Abbott Diabetes Care Inc. | Medical devices and methods |
EP3457121A1 (en) * | 2017-09-18 | 2019-03-20 | Roche Diabetes Care GmbH | Electrochemical sensor and sensor system for detecting at least one analyte |
US10328201B2 (en) | 2008-07-14 | 2019-06-25 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
US10610137B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10641724B2 (en) | 2012-04-13 | 2020-05-05 | Smartcase Technologies Limited | Electrical impedance hematocrit and HBA1C biosensor comprising sample plate and sample apparatus |
US11006872B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11883164B2 (en) | 2004-07-13 | 2024-01-30 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050103624A1 (en) * | 1999-10-04 | 2005-05-19 | Bhullar Raghbir S. | Biosensor and method of making |
EP2889611B1 (en) | 1999-11-15 | 2019-09-04 | PHC Holdings Corporation | Biosensor and measurement apparatus. |
EP3912551B1 (en) * | 2009-02-26 | 2023-08-30 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte sensor |
US20100247775A1 (en) * | 2009-03-31 | 2010-09-30 | Abbott Diabetes Care Inc. | Precise Fluid Dispensing Method and Device |
US20100274515A1 (en) * | 2009-04-28 | 2010-10-28 | Abbott Diabetes Care Inc. | Dynamic Analyte Sensor Calibration Based On Sensor Stability Profile |
WO2011047276A2 (en) * | 2009-10-15 | 2011-04-21 | Interdigital Patent Holdings, Inc. | Registration and credential roll-out for accessing a subscription-based service |
CN103718030A (en) * | 2011-05-05 | 2014-04-09 | 达克雷诊断器材有限公司 | Conductive patterns and methods for making conductive patterns |
US8912447B2 (en) * | 2011-10-18 | 2014-12-16 | Fischer Technology Pte. Ltd. | Method of moulding |
KR101466222B1 (en) * | 2012-06-01 | 2014-12-01 | 주식회사 아이센스 | Electrochemical biosensor with improved accuracy |
ES2759560T3 (en) | 2012-06-28 | 2020-05-11 | Hoffmann La Roche | Device for monitoring at least one bodily function of a user and its manufacturing procedure |
US9523653B2 (en) | 2013-05-09 | 2016-12-20 | Changsha Sinocare Inc. | Disposable test sensor with improved sampling entrance |
EP2840144A1 (en) | 2013-08-20 | 2015-02-25 | Roche Diagniostics GmbH | A method for making a dry sensor element for an enzymatic determination of an analyte in a body fluid, a dry sensor element and article |
EP2840143A1 (en) | 2013-08-20 | 2015-02-25 | Roche Diagniostics GmbH | A method for making a dry sensor element for an enzymatic determination of an analyte in a body fluid and a dry sensor element |
KR20150046627A (en) * | 2013-10-22 | 2015-04-30 | 삼성전자주식회사 | Bio-sensor |
US9518951B2 (en) | 2013-12-06 | 2016-12-13 | Changsha Sinocare Inc. | Disposable test sensor with improved sampling entrance |
US9897566B2 (en) | 2014-01-13 | 2018-02-20 | Changsha Sinocare Inc. | Disposable test sensor |
US9939401B2 (en) | 2014-02-20 | 2018-04-10 | Changsha Sinocare Inc. | Test sensor with multiple sampling routes |
US20150287638A1 (en) * | 2014-04-04 | 2015-10-08 | Jungrae Park | Hybrid wafer dicing approach using collimated laser scribing process and plasma etch |
US9076860B1 (en) * | 2014-04-04 | 2015-07-07 | Applied Materials, Inc. | Residue removal from singulated die sidewall |
US10378098B2 (en) | 2015-03-18 | 2019-08-13 | Materion Corporation | Methods for optimized production of multilayer metal/transparent conducting oxide (TCO) constructs |
US10197522B2 (en) | 2015-03-18 | 2019-02-05 | Materion Corporation | Multilayer constructs for metabolite strips providing inert surface and mechanical advantage |
US10135076B1 (en) | 2015-05-05 | 2018-11-20 | Verily Life Sciences Llc | Tear-activated micro-battery for use on smart contact lenses |
EP3551760A1 (en) | 2016-12-08 | 2019-10-16 | Roche Diabetes Care GmbH | Sensor device for determining the concentration of an analyte underin-vivo |
RU2738794C1 (en) | 2017-03-21 | 2020-12-16 | Ф. Хоффманн-Ля Рош Аг | Medical device and method for its production |
Citations (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3715192A (en) * | 1969-08-12 | 1973-02-06 | Merck Patent Gmbh | Indicator strip |
US4510383A (en) * | 1981-09-18 | 1985-04-09 | Boehringer Mannheim Gmbh | Device for the optical identification of a coding on a diagnostic test strip |
US4571292A (en) * | 1982-08-12 | 1986-02-18 | Case Western Reserve University | Apparatus for electrochemical measurements |
US4578716A (en) * | 1983-07-23 | 1986-03-25 | Boehringer Mannheim Gmbh | Method of and apparatus for making a test strip and a test strip made by such method |
US4797256A (en) * | 1987-06-05 | 1989-01-10 | Boehringer Mannheim Corporation | Registration device for blood test strips |
US4805624A (en) * | 1985-09-09 | 1989-02-21 | The Montefiore Hospital Association Of Western Pa | Low-potential electrochemical redox sensors |
US4897173A (en) * | 1985-06-21 | 1990-01-30 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method for making the same |
US5179005A (en) * | 1986-08-13 | 1993-01-12 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
US5187100A (en) * | 1990-05-29 | 1993-02-16 | Lifescan, Inc. | Dispersion to limit penetration of aqueous solutions into a membrane |
US5192415A (en) * | 1991-03-04 | 1993-03-09 | Matsushita Electric Industrial Co., Ltd. | Biosensor utilizing enzyme and a method for producing the same |
US5281395A (en) * | 1990-12-27 | 1994-01-25 | Boehringer Manheim Gmbh | Test carrier analysis system |
US5286362A (en) * | 1990-02-03 | 1994-02-15 | Boehringer Mannheim Gmbh | Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor |
US5288636A (en) * | 1989-12-15 | 1994-02-22 | Boehringer Mannheim Corporation | Enzyme electrode system |
US5296192A (en) * | 1992-04-03 | 1994-03-22 | Home Diagnostics, Inc. | Diagnostic test strip |
US5306623A (en) * | 1989-08-28 | 1994-04-26 | Lifescan, Inc. | Visual blood glucose concentration test strip |
US5379214A (en) * | 1991-02-27 | 1995-01-03 | Boehringer Mannheim Corporation | Method for reading the concentration of a medically significant component of a biological fluid from a test strip |
US5385846A (en) * | 1993-06-03 | 1995-01-31 | Boehringer Mannheim Corporation | Biosensor and method for hematocrit determination |
US5389215A (en) * | 1992-11-05 | 1995-02-14 | Nippon Telegraph And Telephone Corporation | Electrochemical detection method and apparatus therefor |
US5395504A (en) * | 1993-02-04 | 1995-03-07 | Asulab S.A. | Electrochemical measuring system with multizone sensors |
US5494638A (en) * | 1991-06-19 | 1996-02-27 | Hypoguard (Uk) Limited | Support membrane |
US5498414A (en) * | 1992-10-05 | 1996-03-12 | University Of Victoria | Attenuated strains of Aeromonas salmonicida useful as fish vaccines |
US5508171A (en) * | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
US5509410A (en) * | 1983-06-06 | 1996-04-23 | Medisense, Inc. | Strip electrode including screen printing of a single layer |
US5597532A (en) * | 1994-10-20 | 1997-01-28 | Connolly; James | Apparatus for determining substances contained in a body fluid |
US5605837A (en) * | 1996-02-14 | 1997-02-25 | Lifescan, Inc. | Control solution for a blood glucose monitor |
US5620579A (en) * | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
US5620863A (en) * | 1989-08-28 | 1997-04-15 | Lifescan, Inc. | Blood glucose strip having reduced side reactions |
US5708247A (en) * | 1996-02-14 | 1998-01-13 | Selfcare, Inc. | Disposable glucose test strips, and methods and compositions for making same |
US5720862A (en) * | 1995-04-07 | 1998-02-24 | Kyoto Daiichi Kagaku Co., Ltd. | Sensor and production method of and measurement method using the same |
US5723284A (en) * | 1996-04-01 | 1998-03-03 | Bayer Corporation | Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood |
US5856195A (en) * | 1996-10-30 | 1999-01-05 | Bayer Corporation | Method and apparatus for calibrating a sensor element |
US5869972A (en) * | 1996-02-26 | 1999-02-09 | Birch; Brian Jeffrey | Testing device using a thermochromic display and method of using same |
US5890489A (en) * | 1996-04-23 | 1999-04-06 | Dermal Therapy (Barbados) Inc. | Method for non-invasive determination of glucose in body fluids |
US6036919A (en) * | 1996-07-23 | 2000-03-14 | Roche Diagnostic Gmbh | Diagnostic test carrier with multilayer field |
US6044285A (en) * | 1997-11-12 | 2000-03-28 | Lightouch Medical, Inc. | Method for non-invasive measurement of an analyte |
US6168957B1 (en) * | 1997-06-25 | 2001-01-02 | Lifescan, Inc. | Diagnostic test strip having on-strip calibration |
US6170318B1 (en) * | 1995-03-27 | 2001-01-09 | California Institute Of Technology | Methods of use for sensor based fluid detection devices |
US6174420B1 (en) * | 1996-11-15 | 2001-01-16 | Usf Filtration And Separations Group, Inc. | Electrochemical cell |
US6175752B1 (en) * | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6176988B1 (en) * | 1996-05-25 | 2001-01-23 | Manfred Kessler | Membrane electrode for measuring the glucose concentration in fluids |
US6180062B1 (en) * | 1996-04-26 | 2001-01-30 | Kyoto Daiichi Kagaku Co., Ltd. | Device for analyzing a sample |
US6179979B1 (en) * | 1995-11-16 | 2001-01-30 | Usf Filtration & Separations Group, Inc. | Electrochemical cell |
US6193873B1 (en) * | 1999-06-15 | 2001-02-27 | Lifescan, Inc. | Sample detection to initiate timing of an electrochemical assay |
US6200773B1 (en) * | 1998-09-28 | 2001-03-13 | Lifescan, Inc. | Diagnostics based on tetrazolium compounds |
US6335203B1 (en) * | 1994-09-08 | 2002-01-01 | Lifescan, Inc. | Optically readable strip for analyte detection having on-strip orientation index |
US20020004196A1 (en) * | 2000-07-10 | 2002-01-10 | Bayer Corporation | Thin lance and test sensor having same |
US6338790B1 (en) * | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US6340428B1 (en) * | 1998-04-02 | 2002-01-22 | Matsushita Electric Industrial Co., Inc. | Device and method for determining the concentration of a substrate |
US20020019707A1 (en) * | 2000-06-26 | 2002-02-14 | Cohen Alan M. | Glucose metering system |
US6349230B1 (en) * | 1998-02-26 | 2002-02-19 | Kyoto Daiichi Kagaku Co., Ltd. | Blood measuring instrument |
US20020044890A1 (en) * | 2000-07-20 | 2002-04-18 | Hypoguard Limited | Test member |
US6377896B1 (en) * | 1998-01-06 | 2002-04-23 | Kyoto Daiichi Kagaku Co., Ltd. | Method and apparatus for determination of a substance coexisting with another substance |
US6377894B1 (en) * | 1998-11-30 | 2002-04-23 | Abbott Laboratories | Analyte test instrument having improved calibration and communication processes |
US6379513B1 (en) * | 1997-03-21 | 2002-04-30 | Usf Filtration And Separations Group Inc. | Sensor connection means |
US20030000834A1 (en) * | 1998-06-11 | 2003-01-02 | Matsushita Electric Industrial Co., Ltd. | Method for analyzing a biological sample |
US6503381B1 (en) * | 1997-09-12 | 2003-01-07 | Therasense, Inc. | Biosensor |
US6514769B2 (en) * | 1999-07-29 | 2003-02-04 | Jin Po Lee | Multiple analyte assay device with sample integrity monitoring system |
US6514718B2 (en) * | 1991-03-04 | 2003-02-04 | Therasense, Inc. | Subcutaneous glucose electrode |
US20030024811A1 (en) * | 2000-03-28 | 2003-02-06 | Davies Oliver William Hardwicke | Continuous process for manufacture of disposable electro-chemical sensor |
US20030032875A1 (en) * | 2000-07-24 | 2003-02-13 | Yuko Taniike | Biosensor |
US6521182B1 (en) * | 1998-07-20 | 2003-02-18 | Lifescan, Inc. | Fluidic device for medical diagnostics |
US6521110B1 (en) * | 1995-11-16 | 2003-02-18 | Lifescan, Inc. | Electrochemical cell |
US6526298B1 (en) * | 1998-05-18 | 2003-02-25 | Abbott Laboratories | Method for the non-invasive determination of analytes in a selected volume of tissue |
US6525330B2 (en) * | 2001-02-28 | 2003-02-25 | Home Diagnostics, Inc. | Method of strip insertion detection |
US6525549B1 (en) * | 1999-08-04 | 2003-02-25 | Lre Technology Partner Gmbh | Method for determining the concentration of a substance in a liquid by measuring electrical current in a test strip |
US20030042150A1 (en) * | 2000-03-22 | 2003-03-06 | Jun-Oh Ryu | Electrochemical biosensor test strip with recognition electrode and readout meter using this test strip |
US20030042137A1 (en) * | 2001-05-15 | 2003-03-06 | Therasense, Inc. | Biosensor membranes composed of polymers containing heterocyclic nitrogens |
US6531322B1 (en) * | 1998-08-13 | 2003-03-11 | Lifescan, Inc. | Visual blood glucose test strip |
US6531040B2 (en) * | 1999-08-02 | 2003-03-11 | Bayer Corporation | Electrochemical-sensor design |
US20030046811A1 (en) * | 2001-09-10 | 2003-03-13 | Eumed Biotechnology Co., Ltd. | New spacer forming method used for a biosensor |
US6540890B1 (en) * | 2000-11-01 | 2003-04-01 | Roche Diagnostics Corporation | Biosensor |
US6541266B2 (en) * | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
US6540891B1 (en) * | 1998-05-08 | 2003-04-01 | Abbott Laboratories | Test strip |
US6544474B2 (en) * | 1997-09-30 | 2003-04-08 | Amira Medical | Device for determination of an analyte in a body fluid using small sample sizes |
US6549796B2 (en) * | 2001-05-25 | 2003-04-15 | Lifescan, Inc. | Monitoring analyte concentration using minimally invasive devices |
US6551494B1 (en) * | 1997-02-06 | 2003-04-22 | Therasense, Inc. | Small volume in vitro analyte sensor |
US6555061B1 (en) * | 2000-10-05 | 2003-04-29 | Lifescan, Inc. | Multi-layer reagent test strip |
US20040005721A1 (en) * | 2001-05-29 | 2004-01-08 | Yuko Tanike | Biosensor |
US6676995B2 (en) * | 2001-11-28 | 2004-01-13 | Lifescan, Inc. | Solution striping system |
US20040016642A1 (en) * | 1999-12-03 | 2004-01-29 | Shoji Miyazaki | Biosensor |
US20040020777A1 (en) * | 2002-06-03 | 2004-02-05 | Yoshiko Miyamoto | Biosensor |
US6716620B2 (en) * | 2000-04-17 | 2004-04-06 | Purdue Research Foundation | Biosensor and related method |
US6719887B2 (en) * | 2000-12-27 | 2004-04-13 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
US6723371B2 (en) * | 2000-06-01 | 2004-04-20 | Bioptik Technology, Inc. | Process for preparing an electrochemical test strip |
US6841389B2 (en) * | 2001-02-05 | 2005-01-11 | Glucosens, Inc. | Method of determining concentration of glucose in blood |
US20050008537A1 (en) * | 2003-06-20 | 2005-01-13 | Dan Mosoiu | Method and reagent for producing narrow, homogenous reagent stripes |
US20050019212A1 (en) * | 2003-06-20 | 2005-01-27 | Bhullar Raghbir S. | Test strip with flared sample receiving chamber |
US6856125B2 (en) * | 2001-12-12 | 2005-02-15 | Lifescan, Inc. | Biosensor apparatus and method with sample type and volume detection |
US6860978B2 (en) * | 2000-03-08 | 2005-03-01 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method of producing the same |
US6863800B2 (en) * | 2002-02-01 | 2005-03-08 | Abbott Laboratories | Electrochemical biosensor strip for analysis of liquid samples |
US6881322B2 (en) * | 2000-01-25 | 2005-04-19 | Matsushita Electric Industrial Co., Ltd. | Measuring device using biosensor and biosenor used for it, and dedicated standard liquid |
Family Cites Families (275)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US187100A (en) * | 1877-02-06 | Improvement in cheese-formers for cider-presses | ||
FR2295419A1 (en) | 1974-12-21 | 1976-07-16 | Kyoto Daiichi Kagaku Kk | REFLECTANCE MEASURING DEVICE AND COMPOSITE TEST PAPER STRUCTURE SUBJECT TO SUCH MEASUREMENT |
US4065263A (en) | 1976-04-02 | 1977-12-27 | Woodbridge Iii Richard G | Analytical test strip apparatus |
US4225410A (en) | 1978-12-04 | 1980-09-30 | Technicon Instruments Corporation | Integrated array of electrochemical sensors |
US4323536A (en) | 1980-02-06 | 1982-04-06 | Eastman Kodak Company | Multi-analyte test device |
US4420564A (en) | 1980-11-21 | 1983-12-13 | Fuji Electric Company, Ltd. | Blood sugar analyzer having fixed enzyme membrane sensor |
US4426451A (en) | 1981-01-28 | 1984-01-17 | Eastman Kodak Company | Multi-zoned reaction vessel having pressure-actuatable control means between zones |
DE3133826A1 (en) | 1981-08-27 | 1983-03-10 | Boehringer Mannheim Gmbh, 6800 Mannheim | ANALYSIS TEST STRIP AND METHOD FOR THE PRODUCTION THEREOF |
DE3278334D1 (en) | 1981-10-23 | 1988-05-19 | Genetics Int Inc | Sensor for components of a liquid mixture |
US4679562A (en) | 1983-02-16 | 1987-07-14 | Cardiac Pacemakers, Inc. | Glucose sensor |
CA1226036A (en) | 1983-05-05 | 1987-08-25 | Irving J. Higgins | Analytical equipment and sensor electrodes therefor |
US5682884A (en) | 1983-05-05 | 1997-11-04 | Medisense, Inc. | Strip electrode with screen printing |
GB8406752D0 (en) | 1984-03-15 | 1984-04-18 | Unilever Plc | Chemical and clinical tests |
AU581669B2 (en) | 1984-06-13 | 1989-03-02 | Applied Research Systems Ars Holding N.V. | Photometric instruments, their use in methods of optical analysis, and ancillary devices therefor |
US5141868A (en) | 1984-06-13 | 1992-08-25 | Internationale Octrooi Maatschappij "Octropa" Bv | Device for use in chemical test procedures |
US4671288A (en) | 1985-06-13 | 1987-06-09 | The Regents Of The University Of California | Electrochemical cell sensor for continuous short-term use in tissues and blood |
US4938860A (en) | 1985-06-28 | 1990-07-03 | Miles Inc. | Electrode for electrochemical sensors |
EP0215669A3 (en) | 1985-09-17 | 1989-08-30 | Seiko Instruments Inc. | Analytical device and method for analysis of biochemicals, microbes and cells |
US4714874A (en) | 1985-11-12 | 1987-12-22 | Miles Inc. | Test strip identification and instrument calibration |
US5066372A (en) | 1986-05-02 | 1991-11-19 | Ciba Corning Diagnostics Corp. | Unitary multiple electrode sensor |
GB8612861D0 (en) | 1986-05-27 | 1986-07-02 | Cambridge Life Sciences | Immobilised enzyme biosensors |
JPS636451A (en) | 1986-06-27 | 1988-01-12 | Terumo Corp | Enzyme sensor |
GB8618022D0 (en) | 1986-07-23 | 1986-08-28 | Unilever Plc | Electrochemical measurements |
US5059394A (en) | 1986-08-13 | 1991-10-22 | Lifescan, Inc. | Analytical device for the automated determination of analytes in fluids |
US5049487A (en) | 1986-08-13 | 1991-09-17 | Lifescan, Inc. | Automated initiation of timing of reflectance readings |
GB8626081D0 (en) | 1986-10-31 | 1986-12-03 | Unilever Plc | Printing processes |
GB2201248B (en) | 1987-02-24 | 1991-04-17 | Ici Plc | Enzyme electrode sensors |
CA1315181C (en) | 1987-04-13 | 1993-03-30 | Joel M. Blatt | Test strip device with volume metering capillary gap |
US4877580A (en) | 1988-02-09 | 1989-10-31 | Technimed Corporation | Assay kit including an analyte test strip and a color comparator |
WO1989009397A1 (en) | 1988-03-31 | 1989-10-05 | Matsushita Electric Industrial Co., Ltd. | Biosensor and process for its production |
US5439826A (en) | 1988-12-02 | 1995-08-08 | Bio-Tek Instruments, Inc. | Method of distinguishing among strips for different assays in an automated instrument |
US4878290A (en) | 1989-02-13 | 1989-11-07 | International Business Machines Corporation | Method for making thin film magnetic head |
JP2654682B2 (en) | 1989-02-17 | 1997-09-17 | 富士写真フイルム株式会社 | Biochemical analyzer, biochemical analysis correction method and correction value recording medium |
DE3911539A1 (en) | 1989-04-08 | 1990-10-11 | Boehringer Mannheim Gmbh | TEST CARRIER ANALYSIS SYSTEM |
DE3922478A1 (en) | 1989-07-06 | 1991-01-17 | Schering Ag | Excimer laser structuring or etching process - for plastics-coated copper-clad base materials |
CH677149A5 (en) | 1989-07-07 | 1991-04-15 | Disetronic Ag | |
WO1991002391A1 (en) | 1989-08-02 | 1991-02-21 | Australian Electro Optics Pty. Ltd. | A diode laser system emitting a high quality laser beam of circular cross-section perpendicular to the mounting base |
AU640162B2 (en) | 1989-08-28 | 1993-08-19 | Lifescan, Inc. | Blood separation and analyte detection techniques |
US6395227B1 (en) | 1989-08-28 | 2002-05-28 | Lifescan, Inc. | Test strip for measuring analyte concentration over a broad range of sample volume |
DE3940152A1 (en) | 1989-12-05 | 1991-06-06 | Boehringer Mannheim Gmbh | TEST STRIP EVALUATOR FOR MULTIPLE TEST STRIPS |
US5243516A (en) | 1989-12-15 | 1993-09-07 | Boehringer Mannheim Corporation | Biosensing instrument and method |
FR2657455B1 (en) | 1990-01-19 | 1992-04-10 | Europ Composants Electron | HIGH VOLUME CAPACITOR, SELF-HEALING. |
DE4003194A1 (en) | 1990-02-03 | 1991-08-08 | Boehringer Mannheim Gmbh | Electrochemical determn. of analytes - using oxido-reductase and substance of being reduced, which is re-oxidised on the electrode |
US5141850A (en) | 1990-02-07 | 1992-08-25 | Hygeia Sciences, Inc. | Porous strip form assay device method |
US5250439A (en) | 1990-07-19 | 1993-10-05 | Miles Inc. | Use of conductive sensors in diagnostic assays |
JPH0820412B2 (en) | 1990-07-20 | 1996-03-04 | 松下電器産業株式会社 | Quantitative analysis method and device using disposable sensor |
US5104480A (en) | 1990-10-12 | 1992-04-14 | General Electric Company | Direct patterning of metals over a thermally inefficient surface using a laser |
JP3118015B2 (en) | 1991-05-17 | 2000-12-18 | アークレイ株式会社 | Biosensor and separation and quantification method using the same |
US5264103A (en) | 1991-10-18 | 1993-11-23 | Matsushita Electric Industrial Co., Ltd. | Biosensor and a method for measuring a concentration of a substrate in a sample |
JP3135959B2 (en) | 1991-12-12 | 2001-02-19 | アークレイ株式会社 | Biosensor and separation and quantification method using the same |
GB9221099D0 (en) | 1992-10-07 | 1992-11-18 | Ecossensors Ltd | Improvements in and relating to gas permeable membranes for amperometric gas electrodes |
US5387327A (en) | 1992-10-19 | 1995-02-07 | Duquesne University Of The Holy Ghost | Implantable non-enzymatic electrochemical glucose sensor |
JP2954436B2 (en) | 1992-11-11 | 1999-09-27 | 株式会社日立製作所 | Test piece supply device and analyzer using the same |
US5344754A (en) | 1993-01-13 | 1994-09-06 | Avocet Medical, Inc. | Assay timed by electrical resistance change and test strip |
DE4310106C1 (en) | 1993-03-27 | 1994-10-06 | Bruker Saxonia Analytik Gmbh | Manufacturing process for switching grids of an ion mobility spectrometer and switching grids manufactured according to the process |
DE4310583A1 (en) | 1993-03-31 | 1994-10-06 | Boehringer Mannheim Gmbh | Test strip analysis system |
DE4313253A1 (en) | 1993-04-23 | 1994-10-27 | Boehringer Mannheim Gmbh | System for analyzing the contents of liquid samples |
ES2139684T3 (en) | 1993-04-23 | 2000-02-16 | Roche Diagnostics Gmbh | SYSTEM FOR THE STORAGE OF TEST ELEMENTS. |
US5843691A (en) | 1993-05-15 | 1998-12-01 | Lifescan, Inc. | Visually-readable reagent test strip |
JP3713516B2 (en) | 1993-05-29 | 2005-11-09 | ケンブリッジ ライフ サイエンシズ パブリック リミテッド カンパニー | Sensors based on polymer transformations |
DE4318519C2 (en) | 1993-06-03 | 1996-11-28 | Fraunhofer Ges Forschung | Electrochemical sensor |
CA2153883C (en) | 1993-06-08 | 1999-02-09 | Bradley E. White | Biosensing meter which detects proper electrode engagement and distinguishes sample and check strips |
US5366609A (en) | 1993-06-08 | 1994-11-22 | Boehringer Mannheim Corporation | Biosensing meter with pluggable memory key |
DE705348T1 (en) | 1993-06-21 | 2000-10-05 | Roche Diagnostics Corp | STABILIZER FOR DIAGNOSTIC REAGENTS |
US5658443A (en) | 1993-07-23 | 1997-08-19 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method for producing the same |
US5413690A (en) | 1993-07-23 | 1995-05-09 | Boehringer Mannheim Corporation | Potentiometric biosensor and the method of its use |
CA2170402C (en) | 1993-08-24 | 2000-07-18 | Michael P. Allen | Novel disposable electronic assay device |
US5589326A (en) | 1993-12-30 | 1996-12-31 | Boehringer Mannheim Corporation | Osmium-containing redox mediator |
US5421189A (en) | 1994-01-21 | 1995-06-06 | Ciba Corning Diagnostics Corp. | Electrical connection system for electrochemical sensors |
US5762770A (en) | 1994-02-21 | 1998-06-09 | Boehringer Mannheim Corporation | Electrochemical biosensor test strip |
WO1995022881A1 (en) | 1994-02-22 | 1995-08-24 | Philips Electronics N.V. | Laser etching method |
US5437999A (en) * | 1994-02-22 | 1995-08-01 | Boehringer Mannheim Corporation | Electrochemical sensor |
DE4417245A1 (en) | 1994-04-23 | 1995-10-26 | Lpkf Cad Cam Systeme Gmbh | High resolution structured metallisation prodn. |
JP3331253B2 (en) | 1994-05-10 | 2002-10-07 | バイエルコーポレーション | Test strip removal device for automatic analyzer |
JP3027306B2 (en) | 1994-06-02 | 2000-04-04 | 松下電器産業株式会社 | Biosensor and manufacturing method thereof |
US5547702A (en) | 1994-07-08 | 1996-08-20 | Polymer Technology International Corporation | Method for continuous manufacture of diagnostic test strips |
GB9415499D0 (en) | 1994-08-01 | 1994-09-21 | Bartlett Philip N | Electrodes and their use in analysis |
US5526120A (en) | 1994-09-08 | 1996-06-11 | Lifescan, Inc. | Test strip with an asymmetrical end insuring correct insertion for measuring |
AU709992B2 (en) | 1994-09-08 | 1999-09-09 | Lifescan, Inc. | Analyte detection strip having on-strip standard |
US5515170A (en) | 1994-09-08 | 1996-05-07 | Lifescan, Inc. | Analyte detection device having a serpentine passageway for indicator strips |
US5533393A (en) | 1995-01-13 | 1996-07-09 | Honeywell Inc. | Determination of dew point or absolute humidity |
US5569608A (en) | 1995-01-30 | 1996-10-29 | Bayer Corporation | Quantitative detection of analytes on immunochromatographic strips |
US6153069A (en) | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
EP0727925A1 (en) | 1995-02-14 | 1996-08-21 | Lpkf Cad/Cam Systeme Gmbh | Process for structured metallizing of the surface of substrates |
US5582697A (en) | 1995-03-17 | 1996-12-10 | Matsushita Electric Industrial Co., Ltd. | Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same |
US5650062A (en) | 1995-03-17 | 1997-07-22 | Matsushita Electric Industrial Co., Ltd. | Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same |
US5788833A (en) | 1995-03-27 | 1998-08-04 | California Institute Of Technology | Sensors for detecting analytes in fluids |
US5656502A (en) | 1995-06-07 | 1997-08-12 | Diagnostic Chemicals Limited | Test strip holder and method of use |
AUPN363995A0 (en) | 1995-06-19 | 1995-07-13 | Memtec Limited | Electrochemical cell |
US6413410B1 (en) | 1996-06-19 | 2002-07-02 | Lifescan, Inc. | Electrochemical cell |
DE19535068C2 (en) | 1995-09-21 | 1997-08-21 | Lpkf Cad Cam Systeme Gmbh | Coating for the structured production of conductor tracks on the surface of electrically insulating substrates, method for producing the coating and of structured conductor tracks |
US5665215A (en) | 1995-09-25 | 1997-09-09 | Bayer Corporation | Method and apparatus for making predetermined events with a biosensor |
US5628890A (en) | 1995-09-27 | 1997-05-13 | Medisense, Inc. | Electrochemical sensor |
AU722471B2 (en) | 1995-10-17 | 2000-08-03 | Lifescan, Inc. | Blood glucose strip having reduced sensitivity to hematocrit |
US20030180183A1 (en) | 1995-10-30 | 2003-09-25 | Takao Fukuoka | Method for measuring substance and testing piece |
US6863801B2 (en) | 1995-11-16 | 2005-03-08 | Lifescan, Inc. | Electrochemical cell |
US6638415B1 (en) | 1995-11-16 | 2003-10-28 | Lifescan, Inc. | Antioxidant sensor |
US5755953A (en) | 1995-12-18 | 1998-05-26 | Abbott Laboratories | Interference free biosensor |
JP3365184B2 (en) | 1996-01-10 | 2003-01-08 | 松下電器産業株式会社 | Biosensor |
US5989917A (en) | 1996-02-13 | 1999-11-23 | Selfcare, Inc. | Glucose monitor and test strip containers for use in same |
US6241862B1 (en) | 1996-02-14 | 2001-06-05 | Inverness Medical Technology, Inc. | Disposable test strips with integrated reagent/blood separation layer |
DE19605583A1 (en) | 1996-02-15 | 1997-08-21 | Bayer Ag | Electrochemical sensors with improved selectivity and increased sensitivity |
DE19610115C2 (en) | 1996-03-14 | 2000-11-23 | Fraunhofer Ges Forschung | Detection of molecules and molecular complexes |
US5962215A (en) | 1996-04-05 | 1999-10-05 | Mercury Diagnostics, Inc. | Methods for testing the concentration of an analyte in a body fluid |
US5691486A (en) | 1996-07-30 | 1997-11-25 | Bayer Corporation | Apparatus and methods for selecting a variable number of test sample aliquots to mix with respective reagents |
JP3510740B2 (en) | 1996-08-26 | 2004-03-29 | シャープ株式会社 | Manufacturing method of integrated thin-film solar cell |
US5958791A (en) | 1996-09-27 | 1999-09-28 | Innovative Biotechnologies, Inc. | Interdigitated electrode arrays for liposome-enhanced immunoassay and test device |
US5945341A (en) | 1996-10-21 | 1999-08-31 | Bayer Corporation | System for the optical identification of coding on a diagnostic test strip |
GB9622304D0 (en) | 1996-10-26 | 1996-12-18 | Univ Manchester | Sensor |
US6632349B1 (en) | 1996-11-15 | 2003-10-14 | Lifescan, Inc. | Hemoglobin sensor |
KR100243656B1 (en) | 1996-12-05 | 2000-02-01 | 정선종 | A vertical-cavity surface-emitting LASER with hydrogenation treatment and method for fabricating the same |
JP3460183B2 (en) | 1996-12-24 | 2003-10-27 | 松下電器産業株式会社 | Biosensor |
CA2277306A1 (en) | 1997-01-09 | 1998-07-16 | Mercury Diagnostics, Inc. | Method for applying a reagent to an analytical test device |
AUPO585797A0 (en) | 1997-03-25 | 1997-04-24 | Memtec America Corporation | Improved electrochemical cell |
DE19714674A1 (en) | 1997-04-09 | 1998-10-15 | Lre Technology Partner Gmbh | Test strip pack and measuring device for using one |
US5759364A (en) | 1997-05-02 | 1998-06-02 | Bayer Corporation | Electrochemical biosensor |
US5798031A (en) | 1997-05-12 | 1998-08-25 | Bayer Corporation | Electrochemical biosensor |
US5921925A (en) | 1997-05-30 | 1999-07-13 | Ndm, Inc. | Biomedical electrode having a disposable electrode and a reusable leadwire adapter that interfaces with a standard leadwire connector |
GB9711395D0 (en) | 1997-06-04 | 1997-07-30 | Environmental Sensors Ltd | Improvements to electrodes for the measurement of analytes in small samples |
GB9824627D0 (en) | 1998-11-11 | 1999-01-06 | Cambridge Sensors Ltd | Test strips for small volumes |
US6040195A (en) | 1997-06-10 | 2000-03-21 | Home Diagnostics, Inc. | Diagnostic sanitary test strip |
US6309526B1 (en) | 1997-07-10 | 2001-10-30 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
PT1024358E (en) | 1997-07-22 | 2009-04-16 | Panasonic Corp | Densitometer |
JP3297630B2 (en) | 1997-07-28 | 2002-07-02 | 松下電器産業株式会社 | Biosensor |
JP3375040B2 (en) | 1997-07-29 | 2003-02-10 | 松下電器産業株式会社 | Substrate quantification method |
AUPO855897A0 (en) | 1997-08-13 | 1997-09-04 | Usf Filtration And Separations Group Inc. | Automatic analysing apparatus II |
US6121050A (en) | 1997-08-29 | 2000-09-19 | Han; Chi-Neng Arthur | Analyte detection systems |
US6129823A (en) | 1997-09-05 | 2000-10-10 | Abbott Laboratories | Low volume electrochemical sensor |
US6764581B1 (en) | 1997-09-05 | 2004-07-20 | Abbott Laboratories | Electrode with thin working layer |
US6259937B1 (en) | 1997-09-12 | 2001-07-10 | Alfred E. Mann Foundation | Implantable substrate sensor |
US6007775A (en) | 1997-09-26 | 1999-12-28 | University Of Washington | Multiple analyte diffusion based chemical sensor |
CO5040209A1 (en) * | 1997-10-16 | 2001-05-29 | Abbott Lab | BIOSENSOR ELECTRODES MEDIATORS OF COFACTOR REGENERATION |
FI107080B (en) | 1997-10-27 | 2001-05-31 | Nokia Mobile Phones Ltd | measuring device |
US6102872A (en) | 1997-11-03 | 2000-08-15 | Pacific Biometrics, Inc. | Glucose detector and method |
AU759239B2 (en) | 1997-11-28 | 2003-04-10 | Provalis Diagnostics Limited | Device and apparatus for conducting an assay |
US5997817A (en) | 1997-12-05 | 1999-12-07 | Roche Diagnostics Corporation | Electrochemical biosensor test strip |
US6579690B1 (en) | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
US6162639A (en) | 1997-12-19 | 2000-12-19 | Amira Medical | Embossed test strip system |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6103033A (en) * | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
US6475360B1 (en) | 1998-03-12 | 2002-11-05 | Lifescan, Inc. | Heated electrochemical cell |
US6091975A (en) | 1998-04-01 | 2000-07-18 | Alza Corporation | Minimally invasive detecting device |
US6271044B1 (en) | 1998-05-06 | 2001-08-07 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method and kit for detecting an analyte |
DE69910003T2 (en) | 1998-05-13 | 2004-04-22 | Cygnus, Inc., Redwood City | MONITORING PHYSIOLOGICAL ANALYSIS |
DE69920006T2 (en) | 1998-05-20 | 2005-09-15 | Arkray, Inc. | METHOD AND DEVICE FOR ELECTROCHEMICAL MEASUREMENTS USING STATISTICAL METHODS |
DE29809191U1 (en) | 1998-05-20 | 1998-08-13 | Lre Technology Partner Gmbh | Test strip measuring system |
US6287595B1 (en) | 1998-06-10 | 2001-09-11 | Delsys Pharmaceuticals Corporation | Biomedical assay device |
US6077660A (en) | 1998-06-10 | 2000-06-20 | Abbott Laboratories | Diagnostic assay requiring a small sample of biological fluid |
JP3874321B2 (en) | 1998-06-11 | 2007-01-31 | 松下電器産業株式会社 | Biosensor |
JP2002518998A (en) | 1998-06-24 | 2002-07-02 | セラセンス、インク. | Multi-sensor array and method for electrochemical recognition of nucleotide sequences |
US6656702B1 (en) | 1998-07-03 | 2003-12-02 | Matsushita Electric Industrial Co., Ltd. | Biosensor containing glucose dehydrogenase |
US6638716B2 (en) | 1998-08-24 | 2003-10-28 | Therasense, Inc. | Rapid amperometric verification of PCR amplification of DNA |
US6281006B1 (en) | 1998-08-24 | 2001-08-28 | Therasense, Inc. | Electrochemical affinity assay |
US6251260B1 (en) | 1998-08-24 | 2001-06-26 | Therasense, Inc. | Potentiometric sensors for analytic determination |
US6087182A (en) | 1998-08-27 | 2000-07-11 | Abbott Laboratories | Reagentless analysis of biological samples |
ES2316193T3 (en) | 1998-09-30 | 2009-04-01 | Sicel Technologies, Inc. | PROCEDURES, SYSTEMS AND IMPLANTABLE DEVICES ASSOCIATED FOR DYNAMIC MONITORING OF TUMORS. |
US6591125B1 (en) | 2000-06-27 | 2003-07-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
GB9825992D0 (en) | 1998-11-28 | 1999-01-20 | Moorlodge Biotech Ventures Lim | Electrochemical sensor |
US6565738B1 (en) | 1999-01-28 | 2003-05-20 | Abbott Laboratories | Diagnostic test for the measurement of analyte in abiological fluid |
US6475372B1 (en) | 2000-02-02 | 2002-11-05 | Lifescan, Inc. | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
US6150124A (en) | 1999-05-20 | 2000-11-21 | Umm Electronics, Inc. | Method for passively determining the application of a sample fluid on an analyte strip |
US6258229B1 (en) | 1999-06-02 | 2001-07-10 | Handani Winarta | Disposable sub-microliter volume sensor and method of making |
US6287451B1 (en) | 1999-06-02 | 2001-09-11 | Handani Winarta | Disposable sensor and method of making |
WO2000078992A2 (en) | 1999-06-18 | 2000-12-28 | Therasense, Inc. | Mass transport limited in vivo analyte sensor |
EP1130390A1 (en) | 1999-09-13 | 2001-09-05 | Matsushita Electric Industrial Co., Ltd. | Process for producing lipid-modified enzyme and biosensor |
US7276146B2 (en) | 2001-11-16 | 2007-10-02 | Roche Diagnostics Operations, Inc. | Electrodes, methods, apparatuses comprising micro-electrode arrays |
US6767440B1 (en) | 2001-04-24 | 2004-07-27 | Roche Diagnostics Corporation | Biosensor |
US20050103624A1 (en) * | 1999-10-04 | 2005-05-19 | Bhullar Raghbir S. | Biosensor and method of making |
US6662439B1 (en) | 1999-10-04 | 2003-12-16 | Roche Diagnostics Corporation | Laser defined features for patterned laminates and electrodes |
US7073246B2 (en) * | 1999-10-04 | 2006-07-11 | Roche Diagnostics Operations, Inc. | Method of making a biosensor |
US6645359B1 (en) * | 2000-10-06 | 2003-11-11 | Roche Diagnostics Corporation | Biosensor |
WO2001025776A1 (en) | 1999-10-05 | 2001-04-12 | Matsushita Electric Industrial Co., Ltd. | Glucose sensor |
DE19951721A1 (en) | 1999-10-27 | 2000-06-15 | Lpkf Laser & Electronics Ag | Very fine circuit production on polymer involves structurization by erosion with short wavelength electromagnetic radiation using metal coat penetrated by photons and erosion by plasma formed at interface with polymer |
US20020139668A1 (en) | 1999-11-03 | 2002-10-03 | Raghbir Singh Bhullar | Embedded metallic deposits |
US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
US6923894B2 (en) | 1999-11-11 | 2005-08-02 | Apex Biotechnology Corporation | Biosensor with multiple sampling ways |
EP2889611B1 (en) | 1999-11-15 | 2019-09-04 | PHC Holdings Corporation | Biosensor and measurement apparatus. |
JP4621839B2 (en) | 1999-11-15 | 2011-01-26 | アークレイ株式会社 | Biosensor |
AU1607801A (en) | 1999-11-15 | 2001-05-30 | Therasense, Inc. | Transition metal complexes with bidentate ligand having an imidazole ring |
ATE331949T1 (en) | 1999-11-16 | 2006-07-15 | Matsushita Electric Ind Co Ltd | BIOSENSOR |
JP4050434B2 (en) | 1999-11-29 | 2008-02-20 | 松下電器産業株式会社 | Sample discrimination method |
US6413395B1 (en) | 1999-12-16 | 2002-07-02 | Roche Diagnostics Corporation | Biosensor apparatus |
US6316264B1 (en) | 1999-12-17 | 2001-11-13 | Bayer Corporation | Test strip for the assay of an analyte in a liquid sample |
US6541216B1 (en) | 1999-12-22 | 2003-04-01 | Roche Diagnostics Corporation | Amperometric biosensor test strip |
US6627057B1 (en) | 1999-12-23 | 2003-09-30 | Roche Diagnostic Corporation | Microsphere containing sensor |
JP2001183330A (en) | 1999-12-27 | 2001-07-06 | Matsushita Electric Ind Co Ltd | Biosensor |
ES2238254T3 (en) | 1999-12-27 | 2005-09-01 | Matsushita Electric Industrial Co., Ltd. | BIOSENSOR |
US6716577B1 (en) | 2000-02-02 | 2004-04-06 | Lifescan, Inc. | Electrochemical test strip for use in analyte determination |
US6485923B1 (en) | 2000-02-02 | 2002-11-26 | Lifescan, Inc. | Reagent test strip for analyte determination having hemolyzing agent |
US6733655B1 (en) | 2000-03-08 | 2004-05-11 | Oliver W. H. Davies | Measurement of substances in liquids |
BR0109125A (en) | 2000-03-09 | 2002-11-26 | Clinical Analysis Corp | Medical diagnostic system |
KR100340173B1 (en) | 2000-03-22 | 2002-06-12 | 이동준 | Electrochemical Biosensor Readout Meter |
US6612111B1 (en) | 2000-03-27 | 2003-09-02 | Lifescan, Inc. | Method and device for sampling and analyzing interstitial fluid and whole blood samples |
US6571651B1 (en) | 2000-03-27 | 2003-06-03 | Lifescan, Inc. | Method of preventing short sampling of a capillary or wicking fill device |
RU2266543C2 (en) | 2000-03-28 | 2005-12-20 | Лайфскен, Инк. | Reagent systems for detecting for reduced cofactor |
DE60135583D1 (en) | 2000-03-28 | 2008-10-09 | Diabetes Diagnostics Inc | Timepiece with fast response glucose sensor |
US20020092612A1 (en) | 2000-03-28 | 2002-07-18 | Davies Oliver William Hardwicke | Rapid response glucose sensor |
EP2154522B1 (en) | 2000-03-29 | 2017-03-01 | Panasonic Healthcare Holdings Co., Ltd. | Biosensor |
JP2001281197A (en) | 2000-03-30 | 2001-10-10 | Matsushita Electric Ind Co Ltd | Biosensor measuring apparatus |
ES2269377T3 (en) | 2000-03-31 | 2007-04-01 | Lifescan, Inc. | ELECTRICALLY DRIVING SCHEMES TO MONITOR THE FILLING OF MEDICAL DEVICES. |
US6488827B1 (en) | 2000-03-31 | 2002-12-03 | Lifescan, Inc. | Capillary flow control in a medical diagnostic device |
US6448819B2 (en) * | 2000-04-11 | 2002-09-10 | Chi Hua Lin | Fixed device for the bulb socket |
JP4061816B2 (en) | 2000-04-27 | 2008-03-19 | 松下電器産業株式会社 | Biosensor |
IT1314759B1 (en) | 2000-05-08 | 2003-01-03 | Menarini Farma Ind | INSTRUMENTATION FOR MEASUREMENT AND CONTROL OF THE CONTENT OF GLUCOSIOLACTATE OR OTHER METABOLITES IN BIOLOGICAL FLUIDS |
WO2001088524A1 (en) | 2000-05-12 | 2001-11-22 | Therasense, Inc. | Electrodes with multilayer membranes and methods of using and making the electrodes |
JP3643011B2 (en) | 2000-05-18 | 2005-04-27 | アークレイ株式会社 | Quantitative analysis |
JP3553045B2 (en) | 2000-05-26 | 2004-08-11 | 松下電器産業株式会社 | Biosensor |
JP3542999B2 (en) | 2000-05-29 | 2004-07-14 | 松下電器産業株式会社 | Biosensor and manufacturing method thereof |
KR100513213B1 (en) | 2000-06-01 | 2005-09-08 | 마츠시타 덴끼 산교 가부시키가이샤 | Biosensor and blood component analyzing method |
DE60142394D1 (en) | 2000-06-28 | 2010-07-29 | Panasonic Corp | BIOZENSOR |
US6444115B1 (en) | 2000-07-14 | 2002-09-03 | Lifescan, Inc. | Electrochemical method for measuring chemical reaction rates |
GB2365123A (en) | 2000-07-20 | 2002-02-13 | Hypoguard Ltd | Test strip |
GB0017737D0 (en) | 2000-07-20 | 2000-09-06 | Hypoguard Limited | Test device |
EP1305607A1 (en) | 2000-07-31 | 2003-05-02 | Lifescan, Inc. | Method and apparatus for detecting the presence of a fluid on a test strip |
JP4184073B2 (en) | 2000-07-31 | 2008-11-19 | 松下電器産業株式会社 | Biosensor |
DE60137111D1 (en) | 2000-07-31 | 2009-02-05 | Panasonic Corp | Biosensor |
GB0019694D0 (en) | 2000-08-11 | 2000-09-27 | Cambridge Sensors Ltd | Electrochemical strip test for small volumes |
US6420128B1 (en) | 2000-09-12 | 2002-07-16 | Lifescan, Inc. | Test strips for detecting the presence of a reduced cofactor in a sample and method for using the same |
DE10052066A1 (en) | 2000-10-19 | 2002-05-29 | Inverness Medical Ltd | Screen printable paste for the production of a porous polymer membrane for a biosensor |
EP2388586B1 (en) | 2000-11-30 | 2018-01-10 | Panasonic Healthcare Holdings Co., Ltd. | Method of quantifying substrate |
US6967105B2 (en) | 2000-12-02 | 2005-11-22 | Queststar Medical, Inc. | Surface-modified wick for diagnostic test strip |
US6447657B1 (en) | 2000-12-04 | 2002-09-10 | Roche Diagnostics Corporation | Biosensor |
US6800488B2 (en) | 2000-12-13 | 2004-10-05 | Lifescan, Inc. | Methods of manufacturing reagent test strips |
US7144495B2 (en) | 2000-12-13 | 2006-12-05 | Lifescan, Inc. | Electrochemical test strip with an integrated micro-needle and associated methods |
GB0030929D0 (en) | 2000-12-19 | 2001-01-31 | Inverness Medical Ltd | Analyte measurement |
US6558528B1 (en) | 2000-12-20 | 2003-05-06 | Lifescan, Inc. | Electrochemical test strip cards that include an integral dessicant |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6793802B2 (en) | 2001-01-04 | 2004-09-21 | Tyson Bioresearch, Inc. | Biosensors having improved sample application and measuring properties and uses thereof |
CN1226615C (en) | 2001-01-17 | 2005-11-09 | 松下电器产业株式会社 | Biosensor |
WO2002057768A1 (en) | 2001-01-17 | 2002-07-25 | Arkray, Inc. | Quantitative analyzing method and quantitative analyzer using sensor |
US6562625B2 (en) | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
US20020133064A1 (en) | 2001-03-14 | 2002-09-19 | Matsushita Electric Industrial Co., Ltd. | Blood sugar lever measuring device and semiconductor integrated circuit |
KR100893275B1 (en) | 2001-03-29 | 2009-04-17 | 라이프스캔 스코트랜드 리미티드 | Integrated sample testing meter |
US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
WO2002086483A1 (en) | 2001-04-16 | 2002-10-31 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
DE60205702T2 (en) | 2001-05-15 | 2006-02-02 | Matsushita Electric Industrial Co., Ltd., Kadoma | BIOSENSOR |
US6491803B1 (en) | 2001-05-18 | 2002-12-10 | Apex Biotechnology Corporation | Test strip and biosensor incorporating with nanometer metal particles |
JP4213361B2 (en) | 2001-05-22 | 2009-01-21 | パナソニック株式会社 | Biosensor |
US20020177763A1 (en) | 2001-05-22 | 2002-11-28 | Burns David W. | Integrated lancets and methods |
US7473398B2 (en) | 2001-05-25 | 2009-01-06 | Roche Diagnostics Operations, Inc. | Biosensor |
US6960287B2 (en) | 2001-06-11 | 2005-11-01 | Bayer Corporation | Underfill detection system for a test sensor |
US6501976B1 (en) | 2001-06-12 | 2002-12-31 | Lifescan, Inc. | Percutaneous biological fluid sampling and analyte measurement devices and methods |
WO2002103343A1 (en) | 2001-06-14 | 2002-12-27 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
US6576416B2 (en) | 2001-06-19 | 2003-06-10 | Lifescan, Inc. | Analyte measurement device and method of use |
KR100426638B1 (en) | 2001-07-07 | 2004-04-08 | 주식회사 인포피아 | Glucose strip sensor and glucose measurement method by the strip sensor |
US6767441B1 (en) | 2001-07-31 | 2004-07-27 | Nova Biomedical Corporation | Biosensor with peroxidase enzyme |
KR100550707B1 (en) | 2001-08-09 | 2006-02-08 | 마츠시타 덴끼 산교 가부시키가이샤 | Biosensors and measurement method |
KR100596278B1 (en) | 2001-08-10 | 2006-07-03 | 마츠시타 덴끼 산교 가부시키가이샤 | Biosensor and method for analyzing blood components using it |
US6814844B2 (en) | 2001-08-29 | 2004-11-09 | Roche Diagnostics Corporation | Biosensor with code pattern |
EP1431758B1 (en) | 2001-09-28 | 2013-11-13 | ARKRAY, Inc. | Measurement instrument and concentration measurement apparatus |
US6797150B2 (en) | 2001-10-10 | 2004-09-28 | Lifescan, Inc. | Determination of sample volume adequacy in biosensor devices |
CN1702456A (en) | 2001-10-10 | 2005-11-30 | 生命扫描有限公司 | Electrochemical cell |
CN1489690A (en) | 2001-11-14 | 2004-04-14 | 松下电器产业株式会社 | Biosensor |
EP1445605A4 (en) | 2001-11-14 | 2005-01-12 | Matsushita Electric Ind Co Ltd | Biosensor |
DE60237463D1 (en) | 2001-11-16 | 2010-10-07 | Roche Diagnostics Gmbh | FLEXIBLE SENSOR AND MANUFACTURING PROCESS |
US6872298B2 (en) | 2001-11-20 | 2005-03-29 | Lifescan, Inc. | Determination of sample volume adequacy in biosensor devices |
US6749887B1 (en) | 2001-11-28 | 2004-06-15 | Lifescan, Inc. | Solution drying system |
WO2003048756A1 (en) | 2001-12-05 | 2003-06-12 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
US6872299B2 (en) | 2001-12-10 | 2005-03-29 | Lifescan, Inc. | Passive sample detection to initiate timing of an assay |
US7090764B2 (en) | 2002-01-15 | 2006-08-15 | Agamatrix, Inc. | Method and apparatus for processing electrochemical signals |
JP2005518527A (en) | 2002-02-10 | 2005-06-23 | アガマトリックス, インコーポレイテッド | Methods and apparatus for assays for electrochemical properties |
GB2390602A (en) | 2002-04-02 | 2004-01-14 | Inverness Medical Ltd | Test strip dispenser vial and cassette |
GB2388898B (en) | 2002-04-02 | 2005-10-05 | Inverness Medical Ltd | Integrated sample testing meter |
US7708701B2 (en) | 2002-04-19 | 2010-05-04 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device |
US6946299B2 (en) | 2002-04-25 | 2005-09-20 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
US6743635B2 (en) | 2002-04-25 | 2004-06-01 | Home Diagnostics, Inc. | System and methods for blood glucose sensing |
US6964871B2 (en) | 2002-04-25 | 2005-11-15 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
US20030143113A2 (en) | 2002-05-09 | 2003-07-31 | Lifescan, Inc. | Physiological sample collection devices and methods of using the same |
DE10397018A5 (en) | 2002-07-02 | 2015-05-28 | Panasonic Healthcare Holdings Co., Ltd. | Biosensor, biosensor chip and biosensor device |
IL150910A0 (en) | 2002-07-25 | 2003-02-12 | Rotem Amfert Negev Ltd | Agrochemical composition containing phosphite and process for the preparation thereof |
US6939450B2 (en) | 2002-10-08 | 2005-09-06 | Abbott Laboratories | Device having a flow channel |
US7244264B2 (en) | 2002-12-03 | 2007-07-17 | Roche Diagnostics Operations, Inc. | Dual blade lancing test strip |
US20040127818A1 (en) | 2002-12-27 | 2004-07-01 | Roe Steven N. | Precision depth control lancing tip |
ES2334128T3 (en) | 2002-12-30 | 2010-03-05 | F. Hoffmann-La Roche Ag | BLOOD COLLECTION SUSPENSION SYSTEM. |
EP3361249B1 (en) | 2003-06-20 | 2023-08-02 | Roche Diabetes Care GmbH | Method of using a test meter and associated test strip for measuring a concentration of an analyte in a biological fluid |
-
2004
- 2004-06-18 US US10/871,937 patent/US20050103624A1/en not_active Abandoned
-
2008
- 2008-09-25 US US12/238,101 patent/US8551308B2/en not_active Expired - Fee Related
- 2008-09-25 US US12/238,023 patent/US8287703B2/en not_active Expired - Lifetime
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3715192A (en) * | 1969-08-12 | 1973-02-06 | Merck Patent Gmbh | Indicator strip |
US4510383A (en) * | 1981-09-18 | 1985-04-09 | Boehringer Mannheim Gmbh | Device for the optical identification of a coding on a diagnostic test strip |
US4571292A (en) * | 1982-08-12 | 1986-02-18 | Case Western Reserve University | Apparatus for electrochemical measurements |
US5727548A (en) * | 1983-05-05 | 1998-03-17 | Medisense, Inc. | Strip electrode with screen printing |
US5509410A (en) * | 1983-06-06 | 1996-04-23 | Medisense, Inc. | Strip electrode including screen printing of a single layer |
US4578716A (en) * | 1983-07-23 | 1986-03-25 | Boehringer Mannheim Gmbh | Method of and apparatus for making a test strip and a test strip made by such method |
US4897173A (en) * | 1985-06-21 | 1990-01-30 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method for making the same |
US4805624A (en) * | 1985-09-09 | 1989-02-21 | The Montefiore Hospital Association Of Western Pa | Low-potential electrochemical redox sensors |
US5179005A (en) * | 1986-08-13 | 1993-01-12 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
US20030073153A1 (en) * | 1986-08-13 | 2003-04-17 | Roger Phillips | Minimum procedure system for the determination of analytes |
US20030073152A1 (en) * | 1986-08-13 | 2003-04-17 | Roger Phillips | Minimum procedure system for the determination of analytes |
US5304468A (en) * | 1986-08-13 | 1994-04-19 | Lifescan, Inc. | Reagent test strip and apparatus for determination of blood glucose |
US4797256A (en) * | 1987-06-05 | 1989-01-10 | Boehringer Mannheim Corporation | Registration device for blood test strips |
US5306623A (en) * | 1989-08-28 | 1994-04-26 | Lifescan, Inc. | Visual blood glucose concentration test strip |
US5620863A (en) * | 1989-08-28 | 1997-04-15 | Lifescan, Inc. | Blood glucose strip having reduced side reactions |
US5288636A (en) * | 1989-12-15 | 1994-02-22 | Boehringer Mannheim Corporation | Enzyme electrode system |
US5508171A (en) * | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
US5286362A (en) * | 1990-02-03 | 1994-02-15 | Boehringer Mannheim Gmbh | Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor |
US5187100A (en) * | 1990-05-29 | 1993-02-16 | Lifescan, Inc. | Dispersion to limit penetration of aqueous solutions into a membrane |
US5281395A (en) * | 1990-12-27 | 1994-01-25 | Boehringer Manheim Gmbh | Test carrier analysis system |
US5379214A (en) * | 1991-02-27 | 1995-01-03 | Boehringer Mannheim Corporation | Method for reading the concentration of a medically significant component of a biological fluid from a test strip |
US6514718B2 (en) * | 1991-03-04 | 2003-02-04 | Therasense, Inc. | Subcutaneous glucose electrode |
US5192415A (en) * | 1991-03-04 | 1993-03-09 | Matsushita Electric Industrial Co., Ltd. | Biosensor utilizing enzyme and a method for producing the same |
US5494638A (en) * | 1991-06-19 | 1996-02-27 | Hypoguard (Uk) Limited | Support membrane |
US5296192A (en) * | 1992-04-03 | 1994-03-22 | Home Diagnostics, Inc. | Diagnostic test strip |
US5498414A (en) * | 1992-10-05 | 1996-03-12 | University Of Victoria | Attenuated strains of Aeromonas salmonicida useful as fish vaccines |
US5389215A (en) * | 1992-11-05 | 1995-02-14 | Nippon Telegraph And Telephone Corporation | Electrochemical detection method and apparatus therefor |
US5395504A (en) * | 1993-02-04 | 1995-03-07 | Asulab S.A. | Electrochemical measuring system with multizone sensors |
US5385846A (en) * | 1993-06-03 | 1995-01-31 | Boehringer Mannheim Corporation | Biosensor and method for hematocrit determination |
US6335203B1 (en) * | 1994-09-08 | 2002-01-01 | Lifescan, Inc. | Optically readable strip for analyte detection having on-strip orientation index |
US5597532A (en) * | 1994-10-20 | 1997-01-28 | Connolly; James | Apparatus for determining substances contained in a body fluid |
US6170318B1 (en) * | 1995-03-27 | 2001-01-09 | California Institute Of Technology | Methods of use for sensor based fluid detection devices |
US5720862A (en) * | 1995-04-07 | 1998-02-24 | Kyoto Daiichi Kagaku Co., Ltd. | Sensor and production method of and measurement method using the same |
US5620579A (en) * | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
US6179979B1 (en) * | 1995-11-16 | 2001-01-30 | Usf Filtration & Separations Group, Inc. | Electrochemical cell |
US6521110B1 (en) * | 1995-11-16 | 2003-02-18 | Lifescan, Inc. | Electrochemical cell |
US5708247A (en) * | 1996-02-14 | 1998-01-13 | Selfcare, Inc. | Disposable glucose test strips, and methods and compositions for making same |
US5605837A (en) * | 1996-02-14 | 1997-02-25 | Lifescan, Inc. | Control solution for a blood glucose monitor |
US5869972A (en) * | 1996-02-26 | 1999-02-09 | Birch; Brian Jeffrey | Testing device using a thermochromic display and method of using same |
US5723284A (en) * | 1996-04-01 | 1998-03-03 | Bayer Corporation | Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood |
US5890489A (en) * | 1996-04-23 | 1999-04-06 | Dermal Therapy (Barbados) Inc. | Method for non-invasive determination of glucose in body fluids |
US6180062B1 (en) * | 1996-04-26 | 2001-01-30 | Kyoto Daiichi Kagaku Co., Ltd. | Device for analyzing a sample |
US6176988B1 (en) * | 1996-05-25 | 2001-01-23 | Manfred Kessler | Membrane electrode for measuring the glucose concentration in fluids |
US6036919A (en) * | 1996-07-23 | 2000-03-14 | Roche Diagnostic Gmbh | Diagnostic test carrier with multilayer field |
US5856195A (en) * | 1996-10-30 | 1999-01-05 | Bayer Corporation | Method and apparatus for calibrating a sensor element |
US6174420B1 (en) * | 1996-11-15 | 2001-01-16 | Usf Filtration And Separations Group, Inc. | Electrochemical cell |
US6551494B1 (en) * | 1997-02-06 | 2003-04-22 | Therasense, Inc. | Small volume in vitro analyte sensor |
US6379513B1 (en) * | 1997-03-21 | 2002-04-30 | Usf Filtration And Separations Group Inc. | Sensor connection means |
US6168957B1 (en) * | 1997-06-25 | 2001-01-02 | Lifescan, Inc. | Diagnostic test strip having on-strip calibration |
US6503381B1 (en) * | 1997-09-12 | 2003-01-07 | Therasense, Inc. | Biosensor |
US6544474B2 (en) * | 1997-09-30 | 2003-04-08 | Amira Medical | Device for determination of an analyte in a body fluid using small sample sizes |
US6044285A (en) * | 1997-11-12 | 2000-03-28 | Lightouch Medical, Inc. | Method for non-invasive measurement of an analyte |
US6377896B1 (en) * | 1998-01-06 | 2002-04-23 | Kyoto Daiichi Kagaku Co., Ltd. | Method and apparatus for determination of a substance coexisting with another substance |
US6349230B1 (en) * | 1998-02-26 | 2002-02-19 | Kyoto Daiichi Kagaku Co., Ltd. | Blood measuring instrument |
US6340428B1 (en) * | 1998-04-02 | 2002-01-22 | Matsushita Electric Industrial Co., Inc. | Device and method for determining the concentration of a substrate |
US20020043471A1 (en) * | 1998-04-02 | 2002-04-18 | Matsushita Electric Industrial Co., Ltd. | Device and method for determining the concentration of a substrate |
US6175752B1 (en) * | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6540891B1 (en) * | 1998-05-08 | 2003-04-01 | Abbott Laboratories | Test strip |
US6526298B1 (en) * | 1998-05-18 | 2003-02-25 | Abbott Laboratories | Method for the non-invasive determination of analytes in a selected volume of tissue |
US20030000834A1 (en) * | 1998-06-11 | 2003-01-02 | Matsushita Electric Industrial Co., Ltd. | Method for analyzing a biological sample |
US6521182B1 (en) * | 1998-07-20 | 2003-02-18 | Lifescan, Inc. | Fluidic device for medical diagnostics |
US6531322B1 (en) * | 1998-08-13 | 2003-03-11 | Lifescan, Inc. | Visual blood glucose test strip |
US6200773B1 (en) * | 1998-09-28 | 2001-03-13 | Lifescan, Inc. | Diagnostics based on tetrazolium compounds |
US6338790B1 (en) * | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US6377894B1 (en) * | 1998-11-30 | 2002-04-23 | Abbott Laboratories | Analyte test instrument having improved calibration and communication processes |
US6193873B1 (en) * | 1999-06-15 | 2001-02-27 | Lifescan, Inc. | Sample detection to initiate timing of an electrochemical assay |
US6514769B2 (en) * | 1999-07-29 | 2003-02-04 | Jin Po Lee | Multiple analyte assay device with sample integrity monitoring system |
US6531040B2 (en) * | 1999-08-02 | 2003-03-11 | Bayer Corporation | Electrochemical-sensor design |
US6525549B1 (en) * | 1999-08-04 | 2003-02-25 | Lre Technology Partner Gmbh | Method for determining the concentration of a substance in a liquid by measuring electrical current in a test strip |
US20040016642A1 (en) * | 1999-12-03 | 2004-01-29 | Shoji Miyazaki | Biosensor |
US6881322B2 (en) * | 2000-01-25 | 2005-04-19 | Matsushita Electric Industrial Co., Ltd. | Measuring device using biosensor and biosenor used for it, and dedicated standard liquid |
US6860978B2 (en) * | 2000-03-08 | 2005-03-01 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method of producing the same |
US20030042150A1 (en) * | 2000-03-22 | 2003-03-06 | Jun-Oh Ryu | Electrochemical biosensor test strip with recognition electrode and readout meter using this test strip |
US20030024811A1 (en) * | 2000-03-28 | 2003-02-06 | Davies Oliver William Hardwicke | Continuous process for manufacture of disposable electro-chemical sensor |
US6716620B2 (en) * | 2000-04-17 | 2004-04-06 | Purdue Research Foundation | Biosensor and related method |
US6723371B2 (en) * | 2000-06-01 | 2004-04-20 | Bioptik Technology, Inc. | Process for preparing an electrochemical test strip |
US20020019707A1 (en) * | 2000-06-26 | 2002-02-14 | Cohen Alan M. | Glucose metering system |
US20020004196A1 (en) * | 2000-07-10 | 2002-01-10 | Bayer Corporation | Thin lance and test sensor having same |
US20020044890A1 (en) * | 2000-07-20 | 2002-04-18 | Hypoguard Limited | Test member |
US20030032875A1 (en) * | 2000-07-24 | 2003-02-13 | Yuko Taniike | Biosensor |
US6555061B1 (en) * | 2000-10-05 | 2003-04-29 | Lifescan, Inc. | Multi-layer reagent test strip |
US6540890B1 (en) * | 2000-11-01 | 2003-04-01 | Roche Diagnostics Corporation | Biosensor |
US6719887B2 (en) * | 2000-12-27 | 2004-04-13 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
US6841389B2 (en) * | 2001-02-05 | 2005-01-11 | Glucosens, Inc. | Method of determining concentration of glucose in blood |
US6525330B2 (en) * | 2001-02-28 | 2003-02-25 | Home Diagnostics, Inc. | Method of strip insertion detection |
US6541266B2 (en) * | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
US20030042137A1 (en) * | 2001-05-15 | 2003-03-06 | Therasense, Inc. | Biosensor membranes composed of polymers containing heterocyclic nitrogens |
US6549796B2 (en) * | 2001-05-25 | 2003-04-15 | Lifescan, Inc. | Monitoring analyte concentration using minimally invasive devices |
US20040005721A1 (en) * | 2001-05-29 | 2004-01-08 | Yuko Tanike | Biosensor |
US20030046811A1 (en) * | 2001-09-10 | 2003-03-13 | Eumed Biotechnology Co., Ltd. | New spacer forming method used for a biosensor |
US6676995B2 (en) * | 2001-11-28 | 2004-01-13 | Lifescan, Inc. | Solution striping system |
US6689411B2 (en) * | 2001-11-28 | 2004-02-10 | Lifescan, Inc. | Solution striping system |
US6856125B2 (en) * | 2001-12-12 | 2005-02-15 | Lifescan, Inc. | Biosensor apparatus and method with sample type and volume detection |
US6863800B2 (en) * | 2002-02-01 | 2005-03-08 | Abbott Laboratories | Electrochemical biosensor strip for analysis of liquid samples |
US20040020777A1 (en) * | 2002-06-03 | 2004-02-05 | Yoshiko Miyamoto | Biosensor |
US20050019212A1 (en) * | 2003-06-20 | 2005-01-27 | Bhullar Raghbir S. | Test strip with flared sample receiving chamber |
US20050016844A1 (en) * | 2003-06-20 | 2005-01-27 | Burke David W. | Reagent stripe for test strip |
US20050013731A1 (en) * | 2003-06-20 | 2005-01-20 | Burke David W. | Test strip with slot vent opening |
US20050008537A1 (en) * | 2003-06-20 | 2005-01-13 | Dan Mosoiu | Method and reagent for producing narrow, homogenous reagent stripes |
Cited By (216)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7666149B2 (en) | 1997-12-04 | 2010-02-23 | Peliken Technologies, Inc. | Cassette of lancet cartridges for sampling blood |
US8439872B2 (en) | 1998-03-30 | 2013-05-14 | Sanofi-Aventis Deutschland Gmbh | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8622930B2 (en) | 2001-06-12 | 2014-01-07 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7841992B2 (en) | 2001-06-12 | 2010-11-30 | Pelikan Technologies, Inc. | Tissue penetration device |
US9802007B2 (en) | 2001-06-12 | 2017-10-31 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8206319B2 (en) | 2001-06-12 | 2012-06-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8162853B2 (en) | 2001-06-12 | 2012-04-24 | Pelikan Technologies, Inc. | Tissue penetration device |
US8845550B2 (en) | 2001-06-12 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8123700B2 (en) | 2001-06-12 | 2012-02-28 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8721671B2 (en) | 2001-06-12 | 2014-05-13 | Sanofi-Aventis Deutschland Gmbh | Electric lancet actuator |
US8343075B2 (en) | 2001-06-12 | 2013-01-01 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8679033B2 (en) | 2001-06-12 | 2014-03-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8641643B2 (en) | 2001-06-12 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US8206317B2 (en) | 2001-06-12 | 2012-06-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8211037B2 (en) | 2001-06-12 | 2012-07-03 | Pelikan Technologies, Inc. | Tissue penetration device |
US7699791B2 (en) | 2001-06-12 | 2010-04-20 | Pelikan Technologies, Inc. | Method and apparatus for improving success rate of blood yield from a fingerstick |
US8016774B2 (en) | 2001-06-12 | 2011-09-13 | Pelikan Technologies, Inc. | Tissue penetration device |
US7988645B2 (en) | 2001-06-12 | 2011-08-02 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US8216154B2 (en) | 2001-06-12 | 2012-07-10 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7981055B2 (en) * | 2001-06-12 | 2011-07-19 | Pelikan Technologies, Inc. | Tissue penetration device |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US9694144B2 (en) | 2001-06-12 | 2017-07-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US8360991B2 (en) | 2001-06-12 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7909775B2 (en) | 2001-06-12 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8282577B2 (en) | 2001-06-12 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8382683B2 (en) | 2001-06-12 | 2013-02-26 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7850622B2 (en) | 2001-06-12 | 2010-12-14 | Pelikan Technologies, Inc. | Tissue penetration device |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US8388551B2 (en) | 2002-04-19 | 2013-03-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for multi-use body fluid sampling device with sterility barrier release |
US8382682B2 (en) | 2002-04-19 | 2013-02-26 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8435190B2 (en) | 2002-04-19 | 2013-05-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8414503B2 (en) | 2002-04-19 | 2013-04-09 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8403864B2 (en) | 2002-04-19 | 2013-03-26 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7833171B2 (en) | 2002-04-19 | 2010-11-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7731729B2 (en) | 2002-04-19 | 2010-06-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7862520B2 (en) | 2002-04-19 | 2011-01-04 | Pelikan Technologies, Inc. | Body fluid sampling module with a continuous compression tissue interface surface |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US7874994B2 (en) | 2002-04-19 | 2011-01-25 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9724021B2 (en) | 2002-04-19 | 2017-08-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7909774B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909777B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7914465B2 (en) | 2002-04-19 | 2011-03-29 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7938787B2 (en) | 2002-04-19 | 2011-05-10 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7959582B2 (en) | 2002-04-19 | 2011-06-14 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8430828B2 (en) | 2002-04-19 | 2013-04-30 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7988644B2 (en) | 2002-04-19 | 2011-08-02 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8007446B2 (en) | 2002-04-19 | 2011-08-30 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9498160B2 (en) | 2002-04-19 | 2016-11-22 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US8062231B2 (en) | 2002-04-19 | 2011-11-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8079960B2 (en) | 2002-04-19 | 2011-12-20 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8690796B2 (en) | 2002-04-19 | 2014-04-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8337420B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9089294B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8905945B2 (en) | 2002-04-19 | 2014-12-09 | Dominique M. Freeman | Method and apparatus for penetrating tissue |
US8197421B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8197423B2 (en) | 2002-04-19 | 2012-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8202231B2 (en) | 2002-04-19 | 2012-06-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9186468B2 (en) | 2002-04-19 | 2015-11-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089678B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8333710B2 (en) | 2002-04-19 | 2012-12-18 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US9072842B2 (en) | 2002-04-19 | 2015-07-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8157750B2 (en) | 2002-12-30 | 2012-04-17 | Roche Diagnostics Operations, Inc. | Integrated analytical test element |
US20060100543A1 (en) * | 2002-12-30 | 2006-05-11 | Raney Charles C | Integrated Analytical Test Element |
US7214200B2 (en) | 2002-12-30 | 2007-05-08 | Roche Diagnostics Operations, Inc. | Integrated analytical test element |
US7708703B2 (en) | 2002-12-30 | 2010-05-04 | Roche Diagnostics Operations, Inc. | Integrated analytical test element |
US20100113978A1 (en) * | 2002-12-30 | 2010-05-06 | Raney Charles C | Integrated analytical test element |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8251921B2 (en) | 2003-06-06 | 2012-08-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US10034628B2 (en) | 2003-06-11 | 2018-07-31 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US8945910B2 (en) | 2003-09-29 | 2015-02-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US9561000B2 (en) | 2003-12-31 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US8296918B2 (en) | 2003-12-31 | 2012-10-30 | Sanofi-Aventis Deutschland Gmbh | Method of manufacturing a fluid sampling device with improved analyte detecting member configuration |
US9261476B2 (en) | 2004-05-20 | 2016-02-16 | Sanofi Sa | Printable hydrogel for biosensors |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US11883164B2 (en) | 2004-07-13 | 2024-01-30 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US10898114B2 (en) | 2005-03-10 | 2021-01-26 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918318B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10743801B2 (en) | 2005-03-10 | 2020-08-18 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10856787B2 (en) | 2005-03-10 | 2020-12-08 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610137B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11000213B2 (en) | 2005-03-10 | 2021-05-11 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610135B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11051726B2 (en) | 2005-03-10 | 2021-07-06 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610136B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918317B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10617336B2 (en) | 2005-03-10 | 2020-04-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10925524B2 (en) | 2005-03-10 | 2021-02-23 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10716498B2 (en) | 2005-03-10 | 2020-07-21 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10709364B2 (en) | 2005-03-10 | 2020-07-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918316B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US8652320B2 (en) * | 2005-06-08 | 2014-02-18 | Abbott Laboratories | Biosensors and methods of preparing same |
US20130032284A1 (en) * | 2005-06-08 | 2013-02-07 | Abbott Diabetes Care Inc. | Biosensors and Methods of Preparing Same |
US9535028B2 (en) | 2005-06-08 | 2017-01-03 | Abbott Diabetes Care Inc. | Biosensors and methods of preparing same |
WO2007022215A3 (en) * | 2005-08-16 | 2007-06-21 | Home Diagnostics Inc | Method for test strip manufacturing and analysis |
US20070040567A1 (en) * | 2005-08-16 | 2007-02-22 | Natasha Popovich | Method for test strip manufacturing and test card analysis |
WO2007022215A2 (en) * | 2005-08-16 | 2007-02-22 | Home Diagnostics, Inc. | Method for test strip manufacturing and analysis |
US8880138B2 (en) | 2005-09-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Device for channeling fluid and methods of use |
US20120022352A1 (en) * | 2005-10-12 | 2012-01-26 | Masaki Fujiwara | Blood sensor, blood testing apparatus, and method for controlling blood testing apparatus |
US7510985B1 (en) | 2005-10-26 | 2009-03-31 | Lpkf Laser & Electronics Ag | Method to manufacture high-precision RFID straps and RFID antennas using a laser |
US7826879B2 (en) | 2006-02-28 | 2010-11-02 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US9031630B2 (en) | 2006-02-28 | 2015-05-12 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US7822455B2 (en) | 2006-02-28 | 2010-10-26 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US9844329B2 (en) | 2006-02-28 | 2017-12-19 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US7465597B2 (en) | 2006-06-29 | 2008-12-16 | Home Diagnostics, Inc. | Method of manufacturing a diagnostic test strip |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US20090227898A1 (en) * | 2006-10-15 | 2009-09-10 | Hans-Peter Haar | Diagnostic test element and process for its production |
US8052618B2 (en) * | 2006-10-15 | 2011-11-08 | Roche Diagnostics Operations, Inc. | Diagnostic test element and process for its production |
US20090288964A1 (en) * | 2006-12-13 | 2009-11-26 | Sung-Kwon Jung | Biosensor with coded information and method for manufacturing the same |
US9636450B2 (en) | 2007-02-19 | 2017-05-02 | Udo Hoss | Pump system modular components for delivering medication and analyte sensing at seperate insertion sites |
US8617069B2 (en) | 2007-06-21 | 2013-12-31 | Abbott Diabetes Care Inc. | Health monitor |
US11276492B2 (en) | 2007-06-21 | 2022-03-15 | Abbott Diabetes Care Inc. | Health management devices and methods |
US20080319295A1 (en) * | 2007-06-21 | 2008-12-25 | Abbott Diabetes Care, Inc. | Health management devices and methods |
US8597188B2 (en) | 2007-06-21 | 2013-12-03 | Abbott Diabetes Care Inc. | Health management devices and methods |
US11264133B2 (en) | 2007-06-21 | 2022-03-01 | Abbott Diabetes Care Inc. | Health management devices and methods |
US20090042306A1 (en) * | 2007-08-06 | 2009-02-12 | Reynolds Jeffery S | System and Method for Automatic Calibration |
US7981678B2 (en) | 2007-08-06 | 2011-07-19 | Bayer Healthcare Llc | System and method for automatic calibration |
US20090117571A1 (en) * | 2007-08-15 | 2009-05-07 | State of Oregon by and through the State Board of Higher Education on behalf of Portland State Univ. | Impedance spectroscopy of biomolecules using functionalized nanoparticles |
FR2921157A1 (en) * | 2007-09-18 | 2009-03-20 | Saint Gobain | ELECTRODE FOR MICROFLUIDIC SYSTEM |
WO2009044063A1 (en) * | 2007-09-18 | 2009-04-09 | Saint-Gobain Glass France | Electrode for a microfluid system |
EP3290522A1 (en) | 2007-10-31 | 2018-03-07 | Roche Diabetes Care GmbH | Electrical patterns for biosensor and method of making |
US8603308B2 (en) | 2007-10-31 | 2013-12-10 | Roche Diagnostics Operations, Inc. | Electrical patterns for biosensor and method of making |
US20110000785A1 (en) * | 2007-10-31 | 2011-01-06 | Raghbir Singh Bhullar | Electrical patterns for biosensor and method of making |
US20090113981A1 (en) * | 2007-11-06 | 2009-05-07 | Bayer Healthcare, Llc | Auto-calibrating test sensors |
US8241488B2 (en) | 2007-11-06 | 2012-08-14 | Bayer Healthcare Llc | Auto-calibrating test sensors |
US20090125268A1 (en) * | 2007-11-11 | 2009-05-14 | Bayer Healthcare Llc | Biosensor Coding System |
US7809512B2 (en) | 2007-11-11 | 2010-10-05 | Bayer Healthcare Llc | Biosensor coding system |
US20090205399A1 (en) * | 2008-02-15 | 2009-08-20 | Bayer Healthcare, Llc | Auto-calibrating test sensors |
US8802006B2 (en) | 2008-04-10 | 2014-08-12 | Abbott Diabetes Care Inc. | Method and system for sterilizing an analyte sensor |
US8252229B2 (en) | 2008-04-10 | 2012-08-28 | Abbott Diabetes Care Inc. | Method and system for sterilizing an analyte sensor |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US20090294277A1 (en) * | 2008-05-30 | 2009-12-03 | Abbott Diabetes Care, Inc. | Method and system for producing thin film biosensors |
US10328201B2 (en) | 2008-07-14 | 2019-06-25 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
US11621073B2 (en) | 2008-07-14 | 2023-04-04 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
US20100084466A1 (en) * | 2008-10-07 | 2010-04-08 | Bayer Healthcare Llc | Method of forming an auto-calibration circuit or label |
US8424763B2 (en) | 2008-10-07 | 2013-04-23 | Bayer Healthcare Llc | Method of forming an auto-calibration circuit or label |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US11213229B2 (en) | 2009-02-03 | 2022-01-04 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11166656B2 (en) | 2009-02-03 | 2021-11-09 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11202591B2 (en) | 2009-02-03 | 2021-12-21 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006870B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006872B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006871B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US8685229B2 (en) | 2009-03-30 | 2014-04-01 | Roche Diagnostics Operations, Inc. | Biosensor with predetermined dose response curve and method of manufacturing |
WO2010112168A1 (en) | 2009-03-30 | 2010-10-07 | Roche Diagnostics Gmbh | Biosensor with predetermined dose response curve and method of manufacturing |
US20100243441A1 (en) * | 2009-03-30 | 2010-09-30 | Henning Groll | Biosensor with predetermined dose response curve and method of manufacturing |
US8608937B2 (en) | 2009-03-30 | 2013-12-17 | Roche Diagnostics Operations, Inc. | Biosensor with predetermined dose response curve and method of manufacturing |
KR101293361B1 (en) * | 2009-03-30 | 2013-08-07 | 에프. 호프만-라 로슈 아게 | Biosensor with predetermined dose response curve and method of manufacturing |
EP2594939A1 (en) | 2009-03-30 | 2013-05-22 | Roche Diagniostics GmbH | Biosensor with predetermined dose response curve and method of manufacturing |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11872370B2 (en) | 2009-05-29 | 2024-01-16 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US10827954B2 (en) | 2009-07-23 | 2020-11-10 | Abbott Diabetes Care Inc. | Continuous analyte measurement systems and systems and methods for implanting them |
US9795326B2 (en) | 2009-07-23 | 2017-10-24 | Abbott Diabetes Care Inc. | Continuous analyte measurement systems and systems and methods for implanting them |
US10492685B2 (en) | 2009-08-31 | 2019-12-03 | Abbott Diabetes Care Inc. | Medical devices and methods |
USD1010133S1 (en) | 2009-08-31 | 2024-01-02 | Abbott Diabetes Care Inc. | Analyte sensor assembly |
US10136816B2 (en) | 2009-08-31 | 2018-11-27 | Abbott Diabetes Care Inc. | Medical devices and methods |
US9360444B2 (en) * | 2010-02-19 | 2016-06-07 | Schlumberger Technology Corporation | Fluid sensor and method of using same |
US20130027042A1 (en) * | 2010-02-19 | 2013-01-31 | Schlumberger Technology Corporation | Fluid Sensor and Method of Using Same |
US9011658B2 (en) | 2010-03-30 | 2015-04-21 | Jabil Circuit (Singapore) Pte, Ltd. | Sampling plate |
US8894832B2 (en) | 2010-03-30 | 2014-11-25 | Jabil Circuit (Singapore) Pte, Ltd. | Sampling plate |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
WO2012003306A1 (en) * | 2010-06-30 | 2012-01-05 | Roche Diagnostics Operations, Inc. | Methods for manufacturing a dual biosensor test strip |
CN103038637A (en) * | 2010-06-30 | 2013-04-10 | 霍夫曼-拉罗奇有限公司 | Methods for manufacturing a dual biosensor test strip |
US8468680B2 (en) | 2010-08-24 | 2013-06-25 | Roche Diagnostics Operations, Inc. | Biosensor test member and method for making the same |
US8920728B2 (en) | 2010-08-24 | 2014-12-30 | Roche Diagnostics Operations, Inc. | Biosensor test member and method for making the same |
US8793865B2 (en) | 2010-08-24 | 2014-08-05 | Roche Diagnostics Operations, Inc. | Biosensor test member and method for making the same |
WO2012025208A1 (en) * | 2010-08-24 | 2012-03-01 | Roche Diagnostics Gmbh | Biosensor test member and method for making the same |
US9532737B2 (en) | 2011-02-28 | 2017-01-03 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US9069536B2 (en) | 2011-10-31 | 2015-06-30 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
US9465420B2 (en) | 2011-10-31 | 2016-10-11 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
GB2501128B (en) * | 2012-04-13 | 2017-11-29 | Tape Specialities Ltd | Sampling Apparatus and Method for Sampling |
US10641724B2 (en) | 2012-04-13 | 2020-05-05 | Smartcase Technologies Limited | Electrical impedance hematocrit and HBA1C biosensor comprising sample plate and sample apparatus |
GB2501128A (en) * | 2012-04-13 | 2013-10-16 | Phillip J Ainger | Resistance measurements across first and second electrode pairs to determine glucose and packed cell volume respectively |
US11415541B2 (en) | 2012-04-13 | 2022-08-16 | Smartcare Technologies Ltd | Electrical impedance hematocrit and HbA1c biosensor comprising sample plate and sample apparatus |
GB2548295A (en) * | 2012-04-13 | 2017-09-13 | J Ainger Phillip | Sampling apparatus and method for sampling |
GB2548295B (en) * | 2012-04-13 | 2017-11-29 | Tape Specialities Ltd | Sampling apparatus and method for sampling |
US8992750B1 (en) | 2012-07-02 | 2015-03-31 | Roche Diagnostics Operations, Inc. | Biosensor and methods for manufacturing |
US10066253B2 (en) | 2013-11-27 | 2018-09-04 | Phc Holdings Corporation | Method of measuring blood component amount |
CN105793700A (en) * | 2013-11-27 | 2016-07-20 | 松下健康医疗控股株式会社 | Method of measuring blood component amount |
US10913064B2 (en) | 2014-04-16 | 2021-02-09 | Abbott Laboratories | Droplet actuator fabrication apparatus, systems, and related methods |
CN108656746A (en) * | 2014-04-16 | 2018-10-16 | 雅培制药有限公司 | Droplet actuator manufacturing device, system and correlation technique |
US20150298124A1 (en) * | 2014-04-16 | 2015-10-22 | Abbott Laboratories | Droplet actuator fabrication apparatus, systems, and related methods |
CN107209141A (en) * | 2015-01-26 | 2017-09-26 | 生命扫描苏格兰有限公司 | The reference electrode error trap determined from predetermined sampling time interval and scheduled sampling time |
US9423374B2 (en) * | 2015-01-26 | 2016-08-23 | Lifescan Scotland Limited | Reference electrode error trap determined from a specified sampling time and a pre-determined sampling time |
CN105718504A (en) * | 2015-12-26 | 2016-06-29 | 小米科技有限责任公司 | Method and device for determining positioning information corresponding to address information |
EP3457121A1 (en) * | 2017-09-18 | 2019-03-20 | Roche Diabetes Care GmbH | Electrochemical sensor and sensor system for detecting at least one analyte |
US11774394B2 (en) | 2017-09-18 | 2023-10-03 | Roche Diabetes Care, Inc. | Electrochemical sensor and sensor system for detecting at least one analyte |
WO2019053246A1 (en) * | 2017-09-18 | 2019-03-21 | Roche Diabetes Care Gmbh | Electrochemical sensor and sensor system for detecting at least one analyte |
CN111094961A (en) * | 2017-09-18 | 2020-05-01 | 豪夫迈·罗氏有限公司 | Electrochemical sensor and sensor system for detecting at least one analyte |
JP2020534532A (en) * | 2017-09-18 | 2020-11-26 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | Electrochemical sensors and sensor systems for detecting at least one analyte |
Also Published As
Publication number | Publication date |
---|---|
US8551308B2 (en) | 2013-10-08 |
US20090020502A1 (en) | 2009-01-22 |
US20090056120A1 (en) | 2009-03-05 |
US8287703B2 (en) | 2012-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8551308B2 (en) | Biosensor and method of making | |
US7386937B2 (en) | Method of making a biosensor | |
US10386322B2 (en) | Method for determining the concentration of an analyte in a liquid sample using small volume samples and fast test times | |
US7276146B2 (en) | Electrodes, methods, apparatuses comprising micro-electrode arrays | |
US8603308B2 (en) | Electrical patterns for biosensor and method of making | |
CA2387283C (en) | Biosensor | |
JP2005037406A (en) | Biosensor, electrode set used for biosensor, and method for forming biosensor | |
US8399070B2 (en) | Method of defining electrodes using laser-ablation and dielectric material | |
Bhullar et al. | Biosensor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ROCHE DIAGNOSTICS OPERATIONS, INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BHULLAR, RAGHBIR S.;SURRIDGE, NIGEL A.;DIEBOLD, ERIC R.;AND OTHERS;REEL/FRAME:015200/0051;SIGNING DATES FROM 20040910 TO 20040917 Owner name: ROCHE DIAGNOSTICS OPERATIONS, INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BHULLAR, RAGHBIR S.;SURRIDGE, NIGEL A.;DIEBOLD, ERIC R.;AND OTHERS;REEL/FRAME:015199/0954 Effective date: 20040917 |
|
AS | Assignment |
Owner name: CORANGE INTERNATIONAL LIMITED,BERMUDA Free format text: ASSIGNOR HEREBY CONFIRMS THE ASSIGNMENT TO CORANGE INTERNATIONAL LIMITED OF AN UNDIVIDED ONE-HALF INTEREST IN EACH OF THE APPLICATIONS;ASSIGNOR:ROCHE DIAGNOSTICS OPERATIONS, INC.;REEL/FRAME:019419/0381 Effective date: 20070611 Owner name: CORANGE INTERNATIONAL LIMITED, BERMUDA Free format text: ASSIGNOR HEREBY CONFIRMS THE ASSIGNMENT TO CORANGE INTERNATIONAL LIMITED OF AN UNDIVIDED ONE-HALF INTEREST IN EACH OF THE APPLICATIONS;ASSIGNOR:ROCHE DIAGNOSTICS OPERATIONS, INC.;REEL/FRAME:019419/0381 Effective date: 20070611 |
|
AS | Assignment |
Owner name: ROCHE OPERATIONS LTD., BERMUDA Free format text: CHANGE OF NAME;ASSIGNOR:CORANGE INTERNATIONAL LIMITED;REEL/FRAME:022634/0371 Effective date: 20080715 Owner name: ROCHE OPERATIONS LTD.,BERMUDA Free format text: CHANGE OF NAME;ASSIGNOR:CORANGE INTERNATIONAL LIMITED;REEL/FRAME:022634/0371 Effective date: 20080715 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: ROCHE DIABETES CARE, INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ROCHE DIAGNOSTICS OPERATIONS, INC.;REEL/FRAME:036008/0670 Effective date: 20150302 |